tag:blogger.com,1999:blog-58762572410742223262024-03-13T21:18:13.724-07:00The Lyme Disease Sentinel BlogUnknownnoreply@blogger.comBlogger411125tag:blogger.com,1999:blog-5876257241074222326.post-16605782026028001882017-05-15T07:22:00.000-07:002017-05-15T07:22:54.174-07:00Munchausen's By Proxy and Government Control Of Our Children<div dir="ltr" style="text-align: left;" trbidi="on">
<span style="font-size: large;"><br /></span>
<span style="font-size: large;">I was just watching the news and am very concerned as to where parent's
rights are headed...especially where parents of Lyme patients and children with other vague illnesses are
concerned. Often the media/governments take advantage of legitimate
issues. I think today's news item is an example. Most of us have heard
of or know parents of Lyme patients who have been labeled with
Munchhausen's Syndrome and have even had their children taken away due
to this MISdiagnosis. There is a huge increase in autoimmune/chronic dis<span class="text_exposed_show">eases
that have no legitimate tests or causes and people are being either
assigned meaningless labels or told that it is all in their heads. </span></span><br />
<br />
<span style="font-size: large;"><span class="text_exposed_show">Big
news today on Good Morning America was about a girl who was abused by her mother who had made
her sick or faked her illnesses all her life to get attention for
herself. After many years of abuse the daughter ( Gypsy Blanchard) killed the mother and is
in jail. HBO is coming out with a documentary about it. Because
this is being highlighted in the news...I am suspicious. This may or may
not have happened but I think they may use incidents like this to gain
further control over children, their parents, and perhaps even to hide
some of our chronic illness pandemic. Many Lyme parents try so hard to get
treatment for their children because the medical community is
intentionally kept in the dark as to the symptom complex of Lyme disease and it's co-infections... viral and bacterial. Many of the parents have had Lyme disease themselves so they know how this disease can present in a confusing array of symptoms. Often they have been told it is all in their heads or that they have some mysterious autoimmune disease. I know this from personal experience.</span></span><br />
<br />
<span style="font-size: large;"><span class="text_exposed_show">Testing is inaccurate and symptoms can often affect every system of the
body so then people are labeled as either malingering or as having parents who must be afflicted with Munchausen's by Proxy. It's criminal! There may be some real cases of this
but I never heard of this syndrome till after Lyme disease came on the scene, which is when the diagnosis became more popular. I think that after this movie doctors are going to be even
more suspicious of Lyme parents or parents of those children who may have tick co-infections or retroviruses and other microbes, some of which may be genetically engineered. Doctors are told there is no such thing as chronic active Lyme disease, which we know is a falsehood. There are many studies (which are being ignored by the mainstream) which show that Lyme can be a chronic active or relapsing infection. It can also be passed through the placenta.</span></span><br />
<span style="font-size: large;"><span class="text_exposed_show"><br /></span></span>
<span style="font-size: large;"><span class="text_exposed_show">In an interview, Aaron Russo talked about how Nick Rockefeller admitted that part of the plan was to gain more control over the children and separate them from their parents. This is a tactic used to mold the new generation to whatever desired goals those who are currently in control want to bring about. There are many different ways that are being used to gain control over the children. When both parents work and the children are left with the school or others, then the children's values and ideas are molded more by whomever they spend the most time with. After school parents bring their children to sports where they usually do not interact with their children but only observe from the sidelines. "It takes a village to raise a child" has become a popular propaganda statement.</span></span><br />
<br />
<span style="font-size: large;"><span class="text_exposed_show">There seems to be a movement towards making parents seem incapable of raising their own children. Yes there are legitimate cases of abuse but this legitimate issue is being used to gradually take away parent's rights to raise their own children. If you will notice...many of Lois Lowry's children's books are about women who are assigned to be birth mothers and then the children go to other caretakers. Eugenics is also highlighted . I think that these are rather bizarre themes for children's books. The excuse given as to why these books are acceptable is......because it is warning people that this could happen in our society if we are not vigilant.</span></span><br />
<br />
<span style="font-size: large;"><span class="text_exposed_show"> Well...it seems to be having the opposite effect....more like predictive programming. I don't think that most children are having the discussion with their teachers or parents that for example......forms of eugenics are already taking place. One example......abortion when one discovers they may be carrying a Down's Syndrome child is becoming more popular. I say...let's find out the cause of Down's Syndrome instead. Some feel that it has to do with parental diet before and during conception...as often Down Syndrome children are born to older mothers who may have depleted their body's store of essential nutrients from previous pregnancies. However, our modern drug oriented society does not like to look at uncovering causes because there is less profit when finding the cause of disease.</span></span><br />
<span style="font-size: large;"><span class="text_exposed_show"><br /></span></span>
<span style="font-size: large;"><span class="text_exposed_show">Instead of increasingly blaming parents for their child's illnesses...let's uncover the deception and the real causes of these chronic illnesses and deadly cancers...which may have to do with vaccines, genetic engineering of microbes and our food, pesticides in our food and water, poor parental diet...etc.</span></span><br />
<span style="font-size: large;"><span class="text_exposed_show"><br /></span></span>
<span style="font-size: large;"><span class="text_exposed_show"><a href="http://abcnews.go.com/GMA/video/father-gypsy-blanchard-speaks-mommy-dead-dearest-47410578">http://abcnews.go.com/GMA/video/father-gypsy-blanchard-speaks-mommy-dead-dearest-47410578</a></span></span><br />
<span style="font-size: large;"><span class="text_exposed_show"><br /></span></span>
<span style="font-size: large;"><span class="text_exposed_show"><br /></span></span>
<span class="text_exposed_show"><span style="font-size: large;">VERY IMPORTANT LINK: <a href="https://sites.google.com/site/drjoneskids/symptoms-literature/munchausen-by-proxy">VERY IMPORTANT LINK</a></span></span></div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-5876257241074222326.post-52997775680687810612017-01-26T08:52:00.000-08:002017-01-27T03:30:05.409-08:00TMJ, Malocclusion, Lyme Disease, Substance P, and Overall Health<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
While watching a video concerning malocclusion, TMJ and Substance P, I came across some extremely interesting information that may be helpful to patients with tickborne illness. I will leave the link to this video at the bottom. The speaker being interviewed, Dr Dwight Jennings ( a neuromuscular dentist), shared some fascinating ideas and facts. Here are some of the facts he shared.When someone's bite is misaligned, the body produces a huge amount of substance P, which can cause systemic inflammation in the body. Many things can increase substance P in the body but TMJ/ misalignment is a major factor. Dr. Jennings says that 95% of Lyme patients have TMJ issues......a very high correlation. Systemic inflammation from the substance P allows the spirochete to grow. Substance P opens up cell membranes wide enough to allow the spirochete into the cell. Substance P also controls the collagen/ ligament matrix. If your substance P is high, you don't make high grade collagen. This may be one reason why Lyme patients are so hyper-mobile and have problems with ligament tears and repair.<br />
<br />
The trigeminal vascular system is also affected by misalignment of the jaw.<br />
Lack of blood flow to the frontal cortex can be a result. Correcting the misalignment can be helpful in strengthening the immune system, along with other modalities that target substance P, such as cayenne pepper, etc. If a person feels that misalignment is a problem for him, then it is extremely important to find the right type of dentist which offers the proper treatment. One does not just want to align the teeth...but it's the alignment of the actual jaw that makes the difference. The video below speaks to the issue of what type of dentist specializes in jaw alignment. Your top front teeth and your bottom front teeth need to meet together tip to tip. Many dentists think that the bottom front teeth should be slightly in back of the front top teeth but this is not so. Our ancestors' teeth met tip to tip because of their natural indigenous diet. Today our jaws are so malformed that most of us no longer have adequate room for all of our teeth. The parent's diet determines the shape and size of the child's skeleton.<br />
<br />
Parkinson's, Autism, Multiple Sclerosis, Fibromyalgia, IBS, and Chronic Fatigue Syndrome can often be helped by aligning the jaw. <br />
<div dir="ltr" id="yiv4578752236yui_3_16_0_ym19_1_1485446163967_5269">
<br /></div>
<div dir="ltr" id="yiv4578752236yui_3_16_0_ym19_1_1485446163967_5277">
Many people of the baby boom generation have underdeveloped jaws due to their parent's eating more refined foods than previous generations. The fact that many baby boomers were NOT breast fed also plays a prominent role in why all of our teeth do not fit into our jaws. The jaws can be expanded...even in adults....with the proper devices. Check out this hour video. I found it fascinating!<br />
<br /></div>
</div>
<iframe allowfullscreen="" frameborder="0" height="480" src="https://www.youtube.com/embed/-_CJZi9EEaw" width="854"></iframe></div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-5876257241074222326.post-76914676916438976072016-05-14T06:25:00.002-07:002016-05-14T06:25:06.726-07:00Hiatal Hernia: A Hidden Factor In Chronic Illness<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
A growing number of doctors and researchers are finding that many of those with chronic illness, such as Lyme disease, Chronic Fatigue Syndrome, fibromyalgia, and cancer was even mentioned, will have hiatal hernias as one of the main factors contributing to their illness. Here is a definition of hiatal hernia from medicinenet.com. "An anatomical abnormality in which part of the stomach protrudes up through the diaphragm into the chest." Here are just some of the many symptoms that have been corrected by pulling the stomach down into it's proper position.<br />
Indigestion<br />
Heartburn<br />
Constipation or Diarrhea<br />
Gas and bloating<br />
Asthma<br />
Nausea<br />
Colic in children<br />
Diminished or excessive appetite<br />
Fatigue<br />
Pain in throat, chest, shoulder, spine<br />
Can't take a deep breath or breathe from the abdomen <br />
Allergies<br />
Full feeling at base of throat<br />
Tachycardia<br />
Heaviness at stomach level<br />
Pressure in Chest<br />
Orthostatic hypotension<br />
IBS<br />
Slow gastric emptying<br />
And many more symptoms which you can find in Dr. Baroody's groundbreaking book "Hiatal Hernia Syndrome, The Mother of All Illness, Guide To Self Healing" or at the following link.<br />
<a href="http://castlehighkingdom.proboards.com/thread/99">http://castlehighkingdom.proboards.com/thread/99</a><br />
<br />
Here is a quote from the preface of Dr. Baroody's book. "There is no doubt after many years of wrestling with this invisible plague that my original statistics of 85% of our population being afflicted with the Hiatal Hernia Syndrome to a greater or lesser extent are accurate....maybe even low. Digestion is the key. Without the digestive system completely "on line" all other systems are doomed to break down eventually. Vagus nerve disruption by the Hiatal Hernia Syndrome is the major cause. Dr. Carey Reams, probably the most eminent biochemist of our time, stated again and again that illness begins with vagus nerve problems."<br />
Dr. Baroody covers this issue extensively in his book. His book also contains much helpful information on how to naturally prevent and cure Hiatal Hernia Syndrome (HHS) through massage and chiropractic movements, diet, exercise, and more. Some corrections need to be done by a chiropractor and other techniques can be self applied. A family member or friend can also be taught how to do the corrections. Lifestyle often needs to be modified.<br />
<br />
When the stomach is forced upward by gas and certain movements, and it pushes against and weakens or tears the diaphragm, it can pinch the vagus nerve, which is responsible for many bodily functions. There does not have to be a tear in the diaphragm in order for the vagus nerve to be compressed. To complicate or confuse matters more, hernias can be sliding hernias. In other words, sometimes the stomach can be up in the esophagus and sometimes it can be in the proper position. I would think that this might prevent many people from being properly diagnosed. The placement of the stomach may shift depending on the position the patient is in.<br />
<br />
Surgery is available for this problem, however, surgery is invasive, can form scar tissue, and isn't always effective. It would seem wise to give these natural treatments a try for an adequate amount of time before resorting to the knife.<br />
<br />
I have personally observed that nausea, gas, burping, panic attacks, and other symptoms listed above can be relieved or put into remission by following the advice in Dr. Baroody's book and by applying the techniques shown in the videos below. It makes sense! Here's to your health!</div>
<br />
<br />
<br />
<iframe allowfullscreen="" frameborder="0" height="360" src="https://www.youtube.com/embed/hrdNfaanpIs" width="640"></iframe></div>
<br />
<iframe allowfullscreen="" frameborder="0" height="360" src="https://www.youtube.com/embed/xX0zKB2_-UM" width="640"></iframe></div>
<br />
<iframe allowfullscreen="" frameborder="0" height="360" src="https://www.youtube.com/embed/Td_mMidxqDM" width="640"></iframe></div>
Unknownnoreply@blogger.com1tag:blogger.com,1999:blog-5876257241074222326.post-78974450989906290752015-07-14T06:30:00.000-07:002015-07-14T06:30:33.638-07:00The Brain, Alzheimer's and Infection<div dir="ltr" style="text-align: left;" trbidi="on">
Competent and respected researchers are discovering oral spirochetes and Lyme disease spirochetes(germs) in the brains of Alzheimer's patients. Several studies have shown these pathogens in 100% of the Autopsied Alzheimer's brains and in zero % of the healthy controls. <a href="http://www.miklossy.ch/58601.html">http://www.miklossy.ch/58601.html</a> and <a href="http://alzheimerborreliosis.net/research/">http://alzheimerborreliosis.net/research/</a> The patient whose brain images are below, was sent for a Spect Scan of the brain before being treated for Lyme disease. This scan measures the blood flow to the brain and the radiologist compares the blood flow in patients to the blood flow patterns in specific disease conditions. In this specific case the radiologist reported that the first scan below was consistent with the images of blood flow in Alzheimer's disease. The patient whose scans are below became very ill in 1989 and was diagnosed with the obscure label of "Chronic Fatigue Syndrome" which doesn't label or describe a real disease but only the symptoms of an unidentified disease. Years later the patient below discovered, through blood testing, that he had Lyme disease and as a consequence of being misdiagnosed was left untreated for the cause of his problems for 8 years. This caused the disease to progress and affect many body systems and organs, including the brain.<br />
<br />
In the images below the yellow indicates blood flow in different areas of the brain. In the seventh image(from left to right) one can see a dramatic lack of blood flow to the frontal lobe. The other images also show scattered profusion (hypoperfusion) of blood to the brain. This particular first set of images with the low blood flow was pointed out by the radiologist as being consistent with blood perfusion to the brain in Alzheimer's disease. The patient was then treated for Lyme disease for a year, alternating with different antibiotics to try and match the proper antibiotic with the proper strains and forms of borrelia. This long term treatment was very successful. The patient reported that before the antibiotics, his ability to think and function was extremely hampered and after a year of treatment he was able to think and function much better.<br />
<br />
A year later, because the patient was greatly improved (altho not perfect) from a year of antibiotics, a second scan was done to document whether treatment had helped and whether the patient's condition correlated with the scan. Sure enough, the second scan below shows that the patient's brain was greatly improved and almost normal.<br />
<br />
Due to this improvement the patient was taken off of antibiotics, was fine for a while, and then began to gradually relapse or decline so another Spect scan was done a year or so later to validate the prescribing of more antibiotics. The last scan on this page shows that the patient's brain had declined almost to the severity of the first scan which was done before any antibiotic treatment. This test correlated with the patient's symptoms. The patient was put back on antibiotics and began to improve again. This patient now has his life back but from time to time goes back on short term antibiotics when symptoms flare.... to keep the disease under control...as the Lyme pathogen ( borrelia burgdorferi) is apparently never totally eliminated from the body<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://4.bp.blogspot.com/-OCUa00AgrjQ/VaT7BT_dkVI/AAAAAAAADVQ/CEPm14wYw1U/s1600/DSC_0536.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="640" src="http://4.bp.blogspot.com/-OCUa00AgrjQ/VaT7BT_dkVI/AAAAAAAADVQ/CEPm14wYw1U/s640/DSC_0536.jpg" width="486" /></a></div>
<a href="http://3.bp.blogspot.com/-CGwHRRmtXSw/VaT7A1dS9lI/AAAAAAAADVI/liHWA9NivCY/s1600/spect%2Bscan.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" height="640" src="http://3.bp.blogspot.com/-CGwHRRmtXSw/VaT7A1dS9lI/AAAAAAAADVI/liHWA9NivCY/s640/spect%2Bscan.jpg" width="514" /></a><br />
<br />
<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
<a href="http://2.bp.blogspot.com/-RR74_YBEzC0/VaT7B4IHH3I/AAAAAAAADVU/QC6xlfUA8TY/s1600/DSC_0538.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="596" src="http://2.bp.blogspot.com/-RR74_YBEzC0/VaT7B4IHH3I/AAAAAAAADVU/QC6xlfUA8TY/s640/DSC_0538.jpg" width="640" /></a></div>
The last scan above again shows lack of blood flow to the brain(patchy perfusion) but not quite as severe as before the patient had ever been treated with antibiotics. Of course when on long term antibiotics it is very important to take adequate probiotics to keep the gut microbes in balance.<br />
<br />
Unfortunately, as I have mentioned in previous posts, the medical industry that survives and thrives on profits is not really looking out for our best interests. The drug companies do not want to find the root causes of disease and then treat them because that would drastically cut into their profits. A population of chronically ill people is much more lucrative. Don't cure the people just create as many symptoms as you can so they have to take many different drugs to feel somewhat comfortable...even though the disease is progressing beneath the surface unidentified. I feel that this is what is happening with Alzheimer's and many other of our modern diseases. There is a disease label for every set of symptoms in the book. Anyone can make up labels for symptoms but we want to know the CAUSE! Why are people getting Alzheimer's at a younger and younger age? Common sense then says its NOT just due to old age! If the patient above did not first have a diagnosis of Lyme disease before having the Spect Scan....he most likely would have been diagnosed with Alzheimer's at the age of 44. We have to be our own advocates.</div>
Unknownnoreply@blogger.com2tag:blogger.com,1999:blog-5876257241074222326.post-63478772836379705992015-07-13T08:02:00.003-07:002015-07-13T09:36:30.493-07:00Alzheimer's Disease Caused By Infection<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
Our modern medical industry thrives on the chronically ill. Not too many people will dispute this obvious fact. The question is...how deep does this scenario go? While modern medicine has many helpful new technologies and surgery techniques, why do we require so much medical intervention to begin with? Having personal experience with Lyme disease, I have become aware of how the medical system actually operates. There is no <b>true</b> prevention involved...nor are cures and root causes examined. In fact root causes and legitimate prevention are often discouraged or intentionally covered up.<br />
<br />
Two prime examples of this corrupt and ineffective medical model can be found with Lyme Disease and with Alzheimer's Disease. Lyme disease has been labeled the Great Imitator...secondary only to Syphilis. The Lyme disease germ (borrelia burgdorferi), which is a spirochete as in syphilis, can affect just about every system and organ in the body and it's chronic form is being falsely labeled as many different conditions and diseases. Borrelia burgdorferi is a relapsing infection which will take advantage of a weaker immune system. This pathogenic microbe can also change shape, form biofilms (which protect the germ from antibiotics, from the body's immune system, and from showing up in blood testing). However, the studies that show these facts to be true are ignored by mainstream medicine. The general consensus concerning this strange situation is that the medical system is just stodgy and slow and does not want to accept new ideas. The general public is often not aware that conflicts of interest are most likely the reason why so many of us have chronic conditions.<br />
<br />
The pharmaceutical companies heavily influence what our doctors are taught in medical school and at medical conferences. Their ever-growing profits stem from only treating the symptoms and ignoring the cause. When the cause of disease is ignored, many symptoms appear throughout the body and many systems and organs can be affected. This causes the patient to be sent from one specialist to another to be prescribed specific drugs for each symptom. In the meantime the root cause or disease progresses <b>untreated </b>under the surface<b>.</b> It is believed, and starting to be proven, that Lyme disease and Alzheimer's are related in this manner. Medical science has proven that Syphilis can cause dementia. The plaques in the brain that cause dementia from Syphilis look identical to those found in the Alzheimer's brains where lyme and oral spirochetes are present. Why are corporate and government funded research institutions not spreading this news far and wide? Why is long term antibiotic treatment for lyme disease being discouraged when it is known that Borrelia burgdorferi can be a chronic relapsing infection? Yes, antibiotics can cause certain problems but didn't we learn that if you don't finish your antibiotics...meaning if you don't take enough of them to eradicate the disease...then this is what creates antibiotic resistance? Instead we are being led to<b> under-treat</b> which can create even more serious problems. We are also not informed of the fact that laboratories are intentionally creating antibiotic resistant germs for bio-warfare and also for supposedly benign purposes.<br />
<br />
It has been predicted that Alzheimer's will increase substantially because of the growing elderly population. However, dementia is NOT a normal part of aging so why are we being told that Alzheimer's will increase? This has been stated as an almost indisputable fact. I suspect that the cause of Alzheimer's is known and that the medical industry does not want the root cause(s) known so that the chronically ill population grows along with drug profits. Of course those with dementia may also die sooner which may lessen the burden on social security. That later point is just speculation.<br />
<br />
If this issue matters to you, take the time to watch the video below where Alan MacDonald talks about his research and the research of Judith Miklossy. Their research shows that Lyme disease and other spirochetes and infections appear to play a major role in dementia and Alzheimer's disease. Instead of raising money and handing it over to the corporate charities ,which never to seem to find cures, let's support the private researchers who are looking for the root cause of disease. Also below this video please check out the short video/interview with the very respected Swiss researcher Dr. Judith Miklossy, who is finding the same results as Dr. Macdonald concerning spirochetes as the cause of Alzheimer's. Periodontal issues also relate to how the spirochetes get into the brain. This is very important to understand.<br />
<br />
<br />
<a href="http://www.gofundme.com/z3v2a2k">http://www.gofundme.com/z3v2a2k </a><br />
<br /></div>
<iframe allowfullscreen="" frameborder="0" height="390" src="https://www.youtube.com/embed/pLcDp2kdQF0" width="640"></iframe></div>
<br />
<iframe allowfullscreen="" frameborder="0" height="390" src="https://www.youtube.com/embed/YOSnEF9qxXA" width="640"></iframe></div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-5876257241074222326.post-4227812803200922462015-05-15T05:06:00.001-07:002015-05-15T05:06:13.402-07:00A Possible New Treatment Or Cure For Lyme Disease?<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
There may be a new and very valuable application for a certain common ingredient in allergy medications. Lyme disease is fast becoming the most widespread and debilitating infectious disease in the world. It's boundaries are expanding exponentially and everywhere it spreads controversy reigns. People have a very difficult if sometimes impossible time getting appropriate treatment. While this pandemic is spreading, antibiotics are becoming harder to get....for more than one reason.<br />
<br />
A study published in Drug Design, Development and Therapy discovered that an antihistamine (Loratadine), found in allergy medications, prevented the mineral manganese from entering the cell wall of the Lyme disease pathogen (Borrelia burgdorferi). The lyme disease spirochete uses manganese for vital processes so when the antihistamine Loratadine is combined with Borrelia burgdorferi in a test tube, the pathogen starves to death. It would be an important breakthrough to find an effective treatment for Lyme disease. Antibiotics work but they are not always effective. If patients are partial to natural treatments over drugs, perhaps more research by patients, privately funded researchers, and naturopathic doctors, could reveal natural substances that also prevent manganese from entering the Lyme pathogen's cell wall. You won't find many government or corporate funded studies for natural treatments because patents cannot be developed...at least that is my understanding. There are many natural substances that act as antihistamines...such as...Reishi mushroom, Quercitin, Vitamin C, salt and water, Aloe vera, chamomile, ginger, stinging nettles, and wild oregano or bee balm. I'm sure there are many more examples that we are not aware of. The question is.....would any of these natural antihistamines have the same action as Loratadine? Drugs can be a useful tool but they tend to have more side effects over the natural remedies.<br />
<br />
Many Lyme disease patients also are burdened with allergic issues. Whether this just has something to with the straw that breaks the camel's back or whether the Lyme disease pathogen is directly responsible for food, chemical, and environmental allergies, has yet to be demonstrated. I am wondering if the antihistamine action of the antihistamine is also treating the allergic symptoms that are often attributed to Lyme disease....in addition to actually killing the spirochete.<br />
<br />
Below is a blurb and link to a post about the study.<br />
"Loratadine, an <a href="http://www.empr.com/Allergies/category/3/0" target="_self">antihistamine</a> found in over-the-counter allergy medicines, may be able to help kill the <a href="http://www.empr.com/Bacterial-infections/category/74/0" target="_self">bacteria</a> associated with <a href="http://www.empr.com/infectious-diseases/section/2000/" target="_self">Lyme disease</a> (<i>Borrelia burgdorferi</i>). Findings from this study are published in <i>Drug Design, Development and Therapy</i>." To read the more official version click at the link below<br />
<a href="http://www.empr.com/news/can-a-common-allergy-medication-help-treat-lyme-disease/article/397324/">http://www.empr.com/news/can-a-common-allergy-medication-help-treat-lyme-disease/article/397324/</a><br />
<br />
Here is another similar announcement on this possible breakthrough <a href="http://www.pharmacytimes.com/news/Could-Claritin-Cure-Lyme-Disease">http://www.pharmacytimes.com/news/Could-Claritin-Cure-Lyme-Disease</a> <br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://2.bp.blogspot.com/-sPNcWLrKW4M/VVXcev0aoOI/AAAAAAAADPQ/bya_x5e0JkU/s1600/DSC_0107.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="266" src="http://2.bp.blogspot.com/-sPNcWLrKW4M/VVXcev0aoOI/AAAAAAAADPQ/bya_x5e0JkU/s400/DSC_0107.JPG" width="400" /></a></div>
Stinging Nettles from my nettle patch. Start your own patch!<br />
<br />
I make Reishi mushroom tea and stinging nettle infusion which both support the adrenal glands, to calm the system and help with the allergic response. I have my own patch of stinging nettles (easy to grow but invasive) but buy my Reishi mushroom slices (that I make tea from) from Mountain Rose Herbs whom I have become affiliated with because I think they are a responsible company, have a wide selection of herbs (many or most of which are organic), and if you order in bulk you get a discount....which helps with shipping. Learn more about them at the link below. Here is a link to an article about stinging nettles and how they are a natural antihistamine <a href="http://lymesentinel.blogspot.com/2009/10/health-benefits-of-stinging-nettle.html">http://lymesentinel.blogspot.com/2009/10/health-benefits-of-stinging-nettle.html</a> and a link to a post which talks a bit about the health benefits and how to make Reishi mushroom tea. <a href="http://sootheandheal.blogspot.com/2011/03/medicinal-reishi-mushroom-tea.html">http://sootheandheal.blogspot.com/2011/03/medicinal-reishi-mushroom-tea.html</a> Often drug companies get their ideas from natural ingredients and then try to change the form somehow in order to be able to patent the substance. As I said before...drugs have their place but whole foods nourish and support the body rather than just attacking a specific symptom or germ. <br />
I find that when I stay away from stimulants, such as coffee, tea, and
alcohol and use adaptogens ...my overall health improves. So while we wait for more conclusive evidence that supports the finding that Loratadine helps to kill the Lyme disease pathogen......perhaps we can experiment with healthy natural alternatives that may have similar properties as the drug Loratadine.<br />
<br /></div>
<center>
<a border="0" href="https://www.mountainroseherbs.com/?AID=111632&BID=8039" target="_blank"><img alt="Mountain Rose Herbs" border="0" src="http://mountainroseblog.com/wp-content/uploads/2014/08/1-240x400.jpg" /></a></center>
</div>
Unknownnoreply@blogger.com1tag:blogger.com,1999:blog-5876257241074222326.post-59869670236141459282015-05-08T04:36:00.000-07:002015-05-08T04:36:23.319-07:00LYME DISEASE: THE NEW TUSKEGEE EXPERIMENT<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
The media constantly bombards us with tales of dangerous plaques sweeping the world...Ebola, West Nile Virus, SARS, Bird Flu, Plague, Measles....etc. How many of these diseases pose a very dangerous threat to the general population and have disabled or killed thousands in your area? I have been writing for years about the diversion tactics being used to take attention away from the real dangers while focusing on numerous disease scares that seem to vanish into thin air...sometimes reappearing when politically expedient.I have never known of anyone in recent times who have had any of the above diseases. Through the years of working and associating with people who have Lyme disease, I have noticed a very strange scenario. Doctors, instead of taking this disease seriously and treating it appropriately, often dismiss it and tell the patient their symptoms are all in their heads and that they need antidepressants (which does nothing for the underlying cause and allows the disease to progress). Doctors who treat Chronic Lyme with appropriate antibiotics often come under scrutiny and some lose their licenses to practice medicine. I have been to several protests and hearings involving these doctors who were brave enough to stand up to the "authorities".<br />
<br />
It is not totally clear why Lyme disease is such a political hot potato but some theories have to do with profits for the drug companies involving drugs which treat the many many symptoms of Lyme, an effort to disable our nation to integrate it into world government, another experiment to monitor patients who do not get adequate treatment (such as in the Tuskeegee Study carried out by the CDC with Syphilis and black men) and profits from vaccines and testing. Many very sick CHRONIC lyme patients are being denied proper antibiotics and/or any type of natural treatment which would help to boost the immune system. Instead the cause is completely covered up and the patient's problems are often given the disease labels of Depression, ALS, M.S, Parkinson's, Fibromyalgia, Chronicfatigue Syndrome, Alzheimer's, Etc....which all supposedly have no cure. Then we have disease charities for all of these disease labels. I have never known of a disease charity yet to find a cure for "their" disease. If they did find a cure they would be out of business.<br />
<br />
The disease complex called Lyme disease also includes viruses and other bacteria that can also be passed on through insect bites. Below is a video done by Randy Sykes who has been a tireless warrior for Lyme disease patients even though he himself is sick. He does the best he can in this video to show people documents and clips pf Lyme disease legislative hearings which prove that Lyme disease can be a persistent relapsing infection. It is often the issues that the Media outlets do NOT talk about that need attention and investigation. Don't believe all of their disease fear mongering of the latest plaque...especially if that "plaque" offers a vaccine!<br />
<br />
<br />
<br /></div>
<iframe allowfullscreen="" frameborder="0" height="360" src="https://www.youtube.com/embed/ow53uy1qElI?feature=player_embedded" width="640"></iframe></div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-5876257241074222326.post-71929445576267764762015-05-02T07:51:00.001-07:002015-05-02T07:51:52.730-07:00MORE EVIDENCE OF BACTERIAL INFECTION IN ALZHEIMER'S DISEASE<div dir="ltr" style="text-align: left;" trbidi="on">
Judith Miklossy , the author of the abstract below, has found in several studies, that different types of spirochetes ( oral spirochetes, Syphilis spirochetes and Lyme spirochetes ), are found in many autopsies of Alzheimer's brains and none in the control groups. Alan Macdonald , another Lyme disease researcher has found the same results. Why are we not hearing about this in the media? The media has predicted that Alzheimer's disease will significantly increase in the coming years. How do they know this? Government health agencies state that this will be due to the increase in the aging population. Healthy aging citizens should NOT get Alzheimer's disease and other forms of dementia do not have to be a normal part of aging. Diet and infections...and perhaps vaccines, play a critical role. The government health agencies/drug companies/media completely avoid discussing the Alzheimer's studies done by the above researchers. Alzheimer's seems to be increasing with the growing number of Lyme disease cases, invasive dental procedures....and the increase in flu shots for the elderly. Some researchers feel that gingivitis and dental work may play a role by providing a direct access to the brain by spirochetes and other microbes... through breeches in the oral cavity. This is known to happen with the heart...heart problems resulting from dental work or poor oral health in general.<br />
<br />
The abstract below also speaks about the amyloid plaques in Alzheimer's Disease and how brain colonies of spirochetes can form the filamentous plaques found in Alzheimer's. Let's start talking about this! Alzheimer's may or already has affected someone you know and love. There is a cause so let's not just look at symptomatic treatments....let's find the underlying cause before it is too late!<br />
For more info on bacteria and Alzheimer's Disease....check out the sidebar of this blog.<br /><div class="threadpane " id="yui_3_16_0_1_1430575935937_2327" tabindex="0">
<div class="message thread-content content " id="yui_3_16_0_1_1430575935937_2364" role="presentation">
<div class="thread-item-list" id="yui_3_16_0_1_1430575935937_2354" tabindex="-1">
<div class="thread-item expanded thread-focus" data-action="select-thread" data-mid="_AEUNiWIAAIoSVUTDDAyWqP/QqIc" id="yui_3_16_0_1_1430575935937_2361" role="section" style="height: auto; overflow: visible; transition: none 0s ease 0s;" tabindex="0">
<div class="thread-item-header" id="yui_3_16_0_1_1430575935937_2641" role="presentation">
<div class="contents" id="yui_3_16_0_1_1430575935937_2640" role="presentation">
<span class="loader" role="presentation"></span> <div class="loz" role="presentation">
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="thread-item-header" id="yui_3_16_0_1_1430575935937_2641" role="presentation">
<div class="contents" id="yui_3_16_0_1_1430575935937_2640" role="presentation">
<div class="loz" role="presentation">
</div>
</div>
<div class="thread-info" role="presentation">
<span class="thread-date" role="presentation"> <span class="short" role="presentation" title="Sat, May 2, 2015 at 8:29 AM"><br /><span class="ampm"></span></span> </span> </div>
</div>
<span> </span>
<div id="yiv2843361879ygrp-text">
<br />
<div class="yiv2843361879cit" id="yui_3_16_0_1_1430575935937_2515">
<b id="yui_3_16_0_1_1430575935937_2639"><big id="yui_3_16_0_1_1430575935937_2638">Historic evidence to support a causal
relationship between spirochetal infections and Alzheimer's
disease.
</big></b>
<div class="yiv2843361879auths" id="yui_3_16_0_1_1430575935937_2514">
Miklossy J.</div>
<i id="yui_3_16_0_1_1430575935937_2648">Frontiers in Aging Neuroscience</i>. 2015 Apr 16;7:46.
eCollection 2015.<br clear="none" />
<br clear="none" />
<a href="http://doi.org/10.3389/fnagi.2015.00046" id="yui_3_16_0_1_1430575935937_2649" rel="nofollow" shape="rect" target="_blank">http://doi.org/10.3389/fnagi.2015.00046</a><br clear="none" />
<br clear="none" />
<br clear="none" />
<big>Abstract</big><br clear="none" />
<br clear="none" />
Following previous observations a statistically significant
association between various types of spirochetes and Alzheimer’s
disease (AD) fulfilled Hill’s criteria in favor of a causal
relationship. If spirochetal infections can indeed cause AD, the
pathological and biological hallmarks of AD should also occur in
syphilitic dementia. <br clear="none" />
<br clear="none" />
To answer this question, observations and illustrations on the
detection of spirochetes in the atrophic form of general paresis,
which is known to be associated with slowly progressive dementia,
were reviewed and compared with the characteristic pathology of
AD. Historic observations and illustrations published in the first
half of the 20th Century indeed confirm that the pathological
hallmarks, which define AD, are also present in syphilitic
dementia. <br clear="none" />
<br clear="none" />
Cortical spirochetal colonies are made up by innumerable tightly
spiraled <i id="yui_3_16_0_1_1430575935937_2643">Treponema pallidum</i> spirochetes, which are
morphologically indistinguishable from senile plaques, using
conventional light microscopy. Local brain amyloidosis also occurs
in general paresis and, as in AD, corresponds to amyloid beta. <br clear="none" />
<br clear="none" />
These historic observations enable us to conclude that chronic
spirochetal infections can cause dementia and reproduce the
defining hallmarks of AD. They represent further evidence in
support a causal relationship between various spirochetal
infections and AD. They also indicate that local invasion of the
brain by these helically shaped bacteria reproduce the filamentous
pathology characteristic of AD. <br clear="none" />
<br clear="none" />
Chronic infection by spirochetes, and co-infection with other
bacteria and viruses should be included in our current view on the
etiology of AD. Prompt action is needed as AD might be prevented.</div>
<div class="yiv2843361879cit" id="yui_3_16_0_1_1430575935937_2515">
<br clear="none" />
<a href="http://www.miklossy.ch/473.html">http://www.miklossy.ch/473.html</a><br clear="none" />
<a href="http://doi.org/10.3389/fnagi.2015.00046" rel="nofollow" shape="rect" target="_blank">http://doi.org/10.3389/fnagi.2015.00046</a><br clear="none" />
<br clear="none" />
<b>Free, full text of this <i>Open Access</i> article, (pdf file,
2.5 MB)</b>:<br clear="none" />
<a href="http://journal.frontiersin.org/article/10.3389/fnagi.2015.00046/pdf" rel="nofollow" shape="rect" target="_blank">http://journal.frontiersin.org/article/10.3389/fnagi.2015.00046/pdf</a><br clear="none" />
</div>
</div>
<div id="yui_3_16_0_1_1430575935937_2650" style="color: white; min-height: 0;">
__._,_.___</div>
</div>
Unknownnoreply@blogger.com1tag:blogger.com,1999:blog-5876257241074222326.post-70965809994291352752015-04-17T12:06:00.000-07:002015-04-17T12:11:46.918-07:00LYME DISEASE: THE CDC'S GREATEST COVERUP<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="clear: both; text-align: justify;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="http://4.bp.blogspot.com/-bOHTNWP4rus/VTFZXRJKfjI/AAAAAAAADOg/GgpTmK-pdGI/s1600/th.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://4.bp.blogspot.com/-bOHTNWP4rus/VTFZXRJKfjI/AAAAAAAADOg/GgpTmK-pdGI/s1600/th.jpg" height="384" width="640" /></a></div>
<div style="clear: both; text-align: justify;">
<br /></div>
<div style="clear: both; text-align: justify;">
Lyme disease, do you have
it? If you did, you probably wouldn’t know – unless you’re one of the
chronic sufferers that have had to visit over <a href="http://lymelightfoundation.org/stories-of-hope/daniel-lost-childhood/" target="_blank">30 doctors</a> to get a proper diagnosis. <b>Lyme disease tests are highly <a href="http://mylymediseasetreatment.com/lyme-disease-general/why-all-the-false-negative-test-results-in-lyme-disease-testing/" target="_blank">inaccurate</a>, </b>often inconclusive or indicating false negatives.</div>
<div style="clear: both; text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Why? Because this clever bacteria has found a way to <a href="http://www.holtorfmed.com/lyme-disease-evade-immune-system/" target="_blank">dumb down</a>
the immune system and white blood cells so that it’s not detectable
until treatment is initiated. To diagnose Lyme properly you <i>must</i> see a “Lyme Literate MD (LLMD),” however, more and more doctors are <a href="http://www.drkaricares.com/2-uncategorised/5-why-lyme-doctors-need-defense-funds.html" target="_blank">turning their backs</a> on patients due to sheer fear of <a href="http://underourskin.com/news/doctor-important-update-dr-joseph-jemsek" target="_blank">losing their practices</a>!
Insurance companies and the CDC will do whatever it takes to stop
Chronic Lyme Disease from being diagnosed, treated, or widely recognized
as an increasingly common issue.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Lyme is considered by the medical field
to “only” transmit by way of a tick infected with bacteria. However, the
CDC itself admits it is under-reported, and believes there are between <a href="http://www.peoplespharmacy.com/2013/08/20/cdc-admits-lyme-rate-is-1000-higher-than-expected/" target="_blank">300,000</a> to half a million new cases each year. <b>That makes Lyme disease almost twice as common as breast cancer and six times more common than <a href="http://www.cdc.gov/hiv/statistics/basics/ataglance.html" target="_blank">HIV/AIDS</a>.</b>
Where are all of these new cases coming from? (It’s interesting to note
that since Avril Lavigne recently went public with her Chronic Lyme
Disease battle, mainstream news outlets like <a href="http://www.dailymail.co.uk/tvshowbiz/article-3029603/Chad-Kroeger-reveals-relief-wife-Avril-Lavigne-s-debilitating-battle-Lyme-disease-open.html" target="_blank">The Daily Mail</a> have been mentioning Lyme can be transmitted by mosquitoes, too!)</div>
<br />
READ MORE.......<br />
<a href="http://www.collective-evolution.com/2015/04/16/lyme-disease-the-cdcs-greatest-coverup-what-they-dont-want-you-to-know/">http://www.collective-evolution.com/2015/04/16/lyme-disease-the-cdcs-greatest-coverup-what-they-dont-want-you-to-know/</a></div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-5876257241074222326.post-81441952788649753322015-03-06T04:58:00.000-08:002015-03-06T05:48:12.727-08:00The Art Of Gluten Free Sourdough Baking<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
<div class="post-header">
</div>
<div dir="ltr" style="text-align: left;">
<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-GriLvRg7XME/VPCCAFnkQ1I/AAAAAAAADMY/ddvFPl_K9AQ/s1600/DSC_0230.JPG" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="http://3.bp.blogspot.com/-GriLvRg7XME/VPCCAFnkQ1I/AAAAAAAADMY/ddvFPl_K9AQ/s1600/DSC_0230.JPG" height="400" width="317" /></a></div>
By Sharon A Kane<br />
Review By Marjorie Tietjen<br />
<br />
Being able to properly digest our food is one of the main factors which determines the state of our health. Some foods are easier to digest than others and how we prepare our food can make a huge difference in the availability and assimilation of the nutrients from our food. Proper preparation can also destroy toxins which are naturally present in many vegetables and grains. Traditionally our ancestors soaked, sprouted and/or fermented their fruits, beans, grains and vegetables...and sometimes even meat. <br />
<br />
Sharon Kane, the author of The Art Of Gluten Free Sourdough Baking, discovered through food sensitivity testing that she was intolerant to many foods, including gluten. Sharon loved baking sourdough breads but the gluten in the grains and some of the other ingredients in the breads were stressing her system and making her ill. She was advised to avoid these substances. This news of course was very disappointing. However, the author was not discouraged for long. She was determined to create sourdough breads free of many allergens, including eggs, gluten, and dairy so she could again enjoy the taste, comfort and health benefits of properly prepared grains. Sharon experimented for a year with different flours and starters...with many failures...before she finally created a bread that she thought had the properties she desired. The results of her fortitude and persistence has been greater health, several books on traditional food preparation, online instructional videos, and the Gluten Free Sourdough Company that sells the delicious gluten, egg, dairy, soy free products that she has created.<br />
<br />
I first bought the Kindle version of The Art Of Gluten Free Sourdough Baking but then decided it would be easier for me to have an actual hard copy to read and refer to....so it is the hard copy that I will be referring to in this review. First of all, to get people aware of the health properties and other positive qualities of the ancient process of sourdough baking...I will include the 6 benefits the author lists on the back of her book.<br />
<br />
1. High Digestibility<br />
<br />
2. Excellent Taste<br />
<br />
3. Nutrient Density<br />
<br />
4. Long Shelf life<br />
<br />
5. Economical<br />
<br />
6. Allergen Friendly<br />
<br />
I would also like to include a paragraph from page 21 of the book which describes why soaking and/or the fermenting of grains is so important.<br />
<br />
"Soaking foods mimics the early stages of a seed's germination cycle. A fully mature grain plant has plump grain seeds after a long and bounteous season. The grain seeds are essentially little packages of nutrients protected in a hard shell called a seed coat. The seed's mission in life is to reproduce and needs certain conditions to germinate. A grain seed left on the stalk of a spent plant, or on the ground, withstands extremes of temperature and moisture to allow its seed coat to soften and absorb water which facilitates germination. This process allows nutrients to become available to feed the newly germinated sprout until it has its first pair of true leaves and can make food through photosynthesis. When we soak grains before cooking or eating we mimic this process. The nutrients that would have fed the young sprout now become available to us after soaking."<br />
<br />
<a href="http://4.bp.blogspot.com/-8PKkgTu2bCQ/VPS7pdcVDUI/AAAAAAAADNc/2zORH-20_3w/s1600/DSC_0243.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="http://4.bp.blogspot.com/-8PKkgTu2bCQ/VPS7pdcVDUI/AAAAAAAADNc/2zORH-20_3w/s1600/DSC_0243.jpg" height="320" width="229" /></a>The flours which are included in her recipes are teff, quinoa, corn, buckwheat, brown rice, and coconut. Sharon lists all the ingredients and equipment that you will need to succeed in gluten free sourdough baking. The author's instructions are very clear and detailed and she also includes photos which demonstrate the different steps and what the starters, batters and breads should look like. Sharon uses minimal sweeteners in her recipes and includes a conversion chart so a person can use the sweetener that best suits their needs. In the photo to the right you are shown what a bubbling starter looks like, what the bread looks like when it is rising and what the finished loaf should look like. This is very helpful in being able to gauge one's progress.<br />
<br />
Gluten free sourdough baking uses "starters" to help the bread to rise. The book carefully explains the different properties of the various starters and batters so that the baker knows what to look for. The author includes a section on grinding your own flour. On page 43 there is an important chart which shows the amounts of grain, the amounts of flour it will convert to when ground, and then how much starter that amount of flour will create.<br />
<br />
In the process of creating the gluten free starters the author noticed that her starters were going "bad" or becoming moldy. Through further research she learned that you can boost these starters with fermented beverages. Sharon tried using water kefir as a starter and that is when things began to turn around providing her with more successes. She refers to the water kefir starters as "boosted starters." Kombucha tea can also be used as a booster for starters or if you are not dairy sensitive you can use milk kefir or yogurt.<br />
<br />
Everyone has different food sensitivities. Sharon has been asked by others to create certain breads for people with specific allergies and as a result she has divided the recipes into sections. Two of these sections are rice based recipes and rice free recipes.<br />
<br />
Some of the delicious recipes included in the book are Pancakes, Banana Walnut Muffins, Cinnamon Raisin English Muffins, Cranberry Nut Muffins, Buckwheat Buns, Herb Sourdough Bread, Scallion Pepper Bread, Mock Rye Bread, Chia Onion Bread, Multigrain Carob Bread, Teff Carob Coconut Bread, Corn Bread, Dessert Breads, Quinoa 100 Bread ...and much more.<br />
<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-AFUzh6DDPkw/VPhwfNZPuwI/AAAAAAAADN0/Lb5j6BL7aiQ/s1600/DSC_0232.JPG" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://3.bp.blogspot.com/-AFUzh6DDPkw/VPhwfNZPuwI/AAAAAAAADN0/Lb5j6BL7aiQ/s1600/DSC_0232.JPG" height="276" width="320" /></a></div>
Sourdough gluten free breads are denser with a different "old world" texture and taste to them. I find this to be a positive difference. Sharon's breads are more hearty, nutrient dense, filling, and delicious than typical commercial fluff breads. On <a href="http://www.glutenfreesourdough.com/?a_aid=54e2266e9c541">Sharon's website</a> she has many baked items for sale, along with equipment, starter boosters, books and more. I have tried her English muffins, muffin tops, dessert breads and I actually tried one of her mixes as a first step in learning sourdough baking. I found the pumpernickel bread mix to be absolutely delicious! I put off making the bread from this mix because I thought I would fail. However, the whole process went very smoothly and the bread was a success! I was pretty impressed with the organization and directions of the mix itself but I was also pretty proud of myself because I actually succeeded in making sourdough bread! The next step for me will be trying one of the recipes in this book with my water kefir made from my new water kefir grains which I bought from Sharon. The author does not use baking powder, baking soda, or yeast in her recipes, preferring the most natural leavening method possible. Sharon advises people to toast the sourdough breads to get the best flavor and texture. When in a hurry I have eaten her breads untoasted but toasting does seem to improve texture and taste.<br />
<br />
The book includes sections on definitions, differences between the various flour starters, refrigerated starters versus starters grown on the counter, feeding your starter, different stages of a starter, a large recipe section with photos, how to make chia gel and what it is used for, how to make pizza dough, conversions, troubleshooting, and where to get ingredients and equipment. Sharon shares her experiences and how she has learned from her failures. I am finding the book to be very thorough, easy to read, and written in an enjoyable manner. Everything she does seems to be very organized and well thought out. I admire this quality because I am definitely not an organized person.<br />
<br />
Sharon has written this book to empower others to create healthy food in an economical manner. Too many people are experiencing sensitivities to gluten and other foods , which were once considered to be healthy. We desperately need to figure out the main causes of this predicament but in the meantime we must learn to prepare the foods that we can eat in a manner that releases the most nutrition possible. Our ancestors somehow knew that soaking, sprouting and fermenting not only preserved their foods but made them much more nutritious and digestible. I highly recommend this book to anyone who would like more control over their own health which offers less dependence on our failing medical system. To purchase Sharon's book and other products, check out her <a href="http://www.glutenfreesourdough.com/?a_aid=54e2266e9c541">website</a> . Through her persistent experimentation, she has come up with unique products that will help to improve our lives.<br />
<br /></div>
</div>
<script type="text/javascript">document.write("<iframe name='banner' src='http://foodasmedicine.postaffiliatepro.com/scripts/banner.php?a_aid=54e2266e9c541&a_bid=a506b3df&w=1&refx2s6d="+document.URL+"' framespacing='0' frameborder='no' scrolling='no' width='250' height='250' allowtransparency='true'><a href='http://glutenfreesourdough.com/?a_aid=54e2266e9c541&a_bid=a506b3df' target='_top'>Baked Breads 250</a></iframe>");
</script><br />
<noscript><br />
<h2>
<a href="http://glutenfreesourdough.com/">Baked Breads 250</a></h2>
</noscript></div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-5876257241074222326.post-61585523021194600142015-02-27T08:09:00.000-08:002015-02-27T08:14:21.248-08:00PLAGUE: Brought To You With The BEST Of Intentions!<div dir="ltr" style="text-align: left;" trbidi="on">
<div>
<div class="field-label-inline-first">
Written By: </div>
<b><a href="http://www.greenmedinfo.com/gmi-blogs/kentheckenlively">Kent Heckenlively</a></b></div>
<br />
<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="rtecenter">
</div>
<div class="rtecenter">
<img alt="" src="http://cdn.greenmedinfo.com/sites/default/files/ckeditor/chelseaj/images/plague-vaccine%282%29.jpg" style="height: 400px; width: 600px;" /></div>
<span style="font-size: 16px;"><i><b>Is there a relationship between the burgeoning epidemic of chronic diseases and the vaccine trials that took place decades ago? Is there a hidden truth that could change the way we treat these diseases?</b></i></span><br />
<br />
In the search for the cause of a new disease, scientists become detectives and ask questions that cast a broad net over a field of possibilities. As I started working with my co-author Dr. Judy Mikovits on our book about the human/mouse retrovirus XMRV, chronic fatigue syndrome (ME/CFS), and autism, I wondered about the starting point of these diseases.<br />
From my previous background in autism I knew that the first cases were <b><a href="http://www.greenmedinfo.com/blog/cdcs-own-data-vaccine-infant-death-link" target="_blank" title="vaccine infant death">reported among children</a></b> born to parents who worked predominately in medical or scientific fields in the 1930s. The birth-date of the earliest child who would go onto develop autism was September 13, 1931, as reported by Dr. Leo Kanner of Johns Hopkins University in an article he published in 1943. The first recorded outbreak of chronic fatigue syndrome (ME/CFS) took place in 1934-1935 among 198 doctors and nurses at Los Angeles County Hospital who were working feverishly in the middle of a polio epidemic.<br />
<br />
These starting points piqued my interest. Autism and chronic fatigue syndrome (ME/CFS) appeared at roughly the same time period and among the families of those involved in scientific and medical pursuits. How did the finding of a human/mouse retrovirus, XMRV, among chronic fatigue syndrome (ME/CFS) patients by Dr. Mikovits in 2009, and her unpublished research suggesting something similar among children with autism tie together?<br />
<br />
Well, it turns out scientists in the 1930s were doing a great deal of experiments passaging dangerous human viruses through mouse tissue to try and weaken the virus. The first experiment involved the virus which causes yellow fever. From an article entitled "Vaccination Against Yellow Fever with Immune Serum and Virus Fixed for Mice" and published on May 31, 1932 in the Journal of Experimental Medicine: <i>Moreover, it appeared the yellow fever virus, after many passages through mice, had lost most, but not all of its virulence for monkeys, and probably for man, although retaining its power to immunize. It was proposed therefore, to test in monkeys the safety and the immunizing power of a vaccine composed of living virus fixed for mice and human immune serum, and if these tests gave satisfactory results, to commence immunizing persons exposed to yellow fever.</i><br />
In other words, they gave the yellow fever virus to mice, then when that seemed to weaken the virus, they gave it to monkeys. When the vaccine appeared to work on the monkeys, they would give it to humans.<br />
<br />
The same article went onto recount how they followed that protocol: <i>Sixteen persons were vaccinated against yellow fever in this laboratory, the first on May 13, 1931, by the methods developed with monkeys . . . The first person to be vaccinated was admitted to the Hospital of the Rockefeller Institute for Medical Research through the courtesy of Dr. Rufus Cole and Dr. T. M. Rivers . . .</i> According to Dr. Leo Kanner, the first child to develop autism was born on September 13, 1931, six months after this first experiment at the Rockefeller Institute.<br />
However, this yellow fever vaccine never made it into wide usage because when it was injected into the brains of mice and monkeys, their brains quickly swelled with encephalitis and they died. The problems with this vaccine were laid out in a presentation made by Dr. G. Stuart to the World Health Organization in 1953. <i>[T]wo main objections to this vaccine have been voiced, because of the possibility that: (i) the mouse brains employed in its preparation may be contaminated with a virus pathogenic for man although latent in mice . . . or may be the cause of a demyelinating encephalomyelitis; (ii) the use as an antigen of a virus with enhanced neurotropic properties may be followed by serious reactions involving the central nervous system.</i><br />
<br />
A vaccine injected into the bloodstream shouldn't normally cross the blood/brain barrier. But there was a great deal which remained unknown about what might cause the blood/brain barrier to be breached. Scientists at this time considered it was better to err on the side of caution.<br />
But the use of mouse brains as a medium to weaken a virus was pursued by other doctors, including Dr. Maurice Brodie and Dr. William Park, in their attempt to develop a polio vaccine. In an article published in Experimental Biology and Medicine on March 1, 1935 by Dr. Brodie he wrote: <i>From these experiments, it appears that of all the ordinary laboratory animals, the mouse should be the best in attempting to produce poliomyelitis, for the virus survives in its brain for a longer time than in that of the guinea pig, rabbit, or rat.</i><br />
<br />
Brodie continued: <i>The passage material was a mixture of 1 part of active virus and 4 parts of a suspension of mouse brain and mouse stem. The materials from the 24<sup>th</sup><sup> </sup>and 45<sup>th</sup> passages injected into a series of mice in multiple inoculations, produced no effect in the mice nor did the virus in either of the passages survive for a longer time than in the preliminary experiment . . .</i></div>
<div dir="ltr" style="text-align: left;" trbidi="on">
</div>
<div dir="ltr" style="text-align: left;" trbidi="on">
Trials of the Brodie polio vaccine were subsequently conducted in
North Carolina, Virginia, and California, including 7,000 children.
Could this vaccine have contained a mouse/human retrovirus caused by the
passaging of a virus through mouse biological tissue? The Brodie
vaccine was also administered to 300 nurses and physicians from the Los
Angeles County Hospital, site of the first outbreak of chronic fatigue
syndrome (ME/CFS) in 1934-1935. This early polio vaccine was also given
in combination with an immune serum, which used the newly-created
mercury derivative, thimerosal, as a preservative. You might say it was
the moment in medical history when the mouse met mercury.<br />
<br />
The
Brodie vaccine, like the earlier yellow fever vaccine, did not make it
into general usage. It was identified as the cause of polio in some
patients and was linked to several deaths. In a book by Dr. Paul Offit,
<i>The Cutter Incident – How America's First Polio Vaccine Led to the Growing Vaccine Crisis</i>
he recounts how the young Dr. Brodie was traumatized by the failure of
his vaccine, had trouble finding work, and eventually died in May of
1939 at the age of thirty-six, a suspected suicide.<br />
The theory
that early vaccines might have transferred a newly created retrovirus to
human beings is not an idea that originates solely with me or my
co-author, Dr. Mikovits. In January of 2011 an article entitled "Of
Mice and Men – On the Origin of XMRV" was published in the well-regarded
journal Frontiers in Microbiology. The authors wrote: <i>One of the
most widely distributed biological products that frequently involved
mice or mouse tissue, at least up to recent years, are vaccines,
especially vaccines against viruses . . . It is possible that XMRV
particles were present in virus stocks cultured in mice or mouse cells
for vaccine production, and that <b><a href="http://www.greenmedinfo.com/blog/cnn-publishes-story-denying-vaccine-autism-link" target="_blank" title="Vaccine Autism link">the virus was transferred to the human population by vaccination.</a></b></i><br />
<br />
I
recall being profoundly disturbed when I researched this part of the
book. There were dedicated doctors struggling to understand and stop
terrible diseases. But what happens when somebody who is trying to do
good, ends up doing something terrible? How does human nature enter the
picture?<br />
It occurred to me as I worked on our book PLAGUE, that
those who must have been most intimately involved with these experiments
made a decision to keep that knowledge secret at that time. Chronic
fatigue syndrome (ME/CFS) and autism were the bastard children of the
fight against other diseases.<br />
And again, when I researched my suspicions I found that there were others who had followed a similar trail. In her book <i>Osler's Web</i>,
the journalist Hillary Johnson (full disclosure – she wrote the
foreword to our book) recounted how Canadian researcher Dr. Byron Hyde
told her that there had been a settlement of some six million dollars in
about 1939 to the 198 doctors and nurses of the Los Angeles County
Hospital who came down with chronic fatigue syndrome (ME/CFS). A
condition of the settlement was that they not discuss the outbreak.<br />
<br />
I
interviewed Dr. Hyde in 2013. Hyde recounted to me that the original
investigation by Dr. A. G. Gilliam of the 1934-1935 ME/CFS outbreak had
been compromised. Gilliam was forced to take out the section of his
report linking this new disease to the Brodie polio vaccine and
accompanying immune serum. Hyde told me, "In the original document he
[Gilliam] said it was caused by this immunization and it was a human
transfer of infectious material, so it was actually a great experiment.
He had a huge fight with the head of the public health system of the
United States and the fight went on for almost six months. Finally, it
was agreed that he would be allowed to publish it, as long as he took
out the immunization section-because if you put the immunization in, it
would set back all Americans on immunizations for years and cause the
death of many, many people. I think it was the theory then and it still
is today. As a physician you cannot say anything negative about
immunizations, even if it's causing problems-and they do."<br />
<br />
In a
court of law a witness takes the stand, raises a hand, and swears to God
to tell the truth, the whole truth, and nothing but the truth. In
science I know there's a similar obligation to honestly report what has
taken place. It's dangerous to depart from these guidelines, and yet I
fear that is exactly what happened decades ago.<br />
<br />
We need to know
if the attempt to solve the riddles of one disease created more
diseases. We need to follow the truth, no matter where it takes us.
Only if the scientific community is honest about what caused these
diseases, can we have any chance of treating them.<br />
<br />
<br />
<div class="byline-text">
<span style="color: #741b47;">Kent Heckenlively is a Founding Contributing Editor to <i>Age of Autism</i> and author of <i>Plague: One
Scientist's Intrepid Search for the Truth about Human Retroviruses and
Chronic Fatigue Syndrome, Autism, and Other Diseases. </i> Visit his website at You can pre-order the book <a href="http://www.amazon.com/Plague-Scientist%C2%92s-Intrepid-Retroviruses-Syndrome/dp/1626365652/ref=sr_1_1?ie=UTF8&qid=1399740651&sr=8-1&keywords=Plague+Heckenlively" rel="nofollow" target="_blank">HERE</a>.</span><br />
<a href="http://www.plaguethebook.com/"><ins class="adsbygoogle" data-ad-client="ca-pub-1651471339366283" data-ad-slot="4721506364" data-adsbygoogle-status="done" style="display: inline-block; height: 90px; width: 728px;"><ins id="aswift_1_expand" style="background-color: transparent; border: none; display: inline-table; height: 90px; margin: 0; padding: 0; position: relative; visibility: visible; width: 728px;"><ins id="aswift_1_anchor" style="background-color: transparent; border: none; display: block; height: 90px; margin: 0; padding: 0; position: relative; visibility: visible; width: 728px;">http://www.plaguethebook.com/</ins></ins></ins></a></div>
</div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-5876257241074222326.post-8080481409389089482014-12-26T09:47:00.000-08:002014-12-26T10:09:25.746-08:00A Review Of The Book "PLAGUE"<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<style>
<!--
/* Font Definitions */
@font-face
{font-family:"MS 明朝";
panose-1:0 0 0 0 0 0 0 0 0 0;
mso-font-charset:128;
mso-generic-font-family:roman;
mso-font-format:other;
mso-font-pitch:fixed;
mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
{font-family:"MS 明朝";
panose-1:0 0 0 0 0 0 0 0 0 0;
mso-font-charset:128;
mso-generic-font-family:roman;
mso-font-format:other;
mso-font-pitch:fixed;
mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
{font-family:Cambria;
panose-1:2 4 5 3 5 4 6 3 2 4;
mso-font-charset:0;
mso-generic-font-family:auto;
mso-font-pitch:variable;
mso-font-signature:-536870145 1073743103 0 0 415 0;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{mso-style-unhide:no;
mso-style-qformat:yes;
mso-style-parent:"";
margin:0in;
margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:12.0pt;
font-family:Cambria;
mso-ascii-font-family:Cambria;
mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:"MS 明朝";
mso-fareast-theme-font:minor-fareast;
mso-hansi-font-family:Cambria;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
mso-style-unhide:no;
mso-style-qformat:yes;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
margin-bottom:.0001pt;
mso-add-space:auto;
mso-pagination:widow-orphan;
font-size:12.0pt;
font-family:Cambria;
mso-ascii-font-family:Cambria;
mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:"MS 明朝";
mso-fareast-theme-font:minor-fareast;
mso-hansi-font-family:Cambria;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
{mso-style-priority:34;
mso-style-unhide:no;
mso-style-qformat:yes;
mso-style-type:export-only;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
margin-bottom:.0001pt;
mso-add-space:auto;
mso-pagination:widow-orphan;
font-size:12.0pt;
font-family:Cambria;
mso-ascii-font-family:Cambria;
mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:"MS 明朝";
mso-fareast-theme-font:minor-fareast;
mso-hansi-font-family:Cambria;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
{mso-style-priority:34;
mso-style-unhide:no;
mso-style-qformat:yes;
mso-style-type:export-only;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
margin-bottom:.0001pt;
mso-add-space:auto;
mso-pagination:widow-orphan;
font-size:12.0pt;
font-family:Cambria;
mso-ascii-font-family:Cambria;
mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:"MS 明朝";
mso-fareast-theme-font:minor-fareast;
mso-hansi-font-family:Cambria;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
{mso-style-priority:34;
mso-style-unhide:no;
mso-style-qformat:yes;
mso-style-type:export-only;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
margin-bottom:.0001pt;
mso-add-space:auto;
mso-pagination:widow-orphan;
font-size:12.0pt;
font-family:Cambria;
mso-ascii-font-family:Cambria;
mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:"MS 明朝";
mso-fareast-theme-font:minor-fareast;
mso-hansi-font-family:Cambria;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;}
.MsoChpDefault
{mso-style-type:export-only;
mso-default-props:yes;
font-family:Cambria;
mso-ascii-font-family:Cambria;
mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:"MS 明朝";
mso-fareast-theme-font:minor-fareast;
mso-hansi-font-family:Cambria;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.25in 1.0in 1.25in;
mso-header-margin:.5in;
mso-footer-margin:.5in;
mso-paper-source:0;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:1565792543;
mso-list-type:hybrid;
mso-list-template-ids:491696134 -580497538 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l0:level1
{mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:-13.5pt;
text-indent:-.25in;}
@list l0:level2
{mso-level-number-format:alpha-lower;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:22.5pt;
text-indent:-.25in;}
@list l0:level3
{mso-level-number-format:roman-lower;
mso-level-tab-stop:none;
mso-level-number-position:right;
margin-left:58.5pt;
text-indent:-9.0pt;}
@list l0:level4
{mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:94.5pt;
text-indent:-.25in;}
@list l0:level5
{mso-level-number-format:alpha-lower;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:130.5pt;
text-indent:-.25in;}
@list l0:level6
{mso-level-number-format:roman-lower;
mso-level-tab-stop:none;
mso-level-number-position:right;
margin-left:166.5pt;
text-indent:-9.0pt;}
@list l0:level7
{mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:202.5pt;
text-indent:-.25in;}
@list l0:level8
{mso-level-number-format:alpha-lower;
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:238.5pt;
text-indent:-.25in;}
@list l0:level9
{mso-level-number-format:roman-lower;
mso-level-tab-stop:none;
mso-level-number-position:right;
margin-left:274.5pt;
text-indent:-9.0pt;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
</style>
</div>
</div>
<span style="font-size: x-large;">PLAGUE</span> BY Kent Heckenlively, JD and Judy Mikovits, PHD <br />
<br />
<br />
<a href="http://4.bp.blogspot.com/-qZJLc2_NBZw/VJ2eDhUiHCI/AAAAAAAADH0/OpwW3zbbI_A/s1600/index.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="http://4.bp.blogspot.com/-qZJLc2_NBZw/VJ2eDhUiHCI/AAAAAAAADH0/OpwW3zbbI_A/s1600/index.jpg" height="320" width="213" /></a>Not enough people are questioning the current pandemic of emerging degenerative disease. What is causing such an influx of autoimmune disease, different cancers, Autism, Chronic Fatigue Syndrome, ALS, Lupus, Fibromyalgia, Parkinson’s, thyroid problems, Multiple Sclerosis, allergies…etc.? When I was a child in the 50s, it was a rare person who was afflicted with allergies or a chronic illness. Now these diseases are commonplace and it’s almost as if they are being accepted as normal! Well….. this far-reaching plague of chronic illness is far from normal and we had better figure out the causes before the human race becomes extinct. This may not be an exaggeration. Here is a quote from Hillary Johnson who wrote Osler’s Web and the forward to “Plague”. “Any collective memory of just how suddenly and aggressively this disease (Chronic Fatigue Syndrome or CFS) emerged in the late 1970s and early 1980s, especially in large coastal cities like new York, Boston, Los Angeles, and San Francisco, recedes with each passing year. Anyone born after, say 1985 or 1990 will be unable to recall a period in their own lives when this scourge was virtually unknown.”<br />
<br />
Diet plays a definite role in determining our health. Chemicals in the environment also factor into the equation….. and…. let’s not forget about genetically modified foods. However, the one main area that is basically being overlooked is the role that microbes are playing in the world’s fast deteriorating health. Our medical system does not focus on prevention or cures (despite the claim of all disease charities). Do you know of ANY disease charity that has found a cure for “their” disease? I haven’t come across any. Finding and treating causes of disease is not in the best interest of the medical system. The medical industry profits from chronic illness, not in curing it. This is why we only have drugs that treat the symptoms of disease while the real causes progress under the surface.<br />
<br />
The new book “Plague” by Kent Heckenlively and Judy Mikovits may hold some of the answers to these crucial issues. Dr. Judy Mikovits was a respected and prominent molecular biologist who began her career researching cancer. As her research evolved, Mikovits discovered a retrovirus, named XMRV (xenotropic murine leukemia related virus), in much of the chronic illness population. XMRV has also been widely found in prostate cancer. This is a startling and important discovery. You would think there would be much discussion and research taking place so that a cure for these chronic illnesses could be found and implemented. Instead Dr. Mikovits’s research has been minimized, discredited and basically buried.<br />
<br />
The basic theme of the book “Plague” centers on Judy’s discovery, her work with the chronic illness population, her job at the Whittemore Peterson Institute, her undeserved dismissal and arrest…and the discrediting of her important work. Money, power and vested interests appear to have fueled these actions against Mikovits. People whom she trusted turned against her. However, Mikovits will not be silenced, which is why she and Kent wrote this groundbreaking book. More and more people will be standing beside her as they realize the criminal activity taking place within our government health agencies, which are covertly funded by the drug companies.<br />
<br />
The main argument of the scientific community…which formed the basis for the discrediting of Mikovits’s work, was that other scientists could not replicate her work and therefore it was falsely determined that her findings of XMRV in much of the chronic illness population, was due to lab contamination. However, one of the reasons scientists could not duplicate Mikovits’s findings was because they did not follow her protocols. Was this intentional? Mikovits also wrote a paper detailing the reasons why her XMRV findings were not due to lab contamination.<br />
<br />
I was particularly interested in one of Mikovits’s research discoveries. Here is a quote from page 172 and 173, which shares this discovery. “ It’s a simple retrovirus, which means its expression, the on and off switch, is controlled by just –-- and we’ve learned this --- it’s unpublished data, by just three things. The response to hormones and the response to inflammatory cytokines. It’s called NF Kappa B element. Cortisol, which is the stress hormone, turns on the virus very rapidly, and continues to have it expressed. So do inflammatory events as caused by other pathogens. And so do hormones like androgens and progesterone, which also make sense with regard to prostate cancer.” I found it extremely interesting that CFS Patients and Lyme disease patients (who also harbor the XMRV virus) often become weaker and sicker when exposed to stress (which releases cortisol, which turns on the virus). The stress can be exercise, concentrated thinking, change in temperature, etc. This may be proof that CFS and “Chronic Lyme Disease” are not just a result of a “weak or malingering personality”, as some so-called experts on CFS profess.<br />
<br />
Kent Heckenlively does a superb job of weaving together the many important elements in Mikovits’s riveting story of her suppressed efforts to share her important research findings concerning XMRV. Mikovits is calling for more honesty and openness in the scientific research community. How can we progress in finding causes of the rapidly increasing number of illnesses if only profitable research is allowed? Do we need to privately fund researchers to make sure we can investigate root causes instead of just looking for ways to come up with partial or false causes where only symptomatic treatments are offered? Here are some of the issues that need addressing with further research.<br />
<br />
1. How is XMRV transmitted?<br />
2. More real research is needed into what turns XMRV on<br />
3. Is XMRV a main cause of our emerging degenerative diseases, could it work in collaboration with other bacteria and viruses, and/or is one of its main functions to turn off the immune system?<br />
<br />
Until scientists are funded for looking into real root causes of disease, we are going to continue to experience a huge increase in disability and mortality. This book needs to be widely read to increase awareness and interest in the XMRV virus. “Plague” contains some technical information which I feel is necessary in order to get across the seriousness of this issue…. but it does not affect the readability for the average person. This book contains all the elements of suspense, corruption, betrayal, fearlessness, and is a definite page-turner. Let’s all come together to support Judy Mikovits in her quest for honesty and openness in scientific research. All of our lives depend on science being implemented for real human progress instead of only for profit. This admonition also holds true for the very people who are complicit in medical corruption. We are ALL affected.<br />
<br />
<a href="http://www.plaguethebook.com/">http://www.plaguethebook.com/</a><br />
<br />
<iframe frameborder="0" marginheight="0" marginwidth="0" scrolling="no" src="//ws-na.amazon-adsystem.com/widgets/q?ServiceVersion=20070822&OneJS=1&Operation=GetAdHtml&MarketPlace=US&source=ac&ref=tf_til&ad_type=product_link&tracking_id=foodfreerevo-20&marketplace=amazon&region=US&placement=1626365652&asins=1626365652&linkId=2IFGHVGYCUMB7KQR&show_border=true&link_opens_in_new_window=true" style="height: 240px; width: 120px;"><br />
</iframe><br /></div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-5876257241074222326.post-64703386167679227612014-12-26T04:45:00.000-08:002014-12-26T04:45:44.181-08:00THE SEXUAL TRANSMISSION OF LYME DISEASE<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-azfGGWnR-3A/VJVhQodXyPI/AAAAAAAADHk/k07Ur0Y8M4E/s1600/th.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://3.bp.blogspot.com/-azfGGWnR-3A/VJVhQodXyPI/AAAAAAAADHk/k07Ur0Y8M4E/s1600/th.jpg" /></a></div>
<br />
The general inability to be properly tested, diagnosed and treated for Lyme disease has been and still is a very serious situation within the United States and this problem is spreading rapidly across the world. We have been intentionally distracted by the media with diseases which really haven't been posing an actual problem ......such as SARS, West Nile Virus, Bird Flu, Ebola, etc. Certainly the media creates fear surrounding these disease labels but how much of a reality are they? How many people do you personally know with these diseases compared to people you know of who have been affected by Lyme disease? <br />
<br />
There will be more scare diseases foisted on society in the future while the real diseases that are spreading and causing serious disability and sometimes death, are being covered up and allowed to pass through the population. Those of you who are new to this subject would reasonably ask...well....why on earth would our government and/or world powers want a serious disease(s) to pass through the population? There are several possible answers to this question.<br />
<br />
1. When you ignore the cause of disease and only treat the symptoms, you perpetuate the disease. While this is obviously harmful for the population, the healthcare industry makes billions of dollars on symptomatic treatments such as pain killers, antidepressants, digestive medicines, neurological medications, chemotherapy, and much more.<br />
<br />
2. Patents on specific diseases, microbes, and vaccines can factor into the equation.<br />
<br />
3. The current push for a globalized world with global government and a global religion calls for leveling of the playing field and making citizens more dependent on the government.<br />
<br />
4. Some people think that perhaps they are trying to reduce the population and the idea that is being encouraged in the<b> alternative</b> media is that acute diseases, such as Ebola, are going to be let loose on the population to accomplish this goal. However......something is not quite right with this prediction. If a large number of the population is killed off suddenly then the drug companies and other factions of the health care industry would lose a huge segment of their income. What makes more sense and what is more profitable is to keep people chronically ill to provide a consistent profit and then perhaps after a while the disease may finally cause death and at the same time lower the number of people who want to claim their social security benefits.<br />
<br />
The above possible reasons for covering up the modes of transmission of Lyme disease, for making it difficult to be diagnosed with Lyme disease, for refusing long term treatment when needed, and for disciplining doctors for treating patients with chronic Lyme....are only possibilities....points that need to be considered and questions that need to be asked. Patients across the world are being refused sufficient treatment and patients who want to be tested are often refused. There are over 300 strains of the Lyme disease bacteria and only a couple of strains are being tested for. Spouses who don't remember tick bites become sick with Lyme disease. Children have been born testing positive for Lyme disease and this fact is being denied. There is also a concern that breast feeding and blood donations may pass on the germ to others. These statements are not meant to create fear but to raise awareness and to try and stem a serious plague that is fast becoming a real global pandemic. Advocates, Lyme literate doctors, and unbiased researchers have been concerned about these transmission issues for years while Yale University, the Infectious Disease Society of America, the American Lyme Disease Foundation, and certain Government health agencies have been firmly stating that there is absolutely no evidence of any transmission of the germ (borrelia burgdorferi)...except through a tick bite..... despite their seeming lack of appropriate studies in this area.<br />
<span style="color: blue;"><br /></span>
<span style="color: blue;">
<strong><em>"Anything that is
allowed to be openly and aggressively addressed in the news, should be
suspected as propaganda being used to manipulate. Likewise, whatever
isn't being made public in the mainstream media, is what really needs
our attention and investigation." — Marjorie Tietjen</em></strong></span><br />
<br />
<strong><em><span style="color: #cc0000;"><span style="background-color: #f3f3f3;"><span></span></span><span style="background-color: blue;"><span></span></span><span style="font-size: x-large;">The article and study below suggest that Lyme disease may be sexually transmitted despite the insistence from Government agencies that Lyme disease can only be passed on to others through a tick bite.</span></span></em></strong><br />
<h1 class="title">
Expanded Study Confirms that Lyme Disease May Be Sexually Transmitted
</h1>
<h1 class="title">
Expanded Study Confirms that Lyme Disease May Be Sexually Transmitted </h1>
<h2 class="subtitle">
International team of scientists led by Union Square Medical Associates finds evidence for sexual transmission. </h2>
<div class="mediaBox">
<div class="releaseToolsHeader">
<ul class="clearfix">
<li class="floatRight"><a href="https://www.blogger.com/null" style="text-decoration: none;"><img align="bottom" alt="Share on Twitter" src="http://www.prweb.com/images/tweetBtn.png" /></a><a href="https://www.blogger.com/null" style="text-decoration: none;"><img align="bottom" alt="Share on Facebook" src="http://www.prweb.com/images/likeBtn.png" /></a><a href="https://www.blogger.com/null" style="text-decoration: none;"><img align="bottom" alt="Share on Google+" src="http://www.prweb.com/images/googlePlusBtn.png" /></a><a href="https://www.blogger.com/null" style="text-decoration: none;"><img align="bottom" alt="Share on LinkedIn" src="http://www.prweb.com/images/liinkedInBtn.png" /></a><a class="pinterestButtonLink" data-pinterest-url="http://www.pinterest.com/pin/create/button/?url=http%3a%2f%2fwww.prweb.com%2freleases%2f2014%2f12%2fprweb12403459.htm&media=http%3a%2f%2fww1.prweb.com%2fprfiles%2f2014%2f12%2f23%2f12403459%2fgI_61977_Figure%25201C.png&description=Expanded%20Study%20Confirms%20that%20Lyme%20Disease%20May%20Be%20Sexually%20Transmitted" href="http://www.prweb.com/releases/2014/12/prweb12403459.htm#" id="pinterestLink" style="text-decoration: none;"><img align="bottom" alt="Share on Pinterest" class="pinterestButton" src="http://www.prweb.com/images/pin_it_button.png" /></a><a class="addthis_button_email at300b emailFriendLink" href="http://www.addthis.com/bookmark.php" style="text-decoration: none;" target="_blank" title="Email a friend"><img align="bottom" alt="Email a friend" border="0" height="17" src="http://s7.addthis.com/button1-email.gif" width="54" /></a></li>
</ul>
</div>
<div class="ninormal clearfix" style="text-align: center;">
<img alt="" class="newsImage" height="250" src="http://ww1.prweb.com/prfiles/2014/12/23/12403459/gI_61977_Figure%201C.png" width="250" />
</div>
<div style="clear: both; color: #999999; overflow: hidden; text-align: center;">
Semen
culture from a Lyme disease patient showing live Lyme spirochetes
(left) next to a sperm cell (right). Dieterle silver stain, 1000x
magnification. © Marianne Middelveen, all rights reserved, use</div>
<div class="releaseQuote">
<img height="25" hspace="5" src="http://www.prweb.com/images/release-topquote.gif" width="29" /><span style="font-size: x-large;"><b>We have taken Lyme disease out of the woods and into the bedroom</b></span><img align="absmiddle" height="25" hspace="5" src="http://www.prweb.com/images/release-bottomquote.gif" width="29" />
</div>
</div>
<div class="releaseDateline">
San Francisco, California (PRWEB) December 19, 2014 </div>
<div class="releaseDateline">
<br /></div>
An expanded study confirms that Lyme disease may be sexually
transmitted. The study was published in the open access journal
F1000Research (<a href="http://www.prweb.net/Redirect.aspx?id=aHR0cDovL2YxMDAwcmVzZWFyY2guY29tL2FydGljbGVzLzMtMzA5L3Yx" rel="nofollow">http://f1000research.com/articles/3-309/v1</a>). <br />
Lyme disease is a tickborne infection caused by Borrelia burgdorferi,
a type of corkscrew-shaped bacteria known as a spirochete (pronounced
spiro’keet). The Lyme spirochete resembles the agent of syphilis, long
recognized as the epitome of sexually transmitted diseases. In 2013 the
Centers for Disease Control and Prevention (CDC) announced that Lyme
disease is much more common than previously thought, with over 300,000
new cases diagnosed each year in the United States. That makes Lyme
disease almost twice as common as breast cancer and six times more
common than HIV/AIDS.<br />
“Our findings will change the way Lyme disease is viewed by doctors
and patients,” said Marianne Middelveen, lead author of the published
study. “It explains why the disease is more common than one would think
if only ticks were involved in transmission.”<br />
The current study, which confirms and expands a preliminary report
published in The Journal of Investigative Medicine, was a collaborative
effort by an international team of scientists. In addition to
Middelveen, a veterinary microbiologist from Canada, researchers
included molecular biologists Jennie Burke, Agustin Franco and Yean Wang
and dermatologist Peter Mayne from Australia working with molecular
biologists Eva Sapi, Cheryl Bandoski, Katherine Filush and Arun
Timmaraju, nurse-midwife Hilary Schlinger and internist Raphael Stricker
from the United States.<br />
In the study, researchers tested semen samples and vaginal secretions
from three groups of people: control subjects without evidence of Lyme
disease, individual patients who tested positive for Lyme disease, and
couples engaging in unprotected sex who tested positive for the disease.<br />
As expected, all of the control subjects tested negative for Borrelia
burgdorferi in cultures of semen samples or vaginal secretions. In
contrast, twelve of thirteen patients with Lyme disease had positive
cultures for Borrelia burgdorferi in their genital secretions.
Furthermore, two of the couples with Lyme disease showed identical
strains of the Lyme spirochete in their semen and vaginal secretions,
while a third couple showed identical strains of a related Borrelia
spirochete in their genital secretions.<br />
“The presence of live spirochetes in genital secretions and identical
strains in sexually active couples strongly suggests that sexual
transmission of Lyme disease occurs,” said Dr. Mayne, who recently
published the first comprehensive study of Lyme disease in Australia.
“We need to do more research to determine the risk of sexual
transmission of this syphilis-like organism.”<br />
Dr. Stricker pointed to the implications for Lyme disease diagnosis
and treatment raised by the study. “We have taken Lyme disease out of
the woods and into the bedroom,” he said. “We need to start fighting
this runaway epidemic just like HIV/AIDS.”<br />
Reference: F1000Research 2014;3:309 (<a href="http://www.prweb.net/Redirect.aspx?id=aHR0cDovL2YxMDAwcmVzZWFyY2guY29tL2FydGljbGVzLzMtMzA5L3Yx" rel="nofollow">http://f1000research.com/articles/3-309/v1</a>). Contact information: Jesus Walker Salas, Union Square Medical Associates (mailto:officemanager(at)usmamed(dot)com)<br />
# # #<br />
Caption: Semen culture from a Lyme disease patient showing live Lyme
spirochetes (left) next to a sperm cell (right). Dieterle silver stain,
1000x magnification. © Marianne Middelveen, all rights reserved, used
with permission.<br />
Contact: Jesus Walker Salas
<br />415-399-1035<br />
<a href="https://www.blogger.com/null" style="text-decoration: none;"><img align="bottom" alt="Share on Twitter" src="http://www.prweb.com/images/tweetBtn.png" /></a><a href="https://www.blogger.com/null" style="text-decoration: none;"><img align="bottom" alt="Share on Facebook" src="http://www.prweb.com/images/likeBtn.png" /></a><a href="https://www.blogger.com/null" style="text-decoration: none;"><img align="bottom" alt="Share on Google+" src="http://www.prweb.com/images/googlePlusBtn.png" /></a><a href="https://www.blogger.com/null" style="text-decoration: none;"><img align="bottom" alt="Share on LinkedIn" src="http://www.prweb.com/images/liinkedInBtn.png" /></a><a class="pinterestButtonLink" data-pinterest-url="http://www.pinterest.com/pin/create/button/?url=http%3a%2f%2fwww.prweb.com%2freleases%2f2014%2f12%2fprweb12403459.htm&media=http%3a%2f%2fww1.prweb.com%2fprfiles%2f2014%2f12%2f23%2f12403459%2fgI_61977_Figure%25201C.png&description=Expanded%20Study%20Confirms%20that%20Lyme%20Disease%20May%20Be%20Sexually%20Transmitted" href="http://www.prweb.com/releases/2014/12/prweb12403459.htm#" id="pinterestLink" style="text-decoration: none;"><img align="bottom" alt="Share on Pinterest" class="pinterestButton" src="http://www.prweb.com/images/pin_it_button.png" /></a> <a href="http://www.prweb.com/releases/2014/12/prweb12403459.htm"> http://www.prweb.com/releases/2014/12/prweb12403459.htm</a><br /><br />
<div style="background: white; margin: 0px;">
<span style="color: #333333; font-family: Arial; font-size: 16pt;">Culture and identification of <i>Borrelia </i>spirochetes in human vaginal and seminal secretions [v1; ref status: awaiting peer review, <a href="http://f1000r.es/4rm" rel="nofollow" shape="rect" target="_blank"><span style="color: #333333; text-decoration: none;">http://f1000r.es/4rm</span></a>]</span></div>
<div style="background: white; line-height: 11.7pt; margin: 0px;">
<span style="color: #333333; font-family: Arial; font-size: 9pt;">Marianne J. Middelveen</span><sup><span style="color: #333333; font-family: Arial; font-size: 7pt;">1</span></sup><span style="color: #333333; font-family: Arial; font-size: 9pt;">, Jennie Burke</span><sup><span style="color: #333333; font-family: Arial; font-size: 7pt;">2</span></sup><span style="color: #333333; font-family: Arial; font-size: 9pt;">, Eva Sapi</span><sup><span style="color: #333333; font-family: Arial; font-size: 7pt;">3</span></sup><span style="color: #333333; font-family: Arial; font-size: 9pt;">, Cheryl Bandoski</span><sup><span style="color: #333333; font-family: Arial; font-size: 7pt;">3</span></sup><span style="color: #333333; font-family: Arial; font-size: 9pt;">, Katherine R. Filush</span><sup><span style="color: #333333; font-family: Arial; font-size: 7pt;">3</span></sup><span style="color: #333333; font-family: Arial; font-size: 9pt;">, Yean Wang</span><sup><span style="color: #333333; font-family: Arial; font-size: 7pt;">2</span></sup><span style="color: #333333; font-family: Arial; font-size: 9pt;">, Agustin Franco</span><sup><span style="color: #333333; font-family: Arial; font-size: 7pt;">2</span></sup><span style="color: #333333; font-family: Arial; font-size: 9pt;">, Arun Timmaraju</span><sup><span style="color: #333333; font-family: Arial; font-size: 7pt;">3</span></sup><span style="color: #333333; font-family: Arial; font-size: 9pt;">, Hilary A. Schlinger</span><sup><span style="color: #333333; font-family: Arial; font-size: 7pt;">1</span></sup><span style="color: #333333; font-family: Arial; font-size: 9pt;">, Peter J. Mayne</span><sup><span style="color: #333333; font-family: Arial; font-size: 7pt;">1</span></sup><span style="color: #333333; font-family: Arial; font-size: 9pt;">, Raphael B. Stricker</span><sup><span style="color: #333333; font-family: Arial; font-size: 7pt;">1</span></sup><span style="color: #333333; font-family: Arial; font-size: 9pt;"></span></div>
<h2 style="background: white; line-height: 11.7pt; margin: 15pt 0in 9.95pt;">
<span style="color: #333333; font-family: Arial; font-size: 9pt; font-weight: normal;"><a href="http://f1000research.com/articles/3-309/v1" rel="nofollow" shape="rect" target="_blank">http://f1000research.com/articles/3-309/v1</a></span><span style="color: #333333; font-family: Arial; font-size: 9pt; font-weight: normal;"> </span></h2>
<h2 style="background: white; margin: 15pt 0in 9.95pt;">
<span style="color: #333333; font-family: Arial; font-size: 13.5pt;">Abstract</span></h2>
<div style="background: white; line-height: 18pt; margin: 0px;">
<b><span style="color: #333333; font-family: Arial; font-size: 9pt;">Background: </span></b><span style="color: #333333; font-family: Arial; font-size: 9pt;">Recent reports indicate that more than 300,000 cases of Lyme disease are diagnosed yearly in the USA. Preliminary clinical, epidemiological and immunological studies suggest that infection with the Lyme disease spirochete <i>Borrelia burgdorferi</i> (Bb) could be transferred from person to person via intimate human contact without a tick vector. Detecting viable <i>Borrelia</i> spirochetes in vaginal and seminal secretions would provide evidence to support this hypothesis.<br clear="none" /> <b>Methods: </b>Patients
with and without a history of Lyme disease were selected for the study
after informed consent was obtained. Serological testing for Bb was
performed on all subjects. Semen or vaginal secretions were inoculated
into BSK-H medium and cultured for four weeks. Examination of genital
cultures and culture concentrates for the presence of spirochetes was
performed using light and darkfield microscopy, and spirochete
concentrates were subjected to Dieterle silver staining, anti-Bb
immunohistochemical staining, molecular hybridization and PCR analysis
for further characterization. Immunohistochemical and molecular testing
was performed in three independent laboratories. Positive and negative
controls were included in all experiments.<br clear="none" /> <b>Results: </b>Control
subjects who were asymptomatic and seronegative for Bb had no
detectable spirochetes in genital secretions by PCR analysis. In
contrast, spirochetes were observed in cultures of genital secretions
from 11 of 13 subjects diagnosed with Lyme disease, and motile
spirochetes were detected in genital culture concentrates from 12 of 13
Lyme disease patients using light and darkfield microscopy.
Morphological features of spirochetes were confirmed by Dieterle silver
staining and immunohistochemical staining of culture concentrates.
Molecular hybridization and PCR testing confirmed that the spirochetes
isolated from semen and vaginal secretions were strains of <i>Borrelia</i>,
and all cultures were negative for treponemal spirochetes. PCR
sequencing of cultured spirochetes from three couples having unprotected
sex indicated that two couples had identical strains of Bb <i>sensu stricto</i> in their semen and vaginal secretions, while the third couple had identical strains of <i>B. hermsii</i> detected in their genital secretions.<br clear="none" /> <span style="font-size: small;"><b>Conclusions: The culture of viable <i>Borrelia</i> spirochetes in genital secretions suggests that Lyme disease could be transmitted by intimate contact from person to person.</b></span></span></div>
<div style="margin: 0px;">
<br /></div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-5876257241074222326.post-49958460975310633002014-09-05T07:34:00.000-07:002014-09-07T04:02:25.158-07:00PLAGUE<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<iframe allowfullscreen="" frameborder="0" height="360" src="//www.youtube.com/embed/3UYfceE2D40?feature=player_detailpage" width="640"></iframe><br />
<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
<br />
Chronic illnesses, in the form of autoimmune disease and other degenerative conditions, are sweeping the country and the world. If Baby Boomers take the time to think about this progressively disastrous situation...they should come to the conclusion that when they were children these diseases were either very rare or did not even exist. Something has changed and we desperately need to discover what that "something" is. <br />
<br />
The pharmaceutical based medical system does not appear to be looking for causes of disease and in fact....it is becoming increasingly obvious that they are actually preventing causes and cures from being shared with the public. Yes...poor diet, processing of food, depleted soil, and chemicals in the environment are playing a role in this decline in world health, however, respected scientists have discovered pathogenic microbes that may be playing a central or supportive role in the real plagues we are currently experiencing. Media/ government propaganda is leading us to think that acute diseases , such as Ebola, West Nile Virus, SARS, Anthrax, Swine Flu...etc are our biggest concerns, but in reality it is the slowly disabling diseases, which can eventually even result in cancer, that are our biggest threats. We are being psychologically primed to focus on the "media scare diseases" instead of the real issues.<br />
<br />
Through extensive and meticulous research, molecular biologist, Judy Mikovits, discovered a retrovirus present in many Chronic Fatigue patients, Lyme disease patients, Autism patients and also in many other segments of the autoimmune and chronic illness population. Was her research promoted and expanded on by others or was it aborted and covered up? Is disease being allowed to pass through the population for profit and possible population reduction? I think many factors are involved.<br />
<br />
As a result of Mikovits's research and refusal to compromise her values of honesty and integrity, she was jailed and basically stripped of her respected status in molecular biology. This is not just happening to her but to other scientists also. Scientists are afraid to speak out for fear of suffering the retribution that Dr. Mikovits and others have experienced. Sincere intelligent scientists with the real answers to our health problems are being effectively silenced. However, not everyone is afraid to speak out. Dr Judy Mikovits has written a book called "Plague" that documents her incredible story of deception, betrayal, and intrigue, which has tentacles reaching into the highest levels of government. Devastating disease continues to spread through the world while high officials in government health agencies continue to cover up the real and potential causes of these diseases. More profits are made on chronically ill people than on those who are healthy. Corporations and supposed nonprofit groups are currently meshed with government as documented in "Plague". The first step in correcting this diabolical mess is to learn about the real and deceptive elements involved. Only then can we begin to correct the situation. We desperately need freedom , truth , and honesty reinstated into science if the human race is to survive. I believe that reading the book Plaque, by authors Kent Heckenlively and Dr. Judy Mikovits is an essential step in the right direction. This book should be read by everyone , including those officials who are complicit in this corruption because they are not immune to these diseases and eventually everyone will be affected.<br />
<br /></div>
</div>
<iframe allowfullscreen="" frameborder="0" height="360" src="//www.youtube.com/embed/K-ReDZpqUjs?feature=player_detailpage" width="640"></iframe><br />
<a href="http://www.plaguethebook.com/">http://www.plaguethebook.com/</a></div>
<br />
<iframe frameborder="0" marginheight="0" marginwidth="0" scrolling="no" src="//ws-na.amazon-adsystem.com/widgets/q?ServiceVersion=20070822&OneJS=1&Operation=GetAdHtml&MarketPlace=US&source=ac&ref=tf_til&ad_type=product_link&tracking_id=foodfreerevo-20&marketplace=amazon&region=US&placement=1626365652&asins=1626365652&linkId=BJJUOCOINY5N7HQT&show_border=true&link_opens_in_new_window=true" style="height: 240px; width: 120px;"><br />
</iframe></div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-5876257241074222326.post-6748679771729804712014-08-26T09:53:00.000-07:002014-08-26T10:27:05.724-07:00HOW CAN WE IMPROVE THE ICE BUCKET CHALLENGE?<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="http://2.bp.blogspot.com/-GvnB7b2BiaQ/U_yt8ZGkb7I/AAAAAAAADAc/yJbRFpZB7II/s1600/DSC_0241.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://2.bp.blogspot.com/-GvnB7b2BiaQ/U_yt8ZGkb7I/AAAAAAAADAc/yJbRFpZB7II/s1600/DSC_0241.JPG" height="426" width="640" /></a></div>
The other day when I was shopping for groceries at Bishop's Orchards in Guilford, Connecticut, I ran into the employees preparing for an Ice Bucket Challenge for ALS. I happened to have my camera in the car and ran to get it. I was just in time to capture the icy cold waterfall! After everyone dried out a bit I walked over to the organizer and few of the employees who worked at Bishops and told them that I thought it was great that they were doing this to try and help people in need ......but then I had to add my concerns. I began by sharing the fact that many people who really have neurological Lyme disease are often misdiagnosed with ALS, M.S., Lupus, Parkinson's, Bipolar Depression, Chronic Fatigue Syndrome, Fibromyalgia, Rheumatoid arthritis....etc. I also asked them if they knew of any charity.....any charity at all.....that has ever found a cure.<br />
<br />
Finding a cure is supposed to be a disease charity's main objective....but so far we only have symptomatic treatments. Nobody could think of any charity that has found a cure for any disease. Many of these disease charities , such as the M.S Society, tends to ignore the studies and patients who try to share their misdiagnosis experiences with these charities. The charities continue to focus on symptomatic treatments....instead of cures and prevention....finding the cause. But...finding a cause does not make money so no one funds research into a cause or into prevention.<br />
<br />
Instead, what is taking place is that cures and proper prevention are being suppressed while symptomatic treatments, offered by the drug companies, are the only solutions being given. These drugs never address the cause of the disease. In fact none of these diseases supposedly have any definitive tests, causes or cures. ...but are often thrown into the autoimmune category. After I shared my thoughts, the woman who organized the ice bucket challenge said to me that they were NOT donating to the ALS Foundation but were raising awareness and funds for Amanda's Angels.....a local charity. <a href="http://www.amandas-angels.org/about/">http://www.amandas-angels.org/about/</a> It was very encouraging to hear that they were helping someone local and knew that their time, money and effort would be well used. Amanda is a woman who found out she had ALS almost immediately after discovering she was pregnant. Now Amanda may or may not have the Lyme disease spirochete or other germ as the cause of her illness. She has been told that her case of ALS is genetic.<br />
<br />
However.....what causes our genes to be aberrant and pass through the generations? Science is discovering that the food we eat and the microbes we come into contact with can change our genetics for better or for worse. So...just because we are told that something is genetic...doesn't mean we cannot improve or cure it if we have the proper information on how to do so. But as I mentioned before the drug companies and the charities do not want cures because this would cause them both to be out of business. So...what is happening is that our society treats only the symptoms of disease, lets the real cause simmer under the surface and to progress to a more serious state.<br />
<br />
<a href="http://3.bp.blogspot.com/-xzWjmF-BGsE/U_y2XEoaxTI/AAAAAAAADAo/bjEm86bXxwk/s1600/DSC_0242.JPG" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="http://3.bp.blogspot.com/-xzWjmF-BGsE/U_y2XEoaxTI/AAAAAAAADAo/bjEm86bXxwk/s1600/DSC_0242.JPG" height="426" width="640" /></a>My thought is......why don't we improve our fundraising efforts by still having fundraising events but donating the funds to either local people in need or to PRIVATE researchers who are NOT affiliated with drug companies or charities (which are probably just arms of the drug companies). We should have some sort of better communications between patients, activists, and researchers to determine what research is really needed and then fundraisers could be conducted accordingly. Unfortunately this takes more effort than just donating to any charity that has a good story or gimmick.<br />
<br />
So...the next time you are asked to donate money to a charity...ask whomever is asking for the money...what specific research will be conducted with this money? Will it really be used for finding a cure or will it be used to keep us all sick while only treating the symptoms? Let's let the charities and the drug companies know how we feel! Perhaps if we stop donating to corporate charities and fund private researchers and local people in need......then things might improve.<br />
Thank you Bishop's Orchard for helping out locally!<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://4.bp.blogspot.com/-ZOc0K4ILpzQ/U_y2mHc4cvI/AAAAAAAADAw/ywdSUufHv1U/s1600/DSC_0250.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://4.bp.blogspot.com/-ZOc0K4ILpzQ/U_y2mHc4cvI/AAAAAAAADAw/ywdSUufHv1U/s1600/DSC_0250.JPG" height="426" width="640" /></a></div>
<br /></div>
Unknownnoreply@blogger.com1tag:blogger.com,1999:blog-5876257241074222326.post-64586821122966670922014-08-26T04:52:00.000-07:002014-08-27T03:22:26.503-07:00LYME DISEASE IN AUSTRALIA<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="http://2.bp.blogspot.com/-yZGSB3PiUhw/U_xxn_xZ18I/AAAAAAAADAM/x5gSTuTO-Vc/s1600/th.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://2.bp.blogspot.com/-yZGSB3PiUhw/U_xxn_xZ18I/AAAAAAAADAM/x5gSTuTO-Vc/s1600/th.jpg" height="528" width="640" /></a></div>
<br />
<br />
Lyme Disease has become a worldwide pandemic. This disease is being undiagnosed, misdiagnosed and under-diagnosed around the world. Australia is having a particularly severe problem with the government of Australia denying that Lyme disease even exists in Australia. For some reason the media skips around the severity of this issue and instead focuses on diseases which currently pose no real threat...such as Anthrax, West Nile Virus, SARS, Swine Flu, and even Ebola. Contrary to popular propaganda, acute disease that quickly results in death is<b> not</b> the greatest threat to society. Acute infectious disease is easy to recognize, track, and quarantine which enables health authorities to contain the spread of disease.<br />
<br />
A more dangerous and diabolical scenario is........the complete denial of the presence or severity of an infectious disease which is not immediately lethal but that creates disability and further down the road can produce death. Officials have been quoted in government documents as saying that it is more effective to take down a country (destroying its economic fabric) through using disabling agents rather than microbes which quickly kill. It was stated that when a country experiences many disabled people ...it ties up many others in caring for these people and gradually destroys the economy. Drug companies benefit from misdiagnosing disease as autoimmune. So-called autoimmune diseases usually have no known definitive tests, causes or cures....only symptomatic treatments. When only treating the symptoms of disease...the cause of the disease condition goes untreated, simmers and creates more disease in the patient's body, and passes through the population unchecked...which is exactly what is happening. More chronic illness equals more profits for drug companies and more control by governments.<br />
<br />
Please read the article below to discover that the Lyme disease pandemic is not just being denied in the United States and Canada but it is reported that Australia is experiencing an even more severe denial and lack of treatment. Citizens are being told that there is no such thing as Lyme disease in Australia despite patients who have positive Lyme serology and DNA tests. Instead of being treated for Lyme disease with antibiotics, citizens are receiving more dangerous drugs which only treat the symptoms of disease labels such as Chronic Fatigue Syndrome, Fibromyalgia, M.S, Lupus, Parkinson's and many more.........<br />
<br />
<br />
<div class="yiv3592821842MsoNormal">
<br />
<span style="font-size: x-large;"><b>A False Perception that Lyme Disease is a "Minor Disease"</b></span>.</div>
<div class="yiv3592821842MsoNormal">
<br /></div>
<div class="yiv3592821842MsoNormal">
Recently the US Centers for Disease Control and Prevention
(CDC) updated their official Lyme disease statistics. The old statistics
indicating that there are 30,000 new
cases of Lyme disease in the US every year have been replaced by a 10 fold
higher figure of 300,000 new cases every year. Some health professionals
consider that this figure could be too low by a factor of 10.</div>
<div class="yiv3592821842MsoNormal">
<br /></div>
<div class="yiv3592821842MsoNormal">
Taking the figure of 300,000 diagnosed, this represents
about 0.1% of the US</div>
<div class="yiv3592821842MsoNormal">
population. In comparison, 0.1% of the Australian population
(22m) is approximately 22,000. Of course this is an annual diagnosis figure, so
over 10 years it equates to about 220,000 new Lyme disease diagnoses.</div>
<div class="yiv3592821842MsoNormal">
<br /></div>
<div class="yiv3592821842MsoNormal">
There are a number of overseas studies showing that the
frequency of serum samples positive for Lyme disease using commercial antibody
tests is about 3%. This equates to 660,000 Australians possibly having had
contact with Lyme disease organisms.</div>
<div class="yiv3592821842MsoNormal">
<br /></div>
<div class="yiv3592821842MsoNormal">
The causative organism responsible for Lyme disease is
generally considered to be a member of the <i>Borrelia</i>
bacterial family. <i>Borrelia</i> bacteria
were first identified in 1959 in Australia by the CSIRO, and there have been
other positive reports since that time. The Queensland Health Department recognized
Lyme disease in Australia until the early 1990s. Then mysteriously their policy
was revised. Around this time the NSW Health Department provided advice that
Lyme disease could not be detected in Australian ticks. It has become the dogma
in the psyche of the Australian medical system that Lyme disease does not exist
in Australia.</div>
<div class="yiv3592821842MsoNormal">
<br /></div>
<div class="yiv3592821842MsoNormal">
Against this backdrop there have been many Australians
diagnosed with Lyme disease by serology tests. Estimates would be around 2,000
positive tests in the last 1-2 years. This means that hundreds of thousands
have not even had Lyme tests! Now, rather than using antibody tests it is
possible to use DNA tests that specifically identify the bacterial species. Identification
of Lyme disease in Australia has been identified by these DNA tests. Thus
reputed claims attributed to the Chief Medical Officer and others that there is
no evidence for Lyme disease in Australia are scientifically incorrect.</div>
<div class="yiv3592821842MsoNormal">
<br /></div>
<div class="yiv3592821842MsoNormal">
Incorrect claims by medical overseers may be considered
unethical. These individuals have moral and legal obligations to present
scientifically accurate information to patients.</div>
<div class="yiv3592821842MsoNormal">
<br /></div>
<div class="yiv3592821842MsoNormal">
A bill presented in the NSW Parliament by the Greens Party
recognizing Lyme disease in Australia was defeated by the Liberal/National and Labor
parties. This must rank as one of the most disgraceful and ignorant acts in
Australian history and shames these major parties. Considering the enquiry into
childhood abuse then there is an even stronger case for a Royal Commission into
the mishandling of Lyme disease, and sufferers of medical negligence should be
able to provide their stories. Here again the conspiracy of silence has
condemned many innocent Australians, and likewise the irresponsible authorities
have chosen to do nothing.</div>
<div class="yiv3592821842MsoNormal">
<br /></div>
<div class="yiv3592821842MsoNormal">
The Australian Government has sacrificed thousands of
Australians at Gallipoli, the Somme, Singapore, Vietnam, Iraq and Iran, and
celebrates these "achievements'. To this can be added the sacrifice of
thousands of Lyme disease sufferers (and other misdiagnosed people). Money is
being poured into warplanes ($20-30 billion), Anzac celebrations ($300-600 million)
and even a race around the Albert Park duck pond ($30 -50 per year). The amount
spent on Lyme disease is a big fat zero. At this point the $6</div>
<div class="yiv3592821842MsoNormal">
levy for doctor visits can be considered a fee for non-diagnosis
and misdiagnosis of hundreds of thousands of Australians.</div>
<div class="yiv3592821842MsoNormal">
<br /></div>
<div class="yiv3592821842MsoNormal">
A person from New Zealand was bitten by a koala at an
Australian nature park. This person subsequently suffered tremendously from Lyme
disease, and yet the media triumphantly reports the royal family in the near
presence of a koala with the ongoing risk of Lyme disease. Nature parks should
be legally responsible for the safety of visitors.</div>
<div class="yiv3592821842MsoNormal">
<br /></div>
<div class="yiv3592821842MsoNormal">
Considerable scientific evidence exists that Lyme disease is
"associated or the causative agent" for many diseases. This includes chronic
fatigue syndrome (CFS), fibromyalgia, autism, arthritis, MS etc. About 90-100%
of CFS people in some clinics are Lyme disease positive. Some Lyme disease sufferers have also
been diagnosed with cancers, and an
association between the Lyme bacteria and cancer has been suggested. This
association is strengthened by the codiagnosis of Lyme disease and lymphomas.</div>
<div class="yiv3592821842MsoNormal">
<br /></div>
<div class="yiv3592821842MsoNormal">
In summary, Lyme disease is a growing infectious threat in
Australia. Medical authorities need to take their collective heads out of the
sand and start treating Lyme disease as a serious illness that affects hundreds
of thousands of people in Australia.</div>
<br clear="all" />
<br />
-- <br />
<div>
<div>
<div>
Dr Ivan Hooper BSC PHD</div>
<div>
Down under</div>
Halls Gap</div>
Victoria</div>
Australia</div>
Unknownnoreply@blogger.com1tag:blogger.com,1999:blog-5876257241074222326.post-24515098146893252522014-07-17T07:14:00.004-07:002014-07-17T07:14:53.401-07:00The Connection Between Alzheimer's, Lyme Disease, Cataracts, and Dental Health<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-qcvde2f_OPA/U8e-79Oy3eI/AAAAAAAAC_s/lSpyqr3j_WU/s1600/Amyloid_plaques_alzheimer_disease_HE_stain.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://3.bp.blogspot.com/-qcvde2f_OPA/U8e-79Oy3eI/AAAAAAAAC_s/lSpyqr3j_WU/s1600/Amyloid_plaques_alzheimer_disease_HE_stain.jpg" height="474" width="640" /></a></div>
AMYLOID PLAQUES IN ALZHEIMER'S DISEASE<br />
<br />
First of all, let's establish the connection between Alzheimer's, cataracts, poor dental health (which includes gingivitis,dental cleaning, gum surgery, and root canals), amyloid plaques, oral spirochetes and Lyme spirochetes which may all connect in causing inflammation in the eye and in the brain. It is observed that inflammation from infection causes cataracts and disease of the brain, which includes the amyloid plaques of Alzheimer's disease. This will be a fairly long article with videos, in order to establish these extremely important connections.<br />
Alzheimer's disease, other neuro-degenerative disease, and autoimmune diseases are spreading out of control. In order to stem this tide of sickness and disability, we need to find and treat the ROOT causes instead of only identifying and treating the symptoms. Main stream medicine tells us that they are treating the cause when they prescribe anti-inflammatory drugs, steroids, etc....which temporarily reduce the inflammation ......But government researchers and the pharmaceutical companies are either innocently or intentionally ignoring the CAUSES of inflammation. Infection with bacteria, fungus, and viruses are obvious causes of inflammation in the brain, the heart, the eye and other parts of the body. By only treating the symptoms of inflammation, instead of treating the cause of inflammation, the medical system creates a market for anti-inflammatory drugs and other drugs which ONLY treat the symptoms. This practice allows infections to go undiagnosed and untreated and makes the drug companies rich.<br />
<br />
While much attention is given to marginal or made up diseases, such as SARS, Swine Flu, West Nile Virus....etc.....it appears that the CDC, drug companies and other government agencies are intentionally drawing attention away from the serious long term infections which cause Alzheimer's, possibly autoimmune disease, and other neuro-degenerative diseases such as Lupus, M.S, ALS, Fibromyagia, CFS, cataracts...and the list goes on and on. Is anyone noticing that just about everyone in modern society is now sick with one condition or another....conditions which supposedly have no definitive tests, causes, or cures?<br />
<br clear="none" />
<br />
The work of Judith Miklossy and Alan McDonald needs to be widely distributed and studied. Judith Miklossy, a Swiss researcher, and Dr. Alan McDonald, an MD and Pathologist, have found lyme spirochetes and oral spirochetes in the brains of Alzheimer's patients upon autopsy. Here are a couple links to Miklossy's studies. <a href="http://www.lymesentinel.blogspot.com/search/label/ALZHEIMER%27S%20AND%20INFECTION">http://www.lymesentinel.blogspot.com/search/label/ALZHEIMER%27S%20AND%20INFECTION</a> and <a href="http://lymesentinel.blogspot.com/2011/08/alzheimers-disease-neurospirochetosis.html">http://lymesentinel.blogspot.com/2011/08/alzheimers-disease-neurospirochetosis.html</a><br />
<br clear="none" />
<br />
The work of Alan MacDonald, which coincides with Miklossy's research can be found in the videos at the bottom of this article. The video is in several parts and fairly long but contains vital information.<br />
<br clear="none" />
<br />
<br />
The following message was written to a group of doctors and researchers who specialize in Lyme disease and the many other infections that ticks can spread. The message is conveying that cataracts can be caused by inflammation and that the microbes that cause this inflammation can also cause dementia. It is thought that cataracts are a good indication that Alzheimer's may develop down the road.<br />
<br />
<span style="color: #990000;"><b><br clear="none" /></b></span> <br />
<div dir="ltr" id="yui_3_16_0_1_1405593382746_2740">
<div id="yui_3_16_0_1_1405593382746_2894">
<span style="color: #990000;"><b>To all;</b></span></div>
<div id="yui_3_16_0_1_1405593382746_2739">
</div>
<div id="yui_3_16_0_1_1405593382746_2794">
<span style="color: #990000;"><b> Everyone should know the work of Judith Miklossy. Pubmed it. Always reference number three.</b></span></div>
<div id="yui_3_16_0_1_1405593382746_2744">
</div>
<div id="yui_3_16_0_1_1405593382746_2745">
<span style="color: #990000;"><b> The photomicrographs of Alz's brain and those infected by neurospirochetosis are EXACTLY THE SAME. </b></span></div>
<div id="yui_3_16_0_1_1405593382746_2795">
</div>
<div id="yui_3_16_0_1_1405593382746_2746">
<span style="color: #990000;"><b> The inflammation from intracellular infection causes the amyloid to accumulate. This is seen in the eye as a senile cataract. It was also reported on CBS news last night, as amyloid deposition on the retina, seen 20 years prior to the development of dementia.</b></span></div>
<div id="yui_3_16_0_1_1405593382746_2907">
</div>
<div id="yui_3_16_0_1_1405593382746_2892">
<span style="color: #990000;"><b> All providers can make eye information, available from the patient's opthalomogist, as a method of tracking long term inflammation treatment, and effects on cataract size changes, as well as the retinal nerve fibrogram.</b></span></div>
<div id="yui_3_16_0_1_1405593382746_2893">
</div>
<div id="yui_3_16_0_1_1405593382746_2748">
<span style="color: #990000;"><b> Dr. Clem Trempe....... <a href="http://www.zoominfo.com/p/Clement-Trempe/488187">http://www.zoominfo.com/p/Clement-Trempe/488187</a> has found that such treatment of intracellular infection will result in cataract improvement and improvement in cognitive decline. My review of the records finds improvements in visual acuity about 80 percent of the time. He also finds 85% positive antibody tests to intracellular infections, with 45% more than a single infection. (This sounds familiar for those acquainted with the co-infection rate in Lyme.)</b></span></div>
<div id="yui_3_16_0_1_1405593382746_2749">
</div>
<div id="yui_3_16_0_1_1405593382746_2750">
<span style="color: #990000;"><b> I use information from ILADS to help reverse the cataract decline, as well as the cognitive decline, as Lyme disease is the quintessential, and as far as I can tell, best understood intracellular infection.</b></span></div>
<div id="yui_3_16_0_1_1405593382746_2913">
</div>
<div>
<span style="color: #990000;"><b> So there is hope.</b></span></div>
<div id="yui_3_16_0_1_1405593382746_2912">
</div>
<div id="yui_3_16_0_1_1405593382746_2921">
<span style="color: #990000;"><b> We can on our own, individually begin to treat and reverse Alzheimer's. </b></span></div>
<div id="yui_3_16_0_1_1405593382746_2911">
</div>
<div id="yui_3_16_0_1_1405593382746_2752">
<span style="color: #990000;"><b> Do not wait for the federal government.</b></span></div>
<div id="yui_3_16_0_1_1405593382746_2922">
</div>
<div id="yui_3_16_0_1_1405593382746_2910">
<span style="color: #990000;"><b> Do not trust in single interventions. We know from Lyme that it is best treated with a combined approach.</b></span></div>
<div id="yui_3_16_0_1_1405593382746_2753">
</div>
<div id="yui_3_16_0_1_1405593382746_2754">
<span style="color: #990000;"><b> Do not stop. Proceed. For anyone that wants help in establishing such a clinic, and there are patients who will pay, feel free to reply.</b></span></div>
<div id="yui_3_16_0_1_1405593382746_2755">
</div>
<div id="yui_3_16_0_1_1405593382746_2909">
<span style="color: #990000;"><b> Sincerely,</b></span></div>
<div id="yui_3_16_0_1_1405593382746_2756">
</div>
<div id="yui_3_16_0_1_1405593382746_2758">
<span style="color: #990000;"><b> P. James Seberger, M.D., Ph.D. <span id="yui_3_16_0_1_1405593382746_2734" style="font-family: Arial;"><a href="mailto:pjseberger@gmail.com" id="yui_3_16_0_1_1405593382746_2733" rel="nofollow" shape="rect" target="_blank">pjseberger@gmail.com</a></span></b></span><br />
<br />
<span style="color: #990000;"><b><span id="yui_3_16_0_1_1405593382746_2734" style="font-family: Arial;"><span style="color: #38761d;">Another important factor in the development of dementia may be dental infections and dental work, such as root canals, gingivitis,dental cleaning, and gum surgery , which can create openings in the oral cavity to allow bacteria in the mouth a direct route to the brain, heart, and nervous system. The main point of this article is that bacteria causes inflammation and inflammation causes amyloid plaques which are found in Alzheimer's disease. Also that lyme spirochetes and oral spirochetes (microbes found in the mouth) are two of the probable causes of dementia.</span></span></b></span><br />
<br />
<span style="color: #990000;"><b><span id="yui_3_16_0_1_1405593382746_2734" style="font-family: Arial;"><span style="color: #38761d;">The following are videos concerning the topics above.</span></span></b></span><br />
<span style="color: #990000;"><b><span id="yui_3_16_0_1_1405593382746_2734" style="font-family: Arial;"><span style="color: #38761d;"> </span> </span></b></span></div>
</div>
</div>
<br />
<br />
<iframe allowfullscreen="" frameborder="0" height="360" src="//www.youtube.com/embed/r8tESJVvM88?feature=player_detailpage" width="640"></iframe></div>
<br />
<iframe allowfullscreen="" frameborder="0" height="360" src="//www.youtube.com/embed/2RATCS-3v9Q?feature=player_detailpage" width="640"></iframe></div>
<br />
<iframe allowfullscreen="" frameborder="0" height="360" src="//www.youtube.com/embed/FEjNMlNM3l8?feature=player_detailpage" width="640"></iframe></div>
<br />
The next video is Dr. Nordquist demonstrating the effectiveness of colloidal silver, bleach and then honey with natural herbals on the bacteria in the spaces around the gums. Because it is believed that dementia, heart disease, and other health problems are caused by bacteria in the mouth gaining access to the brain and other parts of the body through dental cleanings or different types of surgeries and root canals, Dr. Nordquist is looking at different methods of cleansing the mouth of bacteria before conducting dental work.<br />
<br />
<iframe allowfullscreen="" frameborder="0" height="360" src="//www.youtube.com/embed/2CAg38kfYH8?feature=player_detailpage" width="640"></iframe></div>
<br />
The following book is written by Dr. Nordquist which explains his theories of lyme spirochetes in the mouth and regular oral spirochetes (which have both been found in the brains of Alzheimer's patients) perhaps causing Alzheimer's disease. Think of the huge pandemic of Lyme disease and the many other infections that ticks are now passing to humans....and also think of the number of people who have invasive dental procedures, AND the growing number of people with Alzheimer's. These issues seem to coincide. I believe this is a very important book. My personal lyme story includes gum surgery and a slowly developing and debilitating illness....which after 8 years of suffering was found to be Lyme disease. I don't remember a specific tick bite at the time I became ill but did have many tick bites previous to my gum surgery. When the Lyme disease was treated with long term combination antibiotic therapy....many of my symptoms disappeared, including extreme cognitive issues of concentration, poor memory, and a lack of organizational abilities. I have brain SPECT scans which show the progression and improvement of the Lyme disease in correlation with antibiotic treatment and discontinuation of treatment. The radiologist wrote that the lack of blood flow to certain parts of my brain were consistent with an Alzheimer's brain. So...treating the infection vastly improved my cognitive problems...if seen in elderly people would be labeled as dementia or Alzheimer's disease.<br />
<br /></div>
<iframe frameborder="0" marginheight="0" marginwidth="0" scrolling="no" src="//ws-na.amazon-adsystem.com/widgets/q?ServiceVersion=20070822&OneJS=1&Operation=GetAdHtml&MarketPlace=US&source=ac&ref=tf_til&ad_type=product_link&tracking_id=foodfreerevo-20&marketplace=amazon&region=US&placement=0976379783&asins=0976379783&linkId=INQRXTVLHDUGUIWE&show_border=true&link_opens_in_new_window=true" style="height: 240px; width: 120px;"><br />
</iframe></div>
Unknownnoreply@blogger.com4tag:blogger.com,1999:blog-5876257241074222326.post-60830288191660712592014-02-03T07:05:00.000-08:002014-02-03T07:05:02.002-08:00STUDY FURTHER SUGGESTS LYME DISEASE MAY BE SEXUALLY TRANSMISSIBLE<div dir="ltr" style="text-align: left;" trbidi="on">
<span style="color: #134f5c;"><b>Lyme disease is the fastest growing infectious disease in the modern world. It is becoming very obvious that we need to understand more about it. How is it spread? Can the Lyme disease pathogen be spread from person to person? The CDC doesn't think so but clinical evidence and new studies indicate otherwise.<br />
</b></span> <span style="color: #134f5c;"><b>The statement below in red came from the CDC website. There are many couples who have both become ill with Lyme disease and due to their exposure circumstances, claim that the disease was sexually transmitted from one partner to the other. Some Lyme literate doctors treat both sexually active partners when one has a known case of Lyme disease. </b></span><br />
<br />
<span style="color: #134f5c;"><b>Syphilis is a spirochete as is Borrelia burgdorferi, the causative agent of Lyme disease. They both behave in similar ways. The Syphilis pathogen is sexually transmissible so it follows that it is a possibility that Borrelia burgdorferi may also be sexually transmitted....especially due to the fact that this pathogen has been found in vaginal secretions and in semen...<span style="color: #990000;">.<i>as the new study below indicates.</i></span> If this disease is sexually transmitted it does not necessarily mean that the the partner whom the germ was transmitted to will become sick. It all seems to depend on the individual's immune system. </b></span><br />
<span style="color: #134f5c;"><b><br />
</b></span> <span style="color: #134f5c;"><b>Not enough studies are being done to investigate transmission issues and government agencies seem to be excessively slack with the research in the areas of transmission of Lyme disease through sexual intercourse and from mother to fetus. For more information on transmission of Lyme disease from mother to baby, please go to the bottom of this post.</b></span><br />
<br />
<span style="color: #134f5c;"><b>It seems irresponsible to me for the CDC to claim irrefutably there is no evidence that Lyme disease can be transmitted from person to person. Remember though that the transmission of the pathogen does not necessarily mean that the receiver of the germ will become ill</b></span>.<span style="color: #990000;"><b> People can harbor a germ and remain well as long as their body's immune defense is up to par.</b></span><br />
<center>
</center>
<h2 id="arethere">
<span style="color: #cc0000;"> CDC Statement</span></h2>
<h2 id="arethere">
<a border="0" href="http://www.mountainroseherbs.com/index.php?AID=111632&BID=13910" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;" target="_blank"><img alt="A passion for organics picture frame" border="0" src="http://www.mountainroseherbs.com/affiliate/graphics/AB2-final.gif" /></a><span style="color: #cc0000;">"Are there other ways to get Lyme disease?</span></h2>
<span style="color: #cc0000;"> </span><br />
<ul>
<li><b><span style="color: #cc0000;">There is no evidence that Lyme disease is transmitted from person-to-person. For example, a person cannot get infected from touching, kissing or having sex with a person who has Lyme disease."</span></b></li>
<li><b><span style="color: #cc0000;"> <a href="http://www.cdc.gov/lyme/Transmission/">http://www.cdc.gov/lyme/Transmission/</a></span></b></li>
</ul>
<div id="yui_3_13_0_ym1_1_1391204301147_8985">
<br clear="none" />
<br clear="none" />
<span style="color: blue;"><b>The following is a study which shows that it is possible for Lyme disease to be transmitted sexually</b></span></div>
<div id="yui_3_13_0_ym1_1_1391204301147_8991">
<span style="font-size: x-large;"><b>"SAVE THE DATE! <span class="yiv3611398173Apple-style-span">7th Annual Medical-Scientific </span><span class="yiv3611398173Apple-style-span">Conference on Morgellons </span></b></span></div>
<div id="yui_3_13_0_ym1_1_1391204301147_8986">
<span style="font-size: x-large;"><b><span class="yiv3611398173Apple-style-span" id="yui_3_13_0_ym1_1_1391204301147_8990">March 29th and 30th, 2014 Austin, TX</span></b></span></div>
<div id="yui_3_13_0_ym1_1_1391204301147_8989">
<b><br clear="none" /></b></div>
<div id="yui_3_13_0_ym1_1_1391204301147_8987">
<b><span id="yui_3_13_0_ym1_1_1391204301147_8988">CONTROL ID: 1848565<br clear="none" />CONTACT (NAME ONLY): Raphael Stricker<br clear="none" />PRESENTATION TYPE: Oral Only<br clear="none" />CURRENT CATEGORY: Infectious Diseases<br clear="none" />Abstract<br clear="none" />TITLE: ISOLATION AND DETECTION OF BORRELIA BURGDORFERI FROM HUMAN VAGINAL AND SEMINAL SECRETIONS<br clear="none" /><br clear="none" />AUTHORS (FIRST NAME, LAST NAME): Marianne J. Middelveen1, Cheryl Bandoski2, Jennie Burke3, Eva Sapi2, Peter J. Mayne4, Raphael B. Stricker5<br clear="none" />INSTITUTIONS (ALL): 1. Atkins Veterinary Services, Calgary, AB, Canada. <br clear="none" />2. University of New Haven, West Haven, CT, United States. <br clear="none" />3. Australian Biologics, Sydney, NSW, Australia. <br clear="none" />4. Laurieton Medical Centre, Laurieton, NSW, Australia. <br clear="none" />5. CPMC, San Francisco, CA, United States. <br clear="none" />ABSTRACT BODY: <br clear="none" />Purpose of Study: Recent reports indicate that more than 300,000 cases of Lyme disease are diagnosed yearly in the USA. Previous epidemiological and immunological studies suggest that infection with the Lyme disease spirochete Borrelia burgdorferi could be transferred from person to person via intimate human contact without a tick vector (Harvey and Salvato, Med Hypotheses 2003;60:742; Stricker et al, J Investig Med 2004;52:S151). Detecting viable spirochetes in vaginal and seminal secretions would provide additional evidence to support this hypothesis.<br clear="none" /><br clear="none" />Methods Used: Three North American patients with a history of Lyme disease, one male and two female, were selected for the study after informed consent was obtained. Serological testing for B. burgdorferi was performed on all three subjects. Blood and semen or vaginal secretions were used to inoculate BSK-H medium for Borrelia culture. Motile spirochetes were detected in cultures by light and/or darkfield microscopy, and cultured spirochete concentrates were subjected to Dieterle silver staining, scanning electron microscopy (SEM) and anti-B. burgdorferi immunohistochemical staining for further characterization. Polymerase chain reaction (PCR) testing was performed by two independent laboratories for specific identification of the cultured isolates. Positive and negative controls for immunohistochemical staining and PCR were performed in all experiments.<br clear="none" /><br clear="none" />Summary of Results: Serum antibodies to B. burgdorferi were detected in all three patients. Motile spirochetes were observed in culture fluid inoculated with blood and genital secretions from the three subjects. Morphological features of spirochetes were confirmed by Dieterle staining, SEM and immunohistochemical staining of culture concentrates. PCR testing confirmed that the spirochetes isolated from blood and genital secretions were strains of B. burgdorferi, and PCR subtyping indicated that the strains were B. burgdorferi sensu stricto.<br clear="none" /><br clear="none" />Conclusions: The culture of viable B. burgdorferi in genital secretions suggests that Lyme disease could be transmitted by intimate contact from person to person."</span></b><br />
<div id="yui_3_13_0_ym1_1_1391204301147_8992">
<b>Journal of Investigative Medicine</b></div>
<div id="yui_3_13_0_ym1_1_1391204301147_8993">
<b><br clear="none" /></b>
<b>For a bit further explanation of this study see <a href="http://www.prweb.com/releases/2014/01/prweb11506441.htm">http://www.prweb.com/releases/2014/01/prweb11506441.htm</a></b><br />
<span style="font-size: large;"><span style="color: #cc0000;"><b><br clear="none" /></b></span></span> <span style="font-size: large;"><span style="color: #cc0000;"><b>The Infectious Disease Society of America claims that there is no proof that Lyme disease can be transmitted from mother to fetus. Here is an important article that completely refutes this unscientific statement. <a href="http://lymesentinel.blogspot.com/2009/07/hearing-tesimonylyme-disease.html">http://lymesentinel.blogspot.com/2009/07/hearing-tesimonylyme-disease.html</a></b></span></span><br />
<br />
<br />
<center>
<a border="0" href="http://www.mountainroseherbs.com/index.php?AID=111632&BID=682" target="_blank"><img alt="Mountain Rose Herbs. A herbs, health and harmony c" border="0" src="http://www.mountainroseherbs.com/affiliate/graphics/logo2.jpg" /></a></center>
</div>
</div>
</div>
Unknownnoreply@blogger.com2tag:blogger.com,1999:blog-5876257241074222326.post-84481008025485632422013-12-26T07:14:00.000-08:002013-12-26T07:14:45.037-08:00YES.....LYME DISEASE IS PRESENT IN AUSTRALIA TOO<div dir="ltr" style="text-align: left;" trbidi="on">
<iframe allowfullscreen="" frameborder="0" height="360" src="//www.youtube.com/embed/hm6yMj-OuP4?feature=player_embedded" width="640"></iframe><br />
<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
<b><span style="color: #990000;">The seriousness and widespread nature of the Lyme Disease and Co-infection pandemic is being denied in every country where it is present. General opinion claims that this odd state of affairs is due to the medical profession's inability or slowness to accept new ideas and the presence of new disease. I don't buy this excuse. What about SARS, Swine Flu, West Nile Virus, etc etc. The medical community seems to have no problems accepting the scare propaganda associated with these diseases which are claimed to be affecting many. I don't know of anyone with these diseases...but I personally do know of hundreds who are very very ill with Lyme disease, Babesia, bartonella, mycoplasma fermentens, erlichia...etc. All of these pathogens can be passed through one tick bite. This fact is known by medical officials in the CDC, NIH...and the Infectious Disease Society of America...however most doctors are not instructed to look for these microbes in patients. Most patients are just given a diagnosis or meaningless label of Chronic Fatigue Syndrome, Multiple Sclerosis, Fibromyalgia...etc......with no effort to try and identify the causes of these disease labels which are basically just identifying the symptoms which results in only treating the symptoms instead of the cause(s).</span></b><br />
<br />
<b><span style="color: #990000;">What is now happening in Australia has also been taking place in the United States and other countries. Doctors who are trying to treat patients appropriately, by discovering and treating the CAUSE....are being systematically investigated and restricted when it comes to treating Lyme disease and the coinfections which are also passed on by ticks and other blood sucking insects. Many doctors have already lost their licenses to practice medicine. </span></b><br />
<br />
<b><span style="color: #990000;">One Bill was passed in Connecticut which had the similar outcome as the orders or restrictions below which are being imposed on a legitimate doctor in Australia who specializes in treating Lyme, Chronic fatigue Syndrome and other mysterious chronic illnesses. The Connecticut Bill stated that if a patient was still sick after receiving the standard length of antibiotic treatment prescribed by their general practitioner...then in order to get further treatment the patient's GP could no longer order further treatment but the patient would have to see either a neurologist or an infectious disease specialist for their opinion as to whether or not they needed more treatment. This may sound like an OK idea on the surface but what we found in Connecticut was that the opinions of most neurologists and infectious disease specialists were seemingly controlled and functionally worthless to chronically ill patients. Rarely would one of these specialists prescribe further antibiotic treatment even if the treatment had been slowly helping the patient...but just wasn't quite enough yet.</span></b><br />
<br />
<b><span style="color: #990000;">Apparently these specialists are either NOT taught the extensive symptom complex of tick-borne infections OR they are somehow coerced into not diagnosing Lyme disease. Part of the problem is the inaccuracy of testing for Lyme and co-infections. There are over 300 strains of Borrelia that can cause Lyme disease but only several are tested for. This organism also changes form which affects diagnosis.The Lyme organism also forms biofilms which can hide the bacteria from antibiotics and testing.</span></b><br />
<br />
<b><span style="color: #990000;">To try and sum up this situation...(as I could go on forever speaking of the many many inconsistencies surrounding the Lyme disease conspiracy)the system has been set up to block the proper diagnosis and treatment of Lyme disease and coinfections...to MISS or to leave untreated much of the chronically ill population. Chronically ill people who do not die are a constant source of profit for the medical industry and chronically ill people are also much easier to control when dependent on the the medical industry and sometimes the State. </span></b><br />
<b><span style="color: #990000;">Yes there are natural ways to HELP treat chronic Lyme disease but what most alternative doctors, patients and Lyme specialists have discovered is that due to the extremely persistent nature of the Lyme disease bacteria, antibiotics are also needed...sometimes long term.</span></b><br />
<br />
<b><span style="color: #990000;">Read the message below that was posted to a private doctors' email list ...and see for yourself the restrictions and loss of patient privacy that are being imposed on the population of our ever increasing globalized and controlled planet. The video at the top show Dr. Ladhams speaking about Lyme disease before he had the restrictions below placed upon him and his patients. Let's stand up for our inherent right to decide for ourselves what treatment we need! High prices of medical care and the seeming necessity of insurance coverage seems to be the main force behind our enslavement or dependency to the medical system. What are we going to do about it....let's put our thinking caps on! Healthy diet and lifestyle can prevent much of the chronic illness we are experiencing, however, we also need investigation into the many ties of the medical industry and into the genetic engineering of microbes and the insect vectors that host these microbes.</span></b><br />
<span style="font-size: x-large;"><b><span style="color: #990000;"> Read the Restrictions below...It's just unbelievable</span></b></span><br />
<span style="font-size: x-large;"><b><span style="color: #990000;"> </span><br />
</b></span> <br />
<div class="yiv4607479809thread-body" id="yui_3_13_0_ym1_1_1387798987617_2408">
<span style="font-size: x-large;"><b> </b></span><br />
<div class="yiv4607479809body yiv4607479809undoreset" id="yui_3_13_0_ym1_1_1387798987617_2407">
<div id="yiv4607479809">
<div dir="ltr" id="yui_3_13_0_ym1_1_1387798987617_2406">
<div class="yiv4607479809MsoNormal" id="yui_3_13_0_ym1_1_1387798987617_2424">
<span style="font-size: x-large;"><b><span id="yui_3_13_0_ym1_1_1387798987617_2423" lang="EN-AU">Well now its happening here in Australia. Dr Ladhams from Qld has just been notified of restrictions on his right to practice medicine by our national authority APHRA the registration body. Specifically it states:</span></b></span></div>
<div class="yiv4607479809MsoNormal" id="yui_3_13_0_ym1_1_1387798987617_2430">
<b><span lang="EN-AU"><br />
</span></b></div>
<div class="yiv4607479809MsoNormal" id="yui_3_13_0_ym1_1_1387798987617_2405" style="margin-left: 6pt;">
<b><span id="yui_3_13_0_ym1_1_1387798987617_2404" style="color: #444444; font-size: 12pt;">On 20 December 2013, the Medical Board of Australia (the Board) imposed the following conditions on the registration of Dr Andrew Ladhams (the practitioner)):<br />
1. The practitioner must not treat Lyme disease in any patient without first obtaining an opinion from an infectious disease specialist who is a Fellow of the Royal Australian College of Physicians (FRACP) which:<br />
a. states the patient suffers with Lyme disease , and<br />
b. prescribes the treatment regimen to be followed by the practitioner.<br />
2. The practitioner must not request the insertion of nor insert a peripherally inserted central catheter or any other form of central venous catheter into any patient.<br />
3. The practitioner must not provide treatment to any patient which may cause a Jarisch- Herxheimer response to such treatment outside of a licensed hospital at which the practitioner holds credentials to perform such treatment.<br />
4. Within 7 (seven) days of these conditions being imposed, the practitioner must notify all partners/employers/employees/colleagues in his practice and every person who is, or may be, responsible for booking consultations with the practitioner, of these conditions.<br />
5. An AHPRA representative for the Board will contact and exchange information with the practitioner’s employer/ partners/colleagues in his practice and every person who is, or may be, responsible for booking consultations with the practitioner, at such time or times as the Board or its representative shall determine for the purpose of monitoring the practitioner’s compliance with these conditions.<br />
6. The Medicare Program, Department of Human Services, Australia and Private Health Insurance Funds are required to provide information to the Board or its representatives about the practitioner’s practice of his profession.<br />
7. The practitioner must allow an AHPRA representative for the Board to access, inspect and copy his patient records, including but not limited to appointment diaries and prescribing records at his practice locations for the purpose of monitoring his compliance with the conditions.</span></b></div>
<div class="yiv4607479809MsoNormal" id="yui_3_13_0_ym1_1_1387798987617_2410" style="margin-left: 6pt;">
<span style="color: #444444; font-size: 12pt;"><br />
</span></div>
<div class="yiv4607479809MsoNormal" id="yui_3_13_0_ym1_1_1387798987617_2412">
<span style="font-size: x-large;"><b><span id="yui_3_13_0_ym1_1_1387798987617_2411" lang="EN-AU">Of course there is no lyme in Australia.</span></b></span><br />
<span style="font-size: x-large;"><b><span id="yui_3_13_0_ym1_1_1387798987617_2411" lang="EN-AU"> Of course it cant come in from overseas.</span></b></span><br />
<span style="font-size: x-large;"><b><span id="yui_3_13_0_ym1_1_1387798987617_2411" lang="EN-AU"> Of course every infectious disease doc in the country is on a par with IDSA perspectives. No one gets a diagnosis of lyme.</span></b></span><br />
</div>
<span style="font-size: x-large;"><b> </b></span><br />
<div class="yiv4607479809MsoNormal" id="yui_3_13_0_ym1_1_1387798987617_2414">
<span style="font-size: x-large;"><b><span id="yui_3_13_0_ym1_1_1387798987617_2413" lang="EN-AU">There is a lot of fuss about a patient having focal tonic clonic reactions as part of herx during IVI treatment. I am standing up and saying I see this too. Am I next? Maybe?</span></b></span><br />
</div>
<span style="font-size: x-large;"><b> </b></span><br />
<div class="yiv4607479809MsoNormal" id="yui_3_13_0_ym1_1_1387798987617_2416">
<span style="font-size: x-large;"><b><span id="yui_3_13_0_ym1_1_1387798987617_2415" lang="EN-AU">So half behind the scenes ACIDS has formed in Australia in the past 5 months and now has 55 members. That stands for Australian Chronic Infectious Disease Society. Several are also members of ILADS. We accept the rejects of ID docs.</span></b></span><br />
</div>
<span style="font-size: x-large;"><b> </b></span><br />
<div class="yiv4607479809MsoNormal" id="yui_3_13_0_ym1_1_1387798987617_2422">
<span style="font-size: x-large;"><b><span id="yui_3_13_0_ym1_1_1387798987617_2421" lang="EN-AU">Today the society issues the following statement:</span></b></span></div>
<span style="font-size: x-large;"><b> </b></span><br />
<div class="yiv4607479809MsoNormal" id="yui_3_13_0_ym1_1_1387798987617_2418">
<span style="font-size: x-large;"><b><span id="yui_3_13_0_ym1_1_1387798987617_2417" lang="EN-AU">We in ACIDS believe infectious disease doctors in this country have not been proactive enough in diagnosing chronic lyme, bartonella and babesia infections in patients in Australia and in particular have been totally blind to the possibility of endemic infections to the point of denial. </span></b></span><br />
<span style="font-size: x-large;"><b><span id="yui_3_13_0_ym1_1_1387798987617_2417" lang="EN-AU">We point out that Murtaghs General Practice handbook has acknowledged the existence of lyme disease on this continent for years.</span></b></span><br />
<br />
<span style="font-size: x-large;"><b><span id="yui_3_13_0_ym1_1_1387798987617_2417" lang="EN-AU"> We announce that we are taking over this area of medicine and are available to ID doctors who need our advice in these areas. We cordially invite such doctors to join with us.</span></b></span><br />
</div>
<span style="font-size: x-large;"><b> </b></span><br />
<div class="yiv4607479809MsoNormal" id="yui_3_13_0_ym1_1_1387798987617_2420">
<span style="font-size: x-large;"><b><span id="yui_3_13_0_ym1_1_1387798987617_2419" lang="EN-AU">This won't make certain elements of the profession here very happy but we are going to stand tall on this issue. </span></b></span></div>
<div id="yui_3_13_0_ym1_1_1387798987617_2431">
<b><br />
</b></div>
<b>-- <br />
from<br />
Dr Peter Mayne</b><br />
<div id="yui_3_13_0_ym1_1_1387798987617_2440">
<b>Laurieton Medical Centre</b></div>
<div id="yui_3_13_0_ym1_1_1387798987617_2432">
<b>Laurieton NSW</b></div>
<div id="yui_3_13_0_ym1_1_1387798987617_2439">
<b>Australia</b></div>
<div id="yui_3_13_0_ym1_1_1387798987617_2438">
<b>+61 2 6559 9277</b></div>
<b> </b></div>
</div>
</div>
<b> </b></div>
<div class="yiv4607479809MsoNormal" id="yui_3_13_0_ym1_1_1387798987617_2433">
<b><span style="color: #00bf60; font-family: Comic Sans MS; font-size: medium;"><span style="color: green; font-family: Arial; font-size: 10pt;"></span></span> </b></div>
</div>
</div>
Unknownnoreply@blogger.com4tag:blogger.com,1999:blog-5876257241074222326.post-9928859299328297172013-12-17T08:26:00.001-08:002013-12-17T08:43:16.742-08:00HOW SAFE IS ANY LYME DISEASE VACCINE?<div dir="ltr" style="text-align: left;" trbidi="on">
<img alt="" height="618" src="data:image/png;base64,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" width="640" /><br />
<br />
Many people today are concerned about the safety of vaccines in general. What are the long term side effects? No long term studies have been conducted....that the public has been made aware of. Are we the long term covert studies? What long term effects does the artificial hyper-activation of the immune system cause? Vaccines do include ingredients to hyper-activate the immune system. It's not a far stretch to suppose or conclude that this unnatural method of immune activation could cause autoimmune disease which is a hyper-activation of the immune system. Could this be one of the reasons or THE reason why autoimmune disease has exponentially risen in the population in conjunction with increased numbers of required vaccines?<br />
<br />
I'm bringing up the subject of vaccines because many people were harmed by the Lymerix vaccine for Lyme disease....that was marketed a few years back. It was known to Smithkline Beecham that 30% of the population had a specific genetic susceptibility and could react to the Lymerix vaccine with a lyme arthritis that would be untreatable...but this information was not shared openly with the public! I personally spoke to several people who had received the vaccine and now they have what is called"fibromyalgia" <br />
<br />
I also attended a Lyme Disease conference put on by the Lyme disease Foundation a few years back...after the Lymerix vaccine had been on the market and had harmed many people. There was a Smithkline Beecham representative attending who gave a presentation. The audience of doctors, patients and activists expected that this rep would share some safety data and side effects of the vaccine. However, his whole presentation was about Lyme rashes and no mention was made of the vaccine. At the end of the presentation a doctor stood up and expressed this concern. He asked what some of the side effects of the vaccine were. The representative had the gaul to stand there and say that there had been no significant side effects reported. The whole audience groaned and several doctors got up and walked out.<br />
Lyme disease has been in the news lately spurred by a press release put out by the CDC. Normally the lyme community has found the CDC to downplay the seriousness of Lyme....to the detriment of many lyme patients. It's interesting that all of a sudden ...according to the CDC... Lyme is a very serious disease and a new Lyme disease vaccine is in the wings. What are the real financial connections between the CDC and Lyme vaccines?<br />
<br />
It's also interesting that when people acquire Lyme disease from a tick and recover, that this infection evidently does not prevent the body from coming down with Lyme again from another tickbite. In other words the infection does not seem to create immunity like with most other diseases. I am not a scientist so maybe someone reading this could post a comment as to how then a lyme vaccine could provide immunity. The following recent article expresses many of my concerns<br />
<br />
<a href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext">http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext</a><br />
<br />
<span style="font-size: x-large;">Lyme disease vaccination: safety first</span><br />
<div class="ja50-article">
<div class="ja50-head">
<div class="ja50-ce-author-group">
<span class="ja50-ce-author"><a class="ja50-ce-author" href="http://www.thelancet.com/search/results?fieldName=Authors&searchTerm=Raphael%20B+Stricker">Raphael B Stricker</a> <a class="ja50-ce-cross-ref" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#aff1" name="back-aff1" title=""><span class="ja50-ce-sup">a</span></a><a class="ja50-ce-e-address" href="mailto:rstricker@usmamed.com"><img alt="Email Address" border="0" src="http://www.thelancet.com/images/article_email.gif" /></a>, </span><span class="ja50-ce-author"><a class="ja50-ce-author" href="http://www.thelancet.com/search/results?fieldName=Authors&searchTerm=Lorraine+Johnson">Lorraine Johnson</a> <a class="ja50-ce-cross-ref" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#aff1" name="back-aff1" title=""><span class="ja50-ce-sup">a</span></a></span></div>
</div>
<div class="$">
<div class="ja50-ce-sections">
<div class="ja50-ce-para">
In the Article by Nina Wressnigg and colleagues<a class="ja50-ce-cross-ref" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#bib1" name="back-bib1" title=""><span class="ja50-ce-sup">1</span></a> and the related Comment by Paul Lantos<a class="ja50-ce-cross-ref" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#bib2" name="back-bib2" title=""><span class="ja50-ce-sup">2</span></a>
describing a novel Lyme vaccine, the authors attempt to avoid
discussion of the side-effects of the previous Lyme vaccine, LYMErix
(SmithKline Beecham, Pittsburgh, USA). This approach to safety issues
bodes ill for the new Lyme vaccine candidate.<br />
</div>
<div class="ja50-ce-para">
</div>
<div class="ja50-ce-para">
LYMErix
was put on the market in 1998 and withdrawn by the manufacturer in
2002, ostensibly because of poor sales. However, the so-called poor
sales were related to safety concerns raised in a class-action lawsuit
by more than 400 patients who claimed that they developed Lyme-like
symptoms after vaccination with LYMErix.<a class="ja50-ce-cross-ref" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#bib3" name="back-bib3"><span class="ja50-ce-sup">3</span></a>, <a class="ja50-ce-cross-ref" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#bib4" name="back-bib4"><span class="ja50-ce-sup">4</span></a> Subsequent studies showed that outer surface protein A (OspA), the antigenic component of <i>Borrelia burgdorferi</i>
used to create both LYMErix and the new candidate vaccine, induced
joint-reactive and nerve-reactive antibodies in animals and human beings
vaccinated with the protein antigen.<a class="ja50-ce-cross-ref" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#bib3" name="back-bib3"><span class="ja50-ce-sup">3—6</span></a>
Even more disturbing, other studies indicated that LYMErix induced
reactivity against multiple target antigens that were never
characterised, and these studies called into question the OspA
specificity of the vaccine.<a class="ja50-ce-cross-ref" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#bib7" name="back-bib7"><span class="ja50-ce-sup">7</span></a>, <a class="ja50-ce-cross-ref" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#bib8" name="back-bib8"><span class="ja50-ce-sup">8</span></a>
By withdrawing LYMErix when it did, the manufacturer avoided releasing
phase 4 post-marketing data that probably would have shown increased
side-effects related to the vaccine.<a class="ja50-ce-cross-ref" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#bib9" name="back-bib9" title=""><span class="ja50-ce-sup">9</span></a>
The data have never been disclosed, and this lack of disclosure has
fostered persistent patient mistrust of Lyme vaccine manufacturers.<br />
</div>
<div class="ja50-ce-para">
</div>
<div class="ja50-ce-para">
Wressnigg
and colleagues provide minimum safety data about the new OspA-based
Lyme vaccine, whereas Lantos glosses over the “largely unsubstantiated
safety concerns” about LYMErix. Adoption of this view by Lyme vaccine
manufacturers, regulators, and promoters has shaken patient confidence
in Lyme vaccines despite the fact that this patient population is
generally pro-vaccination.<a class="ja50-ce-cross-ref" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#bib10" name="back-bib10" title=""><span class="ja50-ce-sup">10</span></a>
Any new Lyme vaccine will need extensive safety testing, more
transparency about side-effects, and improved patient communication on
the part of the vaccine manufacturer to allay valid patient concerns
about safety.<a class="ja50-ce-cross-ref" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#bib4" name="back-bib4"><span class="ja50-ce-sup">4</span></a>, <a class="ja50-ce-cross-ref" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#bib10" name="back-bib10"><span class="ja50-ce-sup">10</span></a>
Let's hope that history does not repeat itself because Lyme vaccine
manufacturers, regulators, and promoters once again underestimate or
ignore justified patient concerns about Lyme vaccination risks.<br />
</div>
<div class="ja50-ce-para">
</div>
<div class="ja50-ce-para">
RBS
serves without compensation on the medical advisory panel of QMedRx
Inc. He has no financial ties to the company. LJ declares that she has
no conflicts of interest.</div>
</div>
</div>
<div class="ja50-ce-bibliography" id="References">
<h2 class="ja50-ce-section-title">
References</h2>
<div class="ja50-ce-bib-reference" id="bib1">
<a class="back-bib" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#back-bib1">1</a> <span class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span class="ja50-ce-surname">Wressnigg</span> <span class="ja50-ce-given-name">N</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Pöllabauer</span> <span class="ja50-ce-given-name">E-M</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Aichinger</span> <span class="ja50-ce-given-name">G</span></span>, et al</span>. <span class="ja50-sb-title"><span class="ja50-sb-maintitle">Safety
and immunogenicity of a novel multivalent OspA vaccine against Lyme
borreliosis in healthy adults: a double-blind, randomised,
dose-escalation phase 1/2 trial</span></span></span>. <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span class="ja50-sb-maintitle">Lancet Infect Dis</span></span> <span class="ja50-sb-date">2013</span>; <span class="ja50-sb-volume-nr">13</span>: </span><span class="ja50-sb-pages">680-689</span>. </span><a class="ref-int-link" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970110-5/abstract">
Summary</a><span class="ref-link-sep"> | </span><a class="ref-int-link" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970110-5/fulltext">
Full Text</a><span class="ref-link-sep"> | </span><a class="ref-int-link" href="http://download.thelancet.com/pdfs/journals/laninf/PIIS1473309913701105.pdf" target="_blank">
PDF(256KB)</a> <span class="ref-link-sep"> | </span><a class="crossref" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970110-5/fulltext" target="_blank">CrossRef</a><span class="ref-link-sep"> | </span><a class="pubmed" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Search&term=Lancet%20Infect%20Dis[Jour]+AND+13[Volume]+AND+680[page]" target="_blank">PubMed</a></div>
<div class="ja50-ce-bib-reference" id="bib2">
<a class="back-bib" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#back-bib2">2</a> <span class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span class="ja50-ce-surname">Lantos</span> <span class="ja50-ce-given-name">PM</span></span></span>. <span class="ja50-sb-title"><span class="ja50-sb-maintitle">Lyme disease vaccination: are we ready to try again?</span></span></span>. <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span class="ja50-sb-maintitle">Lancet Infect Dis</span></span> <span class="ja50-sb-date">2013</span>; <span class="ja50-sb-volume-nr">13</span>: </span><span class="ja50-sb-pages">643-644</span>. </span><a class="ref-int-link" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970085-9/fulltext">
Full Text</a><span class="ref-link-sep"> | </span><a class="ref-int-link" href="http://download.thelancet.com/pdfs/journals/laninf/PIIS1473309913700859.pdf" target="_blank">
PDF(94KB)</a> <span class="ref-link-sep"> | </span><a class="crossref" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970085-9/fulltext" target="_blank">CrossRef</a><span class="ref-link-sep"> | </span><a class="pubmed" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Search&term=Lancet%20Infect%20Dis[Jour]+AND+13[Volume]+AND+643[page]" target="_blank">PubMed</a></div>
<div class="ja50-ce-bib-reference" id="bib3">
<a class="back-bib" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#back-bib3">3</a> <span class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span class="ja50-ce-surname">Stricker</span> <span class="ja50-ce-given-name">RB</span></span></span>. <span class="ja50-sb-title"><span class="ja50-sb-maintitle">Lymerix risks revisited</span></span></span>. <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span class="ja50-sb-maintitle">Microbe</span></span> <span class="ja50-sb-date">2008</span>; <span class="ja50-sb-volume-nr">3</span>: </span><span class="ja50-sb-pages">1-2</span>. </span><a class="pubmed" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Search&term=Microbe[Jour]+AND+3[Volume]+AND+1[page]" target="_blank">PubMed</a></div>
<div class="ja50-ce-bib-reference" id="bib4">
<a class="back-bib" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#back-bib4">4</a> <span class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span class="ja50-ce-surname">Smith</span> <span class="ja50-ce-given-name">P</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Gaito</span> <span class="ja50-ce-given-name">A</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Marks</span> <span class="ja50-ce-given-name">DH</span></span></span>. <span class="ja50-sb-title"><span class="ja50-sb-maintitle">Transcript of FDA Lymerix meeting, Bethesda, MD</span></span></span>. <span class="ja50-sb-host"><a class="ja50-ce-inter-ref" href="http://www.lymediseaseassociation.org/index.php?option=com_content&view=article&id=532:%20lymerix-meeting&catid=129:%20hhsfood-a-drug-administration-fda&Itemid=531" target="_blank">http://www.lymediseaseassociation.org/index.php?option=com_content&view=article&id=532:
lymerix-meeting&catid=129:
hhsfood-a-drug-administration-fda&Itemid=531</a>. </span><span class="ja50-sb-comment">(accessed Nov 29, 2013). </span></div>
<div class="ja50-ce-bib-reference" id="bib5">
<a class="back-bib" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#back-bib5">5</a> <span class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span class="ja50-ce-surname">Souayah</span> <span class="ja50-ce-given-name">N</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Ajroud-Driss</span> <span class="ja50-ce-given-name">S</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Sander</span> <span class="ja50-ce-given-name">HW</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Brannagan</span> <span class="ja50-ce-given-name">TH</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Hays</span> <span class="ja50-ce-given-name">AP</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Chin</span> <span class="ja50-ce-given-name">RL</span></span></span>. <span class="ja50-sb-title"><span class="ja50-sb-maintitle">Small fiber neuropathy following vaccination for rabies, varicella or Lyme disease</span></span></span>. <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span class="ja50-sb-maintitle">Vaccine</span></span> <span class="ja50-sb-date">2009</span>; <span class="ja50-sb-volume-nr">27</span>: </span><span class="ja50-sb-pages">7322-7325</span>. </span><a class="crossref" href="http://dx.doi.org/10.1016/j.vaccine.2009.09.077" target="_blank">CrossRef</a><span class="ref-link-sep"> | </span><a class="pubmed" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Search&term=Vaccine[Jour]+AND+27[Volume]+AND+7322[page]" target="_blank">PubMed</a></div>
<div class="ja50-ce-bib-reference" id="bib6">
<a class="back-bib" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#back-bib6">6</a> <span class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span class="ja50-ce-surname">Marks</span> <span class="ja50-ce-given-name">DH</span></span></span>. <span class="ja50-sb-title"><span class="ja50-sb-maintitle">Neurological complications of vaccination with outer surface protein A (OspA)</span></span></span>. <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span class="ja50-sb-maintitle">Int J Risk Saf Med</span></span> <span class="ja50-sb-date">2011</span>; <span class="ja50-sb-volume-nr">23</span>: </span><span class="ja50-sb-pages">89-96</span>. </span><a class="pubmed" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Search&term=Int%20J%20Risk%20Saf%20Med[Jour]+AND+23[Volume]+AND+89[page]" target="_blank">PubMed</a></div>
<div class="ja50-ce-bib-reference" id="bib7">
<a class="back-bib" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#back-bib7">7</a> <span class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span class="ja50-ce-surname">Molloy</span> <span class="ja50-ce-given-name">PJ</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Berardi</span> <span class="ja50-ce-given-name">VP</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Persing</span> <span class="ja50-ce-given-name">DH</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Sigal</span> <span class="ja50-ce-given-name">LH</span></span></span>. <span class="ja50-sb-title"><span class="ja50-sb-maintitle">Detection
of multiple reactive protein species by immunoblotting after
recombinant outer surface protein A Lyme disease vaccination</span></span></span>. <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span class="ja50-sb-maintitle">Clin Infect Dis</span></span> <span class="ja50-sb-date">2000</span>; <span class="ja50-sb-volume-nr">31</span>: </span><span class="ja50-sb-pages">42-47</span>. </span><a class="crossref" href="http://dx.doi.org/10.1086/313920" target="_blank">CrossRef</a><span class="ref-link-sep"> | </span><a class="pubmed" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Search&term=Clin%20Infect%20Dis[Jour]+AND+31[Volume]+AND+42[page]" target="_blank">PubMed</a></div>
<div class="ja50-ce-bib-reference" id="bib8">
<a class="back-bib" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#back-bib8">8</a> <span class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span class="ja50-ce-surname">Fawcett</span> <span class="ja50-ce-given-name">PT</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Rose</span> <span class="ja50-ce-given-name">CD</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Budd</span> <span class="ja50-ce-given-name">SM</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Gibney</span> <span class="ja50-ce-given-name">KM</span></span></span>. <span class="ja50-sb-title"><span class="ja50-sb-maintitle">Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis</span></span></span>. <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span class="ja50-sb-maintitle">Clin Diagn Lab Immunol</span></span> <span class="ja50-sb-date">2001</span>; <span class="ja50-sb-volume-nr">8</span>: </span><span class="ja50-sb-pages">79-84</span>. </span><a class="pubmed" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Search&term=Clin%20Diagn%20Lab%20Immunol[Jour]+AND+8[Volume]+AND+79[page]" target="_blank">PubMed</a></div>
<div class="ja50-ce-bib-reference" id="bib9">
<a class="back-bib" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#back-bib9">9</a> <span class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span class="ja50-ce-surname">Nardelli</span> <span class="ja50-ce-given-name">DT</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Munson</span> <span class="ja50-ce-given-name">EL</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Callister</span> <span class="ja50-ce-given-name">SM</span>, </span><span class="ja50-sb-author"><span class="ja50-ce-surname">Schell</span> <span class="ja50-ce-given-name">RF</span></span></span>. <span class="ja50-sb-title"><span class="ja50-sb-maintitle">Human Lyme disease vaccines: past and future concerns</span></span></span>. <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span class="ja50-sb-maintitle">Future Microbiol</span></span> <span class="ja50-sb-date">2009</span>; <span class="ja50-sb-volume-nr">4</span>: </span><span class="ja50-sb-pages">457-469</span>. </span><a class="crossref" href="http://dx.doi.org/10.2217/fmb.09.17" target="_blank">CrossRef</a><span class="ref-link-sep"> | </span><a class="pubmed" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Search&term=Future%20Microbiol[Jour]+AND+4[Volume]+AND+457[page]" target="_blank">PubMed</a></div>
<div class="ja50-ce-bib-reference" id="bib10">
<a class="back-bib" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#back-bib10">10</a> <span class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span class="ja50-ce-surname">Smith</span> <span class="ja50-ce-given-name">P</span></span></span>. <span class="ja50-sb-title"><span class="ja50-sb-maintitle">Remarks to Vaccines and Related Biological Products Advisory Committee, Bethesda, MD</span></span></span>. <span class="ja50-sb-host"><a class="ja50-ce-inter-ref" href="http://www.lymediseaseassociation.org/index.php?option=com_content&view=article&id=262:%20vaccine-remarks&catid=80:%20controversy&Itemid=76" target="_blank">http://www.lymediseaseassociation.org/index.php?option=com_content&view=article&id=262:
vaccine-remarks&catid=80: controversy&Itemid=76</a>. </span><span class="ja50-sb-comment">(accessed Nov 29, 2013). </span></div>
</div>
<div class="ja50-ce-affiliations">
<div class="ja50-ce-affiliation" id="aff1">
<a class="back-aff" href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970319-0/fulltext#back-aff1"><span class="ja50-ce-label">a</span></a><span class="ja50-ce-affiliation"> International Lyme and Associated Diseases Society, PO Box 341461, Bethesda, MD 20827-1461, USA</span></div>
</div>
</div>
<div id="article_right">
<br />
<div class="spacer">
</div>
</div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-5876257241074222326.post-21814395776591344632013-11-19T11:11:00.001-08:002013-11-19T11:17:26.932-08:002014 Physician's Round Table Confernce<div dir="ltr" style="text-align: left;" trbidi="on">
<span style="font-size: x-large;"><br /></span>
<br />
<div class="page" title="Page 1">
<div class="section">
<div class="section" style="background-color: white;">
<div class="layoutArea">
<div class="column">
<span style="font-family: 'BacktalkSerif BTN'; font-size: x-large;">The 2014 Physician’s Round Table conference
</span><br />
<span style="color: rgb(15.700000%, 5.100000%, 95.300000%); font-family: 'BacktalkSerif BTN'; font-size: x-large;">Accentuating the </span><span style="color: rgb(15.700000%, 5.100000%, 95.300000%); font-family: 'BacktalkSerif BTN'; font-size: x-large;">“heal” in </span><span style="color: rgb(15.700000%, 5.100000%, 95.300000%); font-family: 'BacktalkSerif BTN'; font-size: x-large;">health
</span><br />
<span style="font-family: 'BacktalkSerif BTN'; font-size: large;">Please join us for the 6</span><span style="font-family: 'BacktalkSerif BTN'; font-size: large; vertical-align: 4pt;">th </span><span style="font-family: 'BacktalkSerif BTN'; font-size: large;">year of quality conferences for clinicians and other healthcare professionals. We have again
put together a conference that will benefit each attendee and exhibitor. Productive exchange of information, peer
networking, and the best in products are the core of the conference. </span><br />
<br /><span style="font-family: 'BacktalkSerif BTN'; font-size: large;">Reasons to join us as an attendee and/or exhibitor: </span></div>
</div>
<div class="layoutArea">
<div class="column">
<span style="color: rgb(58.000000%, 21.200000%, 20.400000%); font-family: 'BacktalkSerif BTN'; font-size: large;">Highly educational</span><br />
<span style="color: rgb(58.000000%, 21.200000%, 20.400000%); font-family: 'BacktalkSerif BTN'; font-size: large;"> Outstanding staff
Networking opportunities</span><br />
<span style="color: rgb(58.000000%, 21.200000%, 20.400000%); font-family: 'BacktalkSerif BTN'; font-size: large;"> CME presentation</span><br />
<span style="color: rgb(58.000000%, 21.200000%, 20.400000%); font-family: 'BacktalkSerif BTN'; font-size: large;"> Gordon-style conference</span><br />
<span style="color: rgb(58.000000%, 21.200000%, 20.400000%); font-family: 'BacktalkSerif BTN'; font-size: large;"> New/innovative products </span><br />
<span style="color: rgb(58.000000%, 21.200000%, 20.400000%); font-family: 'BacktalkSerif BTN'; font-size: large;">Strengthen relationships
Global exhibits
</span></div>
<div class="column">
<span style="color: rgb(58.000000%, 21.200000%, 20.400000%); font-family: 'BacktalkSerif BTN'; font-size: large;">Pleasant, green surroundings </span><br />
<span style="color: rgb(58.000000%, 21.200000%, 20.400000%); font-family: 'BacktalkSerif BTN'; font-size: large;">Extremely easy on your budget</span><br />
<span style="color: rgb(58.000000%, 21.200000%, 20.400000%); font-family: 'BacktalkSerif BTN'; font-size: large;"> Interaction with experts
Distinguished speakers</span><br />
<span style="color: rgb(58.000000%, 21.200000%, 20.400000%); font-family: 'BacktalkSerif BTN'; font-size: large;"> Invaluable Resources
</span><br />
<span style="color: rgb(58.000000%, 21.200000%, 20.400000%); font-family: 'BacktalkSerif BTN'; font-size: large;">Valuable services<br />
New product ideas </span><br />
<span style="color: rgb(58.000000%, 21.200000%, 20.400000%); font-family: 'BacktalkSerif BTN'; font-size: large;">Evidenced-based research
</span></div>
<div class="column">
<span style="color: rgb(58.000000%, 21.200000%, 20.400000%); font-family: 'BacktalkSerif BTN'; font-size: large;">Relaxed atmosphere<br />
Great place for family vacation</span><br />
<span style="color: rgb(58.000000%, 21.200000%, 20.400000%); font-family: 'BacktalkSerif BTN'; font-size: large;"> Hands-on with exhibitors</span><br />
<span style="color: rgb(58.000000%, 21.200000%, 20.400000%); font-family: 'BacktalkSerif BTN'; font-size: large;"> Hand selected products<br />
Vital info for next clinic day</span><br />
<span style="color: rgb(58.000000%, 21.200000%, 20.400000%); font-family: 'BacktalkSerif BTN'; font-size: large;"> New prospects<br />
International resources</span><br />
<span style="color: rgb(58.000000%, 21.200000%, 20.400000%); font-family: 'BacktalkSerif BTN'; font-size: large;"> Relevant clinical material </span></div>
</div>
<div class="layoutArea">
<div class="column">
<span style="font-size: large;"><br /></span></div>
</div>
<div class="layoutArea">
<div class="column">
<span style="font-family: 'BacktalkSerif BTN'; font-size: large;">Who should attend? </span><span style="color: rgb(31.000000%, 38.400000%, 15.700000%); font-family: 'BacktalkSerif BTN'; font-size: large;">M.D.’s, D.O.’s, N.D.’s, D.C.’s, D.D.S.’s, D.M.D.’s, D.V.M.’s, P.A.’s, N.P.’s, </span><span style="color: rgb(31.000000%, 38.400000%, 15.700000%); font-family: 'BacktalkSerif BTN'; font-size: large;">Nurses, Therapists, </span><span style="color: rgb(31.000000%, 38.400000%, 15.700000%); font-family: 'BacktalkSerif BTN'; font-size: large;">Ph.D.’s,
</span><span style="color: rgb(31.000000%, 38.400000%, 15.700000%); font-family: 'BacktalkSerif BTN'; font-size: large;">Medical Students, Hospital/Clinic Administration, Medical Lawyers, Lab Technicians, Healthcare Advocates </span><br />
<br />
<span style="font-family: 'BacktalkSerif BTN'; font-size: large;">Admission: $250.00 single admission Buddy Plan 2/$400.00 (one invoice) </span><br />
<span style="font-size: large;"><br /></span>
<span style="font-family: 'BacktalkSerif BTN'; font-size: large;">Exhibitors:<br />
Pkg 1 </span><span style="font-family: 'BacktalkSerif BTN'; font-size: large;">– </span><span style="font-family: 'BacktalkSerif BTN'; font-size: large;">one table, two chairs/passes, brochure info ad -- $1,500.00</span><br />
<span style="font-family: 'BacktalkSerif BTN'; font-size: large;"><br />
Pkg 2 </span><span style="font-family: 'BacktalkSerif BTN'; font-size: large;">– </span><span style="font-family: 'BacktalkSerif BTN'; font-size: large;">two tables, four chairs/passes, brochure info ad -- $2,000.00</span><br />
<span style="font-family: 'BacktalkSerif BTN'; font-size: large;"><br />
Pkg 3 </span><span style="font-family: 'BacktalkSerif BTN'; font-size: large;">– </span><span style="font-family: 'BacktalkSerif BTN'; font-size: large;">Lunch/your speaker, two tables, 4 passes, soup/salad bar w/beverage </span><span style="font-family: 'BacktalkSerif BTN'; font-size: large;">– </span><span style="font-family: 'BacktalkSerif BTN'; font-size: large;">request details
Pkg 4 </span><span style="font-family: 'BacktalkSerif BTN'; font-size: large;">– </span><span style="font-family: 'BacktalkSerif BTN'; font-size: large;">Gift Bag inserts, 1 pass, brochure info ad -- $750.00 </span><br />
<br />
<span style="font-family: 'BacktalkSerif BTN'; font-size: large;">Group rates availableSpace/Seating is limited Financing available through PayPal </span><br />
<br />
<span style="font-family: 'BacktalkSerif BTN'; font-size: large;">You will receive an invoice via email payable through PayPal with credit or debit card.
For information please email </span><span style="color: rgb(0.000000%, 0.000000%, 100.000000%); font-family: 'BacktalkSerif BTN'; font-size: large;">peerobmagazine@aol.com </span><span style="font-family: 'BacktalkSerif BTN'; font-size: large;">or call us at 717-254-1953
</span><span style="font-family: 'BacktalkSerif BTN'; font-size: large;">This conference is open to all healthcare professionals; limited seating for non-healthcare professionals. </span><br />
<span style="font-size: large;"><br /></span></div>
</div>
<div class="layoutArea">
<div class="column">
<span style="font-family: 'BacktalkSerif BTN'; font-size: large;">SPEAKERS
</span></div>
</div>
<div class="layoutArea">
<div class="column">
<span style="font-family: 'BacktalkSerif BTN'; font-size: large;">O. Amin, Ph.D.<br />
R. Austin<br />
S. Edwards<br />
D. Flockhart, M.D., Ph.D.
S. Jurasunas, N.D.
</span><br />
<span style="font-family: 'BacktalkSerif BTN'; font-size: large;">A. MacDonald, M.D.
J. Mikovits, Ph.D.
D. Nebert, M.D.<br />
A. Rain
</span><br />
<span style="font-family: 'BacktalkSerif BTN'; font-size: large;">M. Ross, M.D.<br />
S. Seneff, Ph.D.
S. Strickland, RN,
</span></div>
<div class="column">
<span style="font-family: 'BacktalkSerif BTN'; font-size: large;">R. Armstrong, M.D.
E. Cutler, D.C..<br />
J. Faber, M.D.<br />
J. Forester, M.D.
</span><br />
<span style="font-family: 'BacktalkSerif BTN'; font-size: large;">T. Larson, Journalist<br />
R. McKenzie, Producer
D. Moyer, LCSW (AK)<br />
M. Payne, MS, CNS, CRC
N. Rawlins, M.D.<br />
D. Scheiderer, M.D.<br />
R. Shoemaker, M.D.<br />
R. Tunkel, M.D.
</span></div>
</div>
</div>
</div>
</div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-5876257241074222326.post-17120106246937898482013-05-13T06:52:00.001-07:002013-05-13T06:52:15.092-07:00A DOCTOR SPEAKS OUT ABOUT LYME DISEASE CORRUPTION<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
<div id="mg_footer" style="clear: both; float: none; font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 1.22em; margin: 0px; outline: none; padding: 0px; text-align: center; zoom: 1;">
<!--[if gte mso 9]><xml>
<o:OfficeDocumentSettings>
<o:PixelsPerInch>96</o:PixelsPerInch>
<o:TargetScreenSize>800x600</o:TargetScreenSize>
</o:OfficeDocumentSettings>
</xml><![endif]-->
<!--[if gte mso 9]><xml>
<w:WordDocument>
<w:View>Normal</w:View>
<w:Zoom>0</w:Zoom>
<w:TrackMoves/>
<w:TrackFormatting/>
<w:PunctuationKerning/>
<w:ValidateAgainstSchemas/>
<w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
<w:IgnoreMixedContent>false</w:IgnoreMixedContent>
<w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
<w:DoNotPromoteQF/>
<w:LidThemeOther>EN-US</w:LidThemeOther>
<w:LidThemeAsian>JA</w:LidThemeAsian>
<w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
<w:Compatibility>
<w:BreakWrappedTables/>
<w:SnapToGridInCell/>
<w:WrapTextWithPunct/>
<w:UseAsianBreakRules/>
<w:DontGrowAutofit/>
<w:SplitPgBreakAndParaMark/>
<w:EnableOpenTypeKerning/>
<w:DontFlipMirrorIndents/>
<w:OverrideTableStyleHps/>
</w:Compatibility>
<m:mathPr>
<m:mathFont m:val="Cambria Math"/>
<m:brkBin m:val="before"/>
<m:brkBinSub m:val="--"/>
<m:smallFrac m:val="off"/>
<m:dispDef/>
<m:lMargin m:val="0"/>
<m:rMargin m:val="0"/>
<m:defJc m:val="centerGroup"/>
<m:wrapIndent m:val="1440"/>
<m:intLim m:val="subSup"/>
<m:naryLim m:val="undOvr"/>
</m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
<w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
DefSemiHidden="true" DefQFormat="false" DefPriority="99"
LatentStyleCount="276">
<w:LsdException Locked="false" Priority="0" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
<w:LsdException Locked="false" Priority="9" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
<w:LsdException Locked="false" Priority="39" Name="toc 1"/>
<w:LsdException Locked="false" Priority="39" Name="toc 2"/>
<w:LsdException Locked="false" Priority="39" Name="toc 3"/>
<w:LsdException Locked="false" Priority="39" Name="toc 4"/>
<w:LsdException Locked="false" Priority="39" Name="toc 5"/>
<w:LsdException Locked="false" Priority="39" Name="toc 6"/>
<w:LsdException Locked="false" Priority="39" Name="toc 7"/>
<w:LsdException Locked="false" Priority="39" Name="toc 8"/>
<w:LsdException Locked="false" Priority="39" Name="toc 9"/>
<w:LsdException Locked="false" Priority="0" Name="header"/>
<w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
<w:LsdException Locked="false" Priority="0" Name="page number"/>
<w:LsdException Locked="false" Priority="10" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Title"/>
<w:LsdException Locked="false" Priority="0" Name="Default Paragraph Font"/>
<w:LsdException Locked="false" Priority="11" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
<w:LsdException Locked="false" Priority="22" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
<w:LsdException Locked="false" Priority="20" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
<w:LsdException Locked="false" Priority="0" Name="HTML Address"/>
<w:LsdException Locked="false" Priority="59" SemiHidden="false"
UnhideWhenUsed="false" Name="Table Grid"/>
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
<w:LsdException Locked="false" Priority="1" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 1"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
<w:LsdException Locked="false" Priority="34" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
<w:LsdException Locked="false" Priority="29" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
<w:LsdException Locked="false" Priority="30" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 1"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 2"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 2"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 3"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 3"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 4"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 4"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 5"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 5"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 6"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 6"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
<w:LsdException Locked="false" Priority="19" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
<w:LsdException Locked="false" Priority="21" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
<w:LsdException Locked="false" Priority="31" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
<w:LsdException Locked="false" Priority="32" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
<w:LsdException Locked="false" Priority="33" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
<w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
<w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
</w:LatentStyles>
</xml><![endif]-->
<!--[if gte mso 10]>
<style>
/* Style Definitions */
table.MsoNormalTable
{mso-style-name:"Table Normal";
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-parent:"";
mso-padding-alt:0in 5.4pt 0in 5.4pt;
mso-para-margin:0in;
mso-para-margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:10.0pt;
font-family:"Times New Roman";}
</style>
<![endif]-->
<!--StartFragment-->
<div align="center" class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 24.0pt;">Remarks: <o:p></o:p></span></b></div>
<div align="center" class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 24.0pt;"><br /></span></b></div>
<div align="center" class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 24.0pt;">World Wide Lyme Rally & Protest<o:p></o:p></span></b></div>
<div align="center" class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 24.0pt;"><br /></span></b></div>
<div align="center" class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 24.0pt;">Friday, May 10, 2013<o:p></o:p></span></b></div>
<div align="center" class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 24.0pt;"><br /></span></b></div>
<div align="center" class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 24.0pt;">Union Square<o:p></o:p></span></b></div>
<div align="center" class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 24.0pt;"><br /></span></b></div>
<div align="center" class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 24.0pt;">New York City<o:p></o:p></span></b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b><span style="background-color: white; font-size: 16pt;"><span style="color: #990000;">“Chronic Lyme disease does
not exist”.<o:p></o:p></span></span></b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b><span style="background-color: white; font-size: 16pt;"><span style="color: #990000;">There are four
possibilities to explain why a person might hold </span></span></b></div>
<div class="MsoNormal">
<b><span style="background-color: white; font-size: 16pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="background-color: white; font-size: 16pt;"><span style="color: #990000;">this view:<o:p></o:p></span></span></b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b><span style="background-color: white; font-size: 16pt;"><span style="color: #990000;">1.They can be ‘dumb as bags
of rocks’. <o:p></o:p></span></span></b></div>
<div class="MsoNormal">
<b><span style="background-color: white; font-size: 16pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="background-color: white; font-size: 16pt;"><span style="color: #990000;">2. They can be
character-disordered, with excessively rigid </span></span></b></div>
<div class="MsoNormal">
<b><span style="background-color: white; font-size: 16pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="background-color: white; font-size: 16pt;"><span style="color: #990000;">thinking, and perfect,
impenetrable circular logic. <o:p></o:p></span></span></b></div>
<div class="MsoNormal">
<b><span style="background-color: white; font-size: 16pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="background-color: white; font-size: 16pt;"><span style="color: #990000;">3. They can be corrupt.<o:p></o:p></span></span></b></div>
<div class="MsoNormal">
<b><span style="background-color: white; font-size: 16pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="background-color: white; font-size: 16pt;"><span style="color: #990000;">4. They can be sociopaths.<o:p></o:p></span></span></b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b><span style="font-size: 16pt;"><span style="background-color: white;"><span style="color: #990000;">One thing is for damn
sure: they are truly lousy clinicians.</span></span><span style="color: #333333;"><o:p></o:p></span></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">In 1991 the Lyme disease
organism, <i>Borrelia burgdorferi</i>, was</span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"> grown from the cerebrospinal fluid
of my patient Vicki Logan at </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">the Centers for Disease Control in Fort Collins,
Colorado </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">despite prior treatment with intravenous antibiotics. Her case </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">made the front page of the New York
Times Science Times in </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">August of 1993.</span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">In 2012, the Embers Rhesus
monkey study demonstrated </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><u><br /></u></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><u>conclusively</u> in a primate model closest to
man, that Lyme </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">infection can persist despite application of intravenous </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">antibiotics and that animals can be seronegative on antibody </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">studies despite
harboring persistent active infection.<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Lyme disease is the first
infectious disease of truly epidemic </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">proportions that emerged hand in hand with
another new </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">phenomenon affecting the health of Americans: the penetration </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">of
managed care in to the health care market place.<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">An infection that can be
chronic and require a long-term </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">treatment approach does not fit the ‘business
model’ of </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">managed care: predictable premiums, predictable costs, </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">predictable
profit. With managed care it became
feasible to </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">control costs by defining away the chronic infectious aspects of </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">Lyme
disease. </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">The Infectious Diseases
Society of America Clinical Practice </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Guidelines for Lyme Disease which appeared
in 2000 and 2006, </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">insist that chronic Lyme disease does not exist. These </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">guidelines have proven an effective
tool for the health </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">insurance industry to justify denial of reimbursement to </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">patients for treatments that their doctors prescribe.<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Health plans and insurers
and hospitals </span></b><b><i><span style="font-size: 20.0pt;">red flag</span></i></b><b><span style="font-size: 16.0pt;"> physicians </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">not conforming to IDSA guidelines for
sanctioning and often </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">report them to State Boards of Medical Practice to ‘break
their </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">knees’. This cowardly and
despicable ‘modus operandi’ is an </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">assault on physicians’ most prized
possession: professional </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">autonomy and independent medical judgment. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"> Hospitals, once proud and independent entities
with </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">endowments and a tradition of ‘charity care’ have been </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">‘captured’ by the
insurance industry and are now, often, little </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">more than ‘corporate profit
centers’.<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Health plans do not want
thinking, feeling professionals: they </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">want ‘trained monkeys’ on a ‘commoditized’ health care </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">assembly line, following
electronic medical record-prompted </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">‘algorithms’ designed to maximize corporate
profit. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">The Hippocratic Oath has
now become a ‘quaint anachronism’ </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">superseded by a new </span></b><b><i><span style="font-size: 20.0pt;">Corporate</span></i></b><b><span style="font-size: 16.0pt;"> Medical Ethic. “He who pays </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">the
piper calls the tune”. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">IDSA guidelines also serve
as a shield for medical neglect, </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">protecting physicians who fail to diagnose or
treat (or treat </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><u><br /></u></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><u>adequately)</u> patients with chronic Lyme disease, who
suffer </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">irreversible neurologic injury as a result.<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">In 2008, Connecticut State
Attorney General Richard Blumenthal </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">undertook an investigation of the way in
which the 2006 IDSA </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Lyme guidelines were developed and found significant flaws
in </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">the IDSA’s guideline development process and many </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">undisclosed conflicts of
interest. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Attorney General
Blumenthal opted to negotiate a settlement </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">with the IDSA with the creation of a
Lyme Disease Review Panel </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">to revisit the IDSA guidelines. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Unfortunately, all panel
members were hand-picked by the IDSA </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">and physicians earning more than
$10,000/year caring for </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">persons with Lyme disease were excluded from the
panel. As a </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">result no physician who
actually cared for persons with chronic </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Lyme disease served on the Lyme Review
Panel. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">In retrospect, a
negotiated settlement instead of litigation, was a </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">strategic error because the
review was under the complete </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">control of the IDSA. Consequently, no meaningful changes in </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">the
guidelines were recommended. The <u>fox</u>
was guarding the </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">chicken coop!<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">However, Attorney General
Blumenthal’s investigation and the </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">presentations of evidence before the IDSA
Lyme Disease </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Review Panel were of some utility.
When the Institute of </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Medicine brought forth its monograph on the
development of </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><u><br /></u></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><u>trustworthy</u> practice guidelines, it pointed to the IDSA
Lyme </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Disease guidelines as an example of a guideline development </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">process ‘gone
awry’. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Raymond J. Dattwyler,
signatory to the 2006 Lyme disease </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">guidelines which assert that chronic Lyme
disease does not </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">exist states <i><u>exactly</u></i> the opposite in a United
States patent that </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">issued almost contemporaneously with the IDSA
Guidelines. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">Allen C. Steere, signatory
to the 2006 IDSA Lyme Disease </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">Guidelines which declare chronic Lyme disease
does not exist, </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">states <i><u>exactly</u></i> the opposite in his published scientific
articles </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">and private letters. He sought
a correction when his first name </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">was incorrectly listed in the 1993 Logan
Science Times article </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">as “Robert’ and advised the Times his opinion had been </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">incompletely reported and requested it be clarified. According </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">to the Times correction: “he says
that the small percentage of </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">patients who have inflammation of the brain
despite standard </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">antibiotic treatment <i><u>do</u></i> have persistent
infection.”<o:p></o:p></span></span></b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b><span style="font-size: 16pt;"><span style="color: #990000;">You <u>cannot</u> have it
both ways!</span><span style="color: #333333;"><o:p></o:p></span></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">When a physician signs on
to a practice guideline that directly </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">contradicts their position in their own
published peer-reviewed </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">journal articles, statements in the public record,
private letters </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">and in their own United States Patents, does that signify </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16pt;"><span style="color: #990000;">medical and scientific misconduct?</span><span style="color: #333333;"><o:p></o:p></span></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Additionally, Dr.
Dattwyler served as an expert consultant to </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Empire Blue Cross Blue Shield in
its defense against the Logan </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">lawsuit which sought to compel Empire to cover
the cost of </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">treatment for chronic Lyme disease.
This was not disclosed in </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">the published IDSA 2006 Lyme guidelines. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Gary Wormser, lead IDSA
Lyme guidelines author, quashed all </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">abstracts on chronic Lyme disease from
being accepted at the </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">2002 International Lyme Conference at the Hyatt Hotel in
New </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">York City. When I asked him if the
conference was sponsored </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">by the CDC, he adamantly denied it. This was important </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">because if it was known to
be a CDC-sponsored event it might </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">have been possible for legislators to
intervene to open up the </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">process. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Dr. Wormser either did not
know that the event was CDC-</span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">sponsored (which seems highly implausible) or he
chose to </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">conceal that fact from me. Materials distributed at the time of </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">the
conference showed the event was, in fact, CDC-sponsored. </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16pt;"><span style="color: #990000;">During the conference, whenever attendees
attempted to bring </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">up the issue of chronic Lyme disease, they were censored,
and </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">microphones were shut off so their challenges could not be </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16pt;"><span style="color: #990000;">heard.</span><span style="color: #333333;"><o:p></o:p></span></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal">
<b><span style="font-size: 16pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">When a physician acts in a
way to suppress expression of </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">opposing views in a government-sponsored
international </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">scientific conference, does that constitute an abuse of
power? </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">Does it constitute medical and
scientific misconduct?<o:p></o:p></span></span></b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b><u><span style="font-size: 16.0pt;"><span style="color: #990000;">Honest</span></span></u></b><b><span style="font-size: 16pt;"><span style="color: #990000;"> science does not need to suppress opposing views.</span><span style="color: #333333;"><o:p></o:p></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Vicki Logan and other
patients sued Empire Blue Cross Blue </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Shield to cover the cost of needed
treatment. The case was </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">settled out of
court with terms that were confidential.
Whatever </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">the settlement was, it did not include Vicki’s right to be </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">reimbursed for the cost of intravenous antibiotic therapy, which </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">she needed.<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">During the litigation, a
deposition under oath was taken by </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Empire Blue Cross Blue Shield Senior Vice
President Richard </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Sanchez, M.D. He
testified that Empire’s <u>accountants</u>, Deloitte </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">& Touche, advised Empire
that their review physicians needed </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">to issue more denials in order to increase
its profitability. </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Empire was
transitioning from a not for profit to a for profit </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">entity. They raised the bar to make it more difficult
for patients </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">with costly conditions, such as Lyme disease, to get </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">reimbursement
for treatment. His testimony indicated
that </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Empire senior personnel knew that some patients who actually </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">had Lyme
disease would be denied treatment and that some </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">would suffer as a result. He said it was ‘rationalized’ that </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">patients
could appeal their denials and that that was a way that </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Empire physicians could
‘sleep at night’. But he also </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">acknowledged that some patients might be unable to negotiate </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">the tortuous
appeals process and might ‘fall by the wayside’ </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">and might sustain irreversible
injury as a result. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Empire Blue Cross &
Blue Shield ultimately did transition to a </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">‘for profit’ entity. Empire executives got ‘golden parachutes’ </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">worth hundreds of millions of dollars in personal profit. Vicki </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Logan got a ‘handbasket to hell’.<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">When patients suffer,
deteriorate neurologically and die due to </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">corporate decisions, <i><u>who</u></i>
is responsible? Is there impunity? Or </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">is there a </span></b><b><i><span style="font-size: 20.0pt;">penalty</span></i></b><b><span style="font-size: 16.0pt;">?<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">There’s the case of a 6
year-old Fairfield County, Connecticut </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">child whose mother pleaded with her
pediatrician to treat for a </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">fully engorged deer tick attachment on the side of
her neck </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Spring of 1995. The
pediatrician refused. Flu-like symptoms </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">developed that summer, and headache, stiff neck and swelling </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">of the glands
draining the tick bite site developed in the Fall. </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Personality change,
hypersomnolence and later, <i>status </i></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><i><br /></i></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><i>epilepticus</i> developed. Seizures were
so severe that </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">pentobarbital coma was required to control them. She came </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">under the care of Charles Ray Jones,
MD, who referred her to </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">me for a spinal tap.
At the time of the tap, Lyme Western blot in </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">serum at Stony Brook showed
4/5 CDC-specific IgG bands, but </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">her ELISA screening test was negative.</span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"> </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Dr. Jones treated her with intravenous
antibiotics. Although </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">she had sustained
a degree of irreversible neurologic injury </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">from her illness, she was making
good progress on IV </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">antibiotics for several months. Intracorp’s review physician </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">refused to
authorize reimbursement to the family for </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">continuation of intravenous
antibiotics even though she was </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">still improving. After cessation of intravenous antibiotics, </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">intractable
<i>status epilepticus</i> recurred, she was
admitted to a </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">tertiary care hospital and died within one month. An autopsy </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">was performed. Both Dr. Charles Ray Jones and I </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><i><u><br /></u></i></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><i><u>independently</u></i>
telephoned the health officer charged with Lyme </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">disease epidemiology for the
Connecticut Department of Public </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Health, pleading with him to take the case. The purpose of our </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">request was not to <i><u>punish</u></i>
any physician, but to <i><u>learn</u></i> from the </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">case. His response to me was: “Well…..what evidence was </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">there, really, that
this child had Lyme disease?” and
declined </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">to accept the case.<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">So, you take the one
physician in Connecticut who cares for all </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">the children <i><u>sick</u></i> with chronic Lyme disease who has never </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">harmed a child,
but only helped, and put him through an </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">attempted public crucifixion. And the court allows pediatrician </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">John
Senechal, who expressed vituperative malice towards Dr. </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Jones, to sit on the
Committee determining Dr. Jones’ fate?<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal">
<b><span style="font-size: 16pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">But when a physician fails
to treat a child with an engorged deer </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">tick bite despite a mother’s plea and
fails to recognize Lyme </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">disease when the
child becomes ill including <i>status
epilepticus</i> </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">and the child dies
within 30 days of discontinuance of IV </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">antibiotics made necessary by the
decision of an insurance </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">company review physician, and <i><u>two</u></i>
physicians report the case </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">to the Connecticut Department of Public Health, you <i><u>DON’T</u></i> </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">investigate?<o:p></o:p></span></span></b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<span style="color: #990000;"><b><span style="font-size: 16.0pt;">What is </span></b><b><i><u><span style="font-size: 22.0pt;">wrong</span></u></i></b></span><b><span style="font-size: 16pt;"><span style="color: #990000;"> with this picture?</span><span style="color: #333333;"><o:p></o:p></span></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">I call on Dr. Jewel
Mullen, Commissioner of the Connecticut </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Department of Public Health, to
investigate this case <i>now</i> and </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">determine <i>why</i> there was a failure
to investigate it in 1997.<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">I call on Connecticut
Governor Dannel Molloy to direct the </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Department of Public Health to disclose
how many hundreds of </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">thousands of taxpayers’ dollars have been wasted by the </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Connecticut Medical Examining Board’s attempt to burn Dr. </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Charles Ray Jones at
the stake. Bring this travesty of
justice to </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">an end!<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">In 2005 a memorandum of
understanding with the New York </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">State Department of Health’s Office of Professional
Medical </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Conduct (OPMC) was reached through the efforts of </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Assemblymen Joel
Miller and Adam Bradley and </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Assemblywoman Nettie Meyersohn in conjunction with </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Governor Pataki’s Chief Counsel, not to investigate physicians </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">merely because
they held a minority opinion concerning </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">diagnosis and treatment of Lyme
disease. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Recently, in New York
State, six physicians who care for </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">persons with chronic Lyme disease have been
simultaneously </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">under investigation by the OPMC.
What message does this </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">send to other physicians? What implications does this have for </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">persons with chronic Lyme disease to access proper
care </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">within the State of New York and elsewhere?<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">If nothing else, it
indicates that a memorandum of </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">understanding is <u>inadequate</u> to protect
physicians and the </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">patients with chronic Lyme disease who depend on them for </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">care. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Force of law is necessary to
accomplish this, <u>and</u> to compel </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">insurers to pay for treatment their
physicians have determined </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">is medically necessary for this condition. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Legislation containing
some or all of these elements has been </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">passed or is currently under
consideration in a number of </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">States. Insurers
can <u>never</u> be trusted to do the right thing for </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">patients with chronic
Lyme disease.</span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"> Such decisions <u>must</u>
be taken out of the hands of the </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">insurance industry. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Then, there’s the case of
Jennifer Lilly. She sustained a tick </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">bite while in western New Jersey, followed by a classic Bull’s </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Eye rash, and
severe headache. She was told by a
succession </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">of physicians she </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><i><br /></i></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><i>could</i>
not have Lyme disease because her screening tests for </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Lyme disease were
negative and she received no treatment </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">during the first three years of her
illness. When I saw her, I </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">diagnosed
Lyme disease based on her history and instituted </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">treatment at her initial visit. Her Lyme ELISA at SUNY Stony </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Brook was <u>still</u>
negative, but her IgM and IgG Western blots </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">were fully diagnostic. Most likely because of the delay in her </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">diagnosis, lesions were evident on an MRI of her brain and this </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">formerly highly
productive woman has had to seek disability. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">When the Frederick County,
Maryland Department of Health </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">contacted me to complete a Lyme disease reporting
form, I </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">decided to accompany it with a detailed letter which I copied to </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Dr.
Thomas Frieden, former New York City Health </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Commissioner, and now Director of
the Centers for Disease </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Control, since Jennifer’s case was a <i>glaring</i> example of the </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">deficiencies of
the two-tiered system of Lyme disease testing </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">recommended by the CDC and
responsible for <i><u>so</u></i> much patient </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><i><u><br /></u></i></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><i><u>suffering</u></i>. Dr.
Frieden <i>never</i> personally responded to
my letter.<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal">
<span style="font-size: 16pt;"><span style="color: #990000;"><b><br /></b></span></span></div>
<div class="MsoNormal">
<span style="font-size: 16pt;"><span style="color: #990000;"><b>Presently we have underway
a vast, <i>de facto</i> nation- and world-</b></span></span></div>
<div class="MsoNormal">
<span style="font-size: 16.0pt;"><span style="color: #990000;"><b><br /></b></span></span></div>
<div class="MsoNormal">
<span style="color: #990000;"><b><span style="font-size: 16.0pt;">wide “Tuskegee Expe</span><span style="line-height: 1.22em;"><span style="font-size: 16.0pt;">riment” of <i><u>un</u>treated</i> or <i>under-treated</i> </span></span></b></span></div>
<div class="MsoNormal">
<span style="line-height: 1.22em;"><span style="font-size: 16.0pt;"><span style="color: #990000;"><b><br /></b></span></span></span></div>
<div class="MsoNormal">
<span style="line-height: 1.22em;"><span style="font-size: 16pt;"><span style="color: #990000;"><b>chronic Lyme disease.</b></span></span></span></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">Neither the United States
Public Health Service, predecessor to </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">the CDC, nor the medical profession
brought the Tuskegee </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">Experiment to a halt. Senator Edward Kennedy’s hearings held </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;">in 1972
ended that shameful episode. <i><u>Moral</u>
<u>force</u></i> brought the </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16pt;"><span style="color: #990000;">ignominious
Tuskegee Experiment to an end.</span><span style="color: #333333;"><o:p></o:p></span></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">In the year 2000, due to
fortuitous circumstances, and </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">unbeknownst to Dr. Dattwyler, I gained access to
CDC-funded </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">experimental methods in his research laboratory for more than </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">140
specimens of frozen cerebrospinal fluid on my patients. </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Whereas only 2% of specimens tested positive
on standard </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">spinal fluid tests, some 62 % of specimens tested positive on </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">one
or more of the four experimental assays used.</span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">
Ironically, Vicki Logan’s CSF tested more than 7 times higher </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">than the
positive cut-off for detection of Outer surface protein C </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">antigen, in the very laboratory
of Empire Blue Cross & Blue </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Shield’s own expert consultant.<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">I asked Laboratory
Supervisor, Priscilla Munoz, how they knew </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">these methods were valid. She replied that the three </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">collaborating
research laboratories shared aliquots of samples </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">and found excellent
reproducibility between the three labs.<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">The results of these
CDC-funded studies on direct detection of </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">OspA and OspC antigen and IgG and IgM
borrelia-specific </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">immune complexes in spinal fluid have never been published.<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">Why not? Did someone at CDC “deep six” the results of
this </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">research project? If so, who made
this decision, and why?</span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">I <i>demand</i> the “raw data” from these CDC-funded research </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">studies, which
have never seen the light of day, be made public </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><u><br /></u></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><u>immediately</u>.<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Thomas Frieden, as <u>Director</u>
of CDC can ‘set the tone’ for the </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">agency.
I call on him, to ‘step <u>up</u> to the plate’ and <u>fix</u> the <u>mess</u> </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">created by CDC. Dr. Frieden can ‘redeem’
the reputation of </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">CDC, which is composed
of fine physicians and scientists. </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Dissociate CDC from the disgraced IDSA Lyme disease </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">guidelines. Otherwise, </span></b><b><span style="font-size: 20.0pt;">step down!</span></b><b><span style="font-size: 16.0pt;"><o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">I call on NYS Attorney
General Eric Schneiderman to undertake </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">an additional, independent, in depth and
far reaching </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">investigation with subpoena power and testimony under oath, </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">of the
2006 IDSA Lyme Disease Guidelines and of the health </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">insurance industry, in order to determine
whether or not, in the </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">matter of chronic and seronegative Lyme disease, there
has </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">been collusion to perpetrate a premeditated, systematic and </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">pervasive
health care fraud upon the citizens of New York State </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><u>he</u> has a sworn duty
to <u>protect</u>. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">Has anyone here been
shafted by MEDCO??? <u>Investigate</u> </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">MEDCO!!! When there exist two schools of
thought, you </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">endorse only <i>that</i> school of thought that maximizes short
term </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">profit, <i>regardless</i> of individual patient circumstances or the </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;"><i><br /></i></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;"><i>suffering</i>
that it causes?</span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Remember A.I.D.S.? Persons with H.I.V. were abused, despised </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">and
neglected until <u>ACT-UP-activists</u> threw <u>blood</u> on the steps </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">of St.
Patrick’s Cathedral. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Only <u>then</u> did
things begin to change. Because of that activism, </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">$2 billion/year has been
expended on A.I.D.S. research and </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">treatment over the past several decades and <u>real</u>
progress has </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">been made. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Contrast that with some
$20 million/year spent on Lyme disease </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">by the Federal government. Why are resources commensurate </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">with the
threat posed by Lyme disease <u>not</u> being allocated? </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Start funding to the
tune of <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">$2 billion /year for Lyme
and tick-borne diseases and, <i>trust</i>
me, </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">you’ll see <u>progress</u>!</span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"> <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Federal funds should not
be <i>squandered</i> further on those who </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">are ideologically committed to the <u>false</u>
proposition that chronic </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Lyme disease does not exist.<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Paul Starr, who graduated Columbia
College a year ahead of </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">me, correctly predicted the ‘coming of the corporation’
in his </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">prescient book “The Social Transformation of American </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Medicine”. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"> But Starr also commented that the future of
American Medicine </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">is ours to shape by the choices that we make.<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Patients have the
Power. But, they must be </span></b><b><i><u><span style="font-size: 20.0pt;">united</span></u></i></b><b><span style="font-size: 16.0pt;"> and not </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">squabbling with one another.
They must be pro-active, militant </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">and resolute. <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">There are lots of things
patients can do. They can <i>write</i> to their </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">State Assemblypersons and
State Senators. They can <i>MEET</i> </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">with their State Assemblypersons
and State Senators. They can </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">do the same
with their U.S. Congress-persons & Senators <o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">& their states’
Governors. </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal">
<b><span style="font-size: 16pt;"><span style="color: #990000;">They can write to
Connecticut Governor Molloy and tell him to<o:p></o:p></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16.0pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 16pt;"><span style="color: #990000;">“call off the <u>dogs</u>”!</span><span style="color: #333333;"><o:p></o:p></span></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">They can write to Attorney
General Schneiderman with details of </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">their cases and how they have been mistreated
by insurers </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">girded by IDSA guidelines that are scientifically, therapeutically </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">and morally bankrupt <i><u>and</u></i> which <i>endorse</i> and <i>enable</i> medical </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">neglect as a ‘standard
of care’ for persons with chronic Lyme </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b style="line-height: 1.22em;"><span style="font-size: 16.0pt;">disease. </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<br /></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">They can write to Governor
Cuomo, President Obama and First </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Lady Michelle Obama, persons of <i>conscience</i>
and <i>compassion</i>, </span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">urging them to <u>act</u>.<o:p></o:p></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 24pt;"><span style="color: #990000;"><br /></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 24pt;"><span style="color: #990000;">Sometimes, a <i>little</i>
‘rebellion’ is </span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 24pt;"><span style="color: #990000;"><u><br /></u></span></span></b></div>
<div class="MsoNormal">
<b><span style="font-size: 24pt;"><span style="color: #990000;"><u>necessary</u>.</span><span style="color: #333333;"><o:p></o:p></span></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Thank you for your
attention.<o:p></o:p></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;"><br /></span></b></div>
<div class="MsoNormal" style="color: #333333;">
<b><span style="font-size: 16.0pt;">Kenneth B. Liegner, M.D. <o:p></o:p></span></b></div>
<!--EndFragment--></div>
</div>
Unknownnoreply@blogger.com6tag:blogger.com,1999:blog-5876257241074222326.post-70457821751934558452013-05-08T16:12:00.000-07:002013-05-09T03:15:59.004-07:00Jon Stewart, Healthcare Reform, and Lyme Disease<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
<!--[if gte mso 9]><xml>
<o:OfficeDocumentSettings>
<o:AllowPNG/>
</o:OfficeDocumentSettings>
</xml><![endif]-->
<!--[if gte mso 9]><xml>
<w:WordDocument>
<w:View>Normal</w:View>
<w:Zoom>0</w:Zoom>
<w:TrackMoves/>
<w:TrackFormatting/>
<w:PunctuationKerning/>
<w:ValidateAgainstSchemas/>
<w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
<w:IgnoreMixedContent>false</w:IgnoreMixedContent>
<w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
<w:DoNotPromoteQF/>
<w:LidThemeOther>EN-US</w:LidThemeOther>
<w:LidThemeAsian>JA</w:LidThemeAsian>
<w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
<w:Compatibility>
<w:BreakWrappedTables/>
<w:SnapToGridInCell/>
<w:WrapTextWithPunct/>
<w:UseAsianBreakRules/>
<w:DontGrowAutofit/>
<w:SplitPgBreakAndParaMark/>
<w:EnableOpenTypeKerning/>
<w:DontFlipMirrorIndents/>
<w:OverrideTableStyleHps/>
</w:Compatibility>
<m:mathPr>
<m:mathFont m:val="Cambria Math"/>
<m:brkBin m:val="before"/>
<m:brkBinSub m:val="--"/>
<m:smallFrac m:val="off"/>
<m:dispDef/>
<m:lMargin m:val="0"/>
<m:rMargin m:val="0"/>
<m:defJc m:val="centerGroup"/>
<m:wrapIndent m:val="1440"/>
<m:intLim m:val="subSup"/>
<m:naryLim m:val="undOvr"/>
</m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
<w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
DefSemiHidden="true" DefQFormat="false" DefPriority="99"
LatentStyleCount="276">
<w:LsdException Locked="false" Priority="0" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
<w:LsdException Locked="false" Priority="9" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
<w:LsdException Locked="false" Priority="39" Name="toc 1"/>
<w:LsdException Locked="false" Priority="39" Name="toc 2"/>
<w:LsdException Locked="false" Priority="39" Name="toc 3"/>
<w:LsdException Locked="false" Priority="39" Name="toc 4"/>
<w:LsdException Locked="false" Priority="39" Name="toc 5"/>
<w:LsdException Locked="false" Priority="39" Name="toc 6"/>
<w:LsdException Locked="false" Priority="39" Name="toc 7"/>
<w:LsdException Locked="false" Priority="39" Name="toc 8"/>
<w:LsdException Locked="false" Priority="39" Name="toc 9"/>
<w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
<w:LsdException Locked="false" Priority="10" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Title"/>
<w:LsdException Locked="false" Priority="0" Name="Default Paragraph Font"/>
<w:LsdException Locked="false" Priority="11" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
<w:LsdException Locked="false" Priority="22" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
<w:LsdException Locked="false" Priority="20" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
<w:LsdException Locked="false" Priority="0" Name="HTML Address"/>
<w:LsdException Locked="false" Priority="59" SemiHidden="false"
UnhideWhenUsed="false" Name="Table Grid"/>
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
<w:LsdException Locked="false" Priority="1" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 1"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
<w:LsdException Locked="false" Priority="34" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
<w:LsdException Locked="false" Priority="29" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
<w:LsdException Locked="false" Priority="30" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 1"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 2"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 2"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 3"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 3"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 4"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 4"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 5"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 5"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 6"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 6"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
<w:LsdException Locked="false" Priority="19" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
<w:LsdException Locked="false" Priority="21" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
<w:LsdException Locked="false" Priority="31" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
<w:LsdException Locked="false" Priority="32" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
<w:LsdException Locked="false" Priority="33" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
<w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
<w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
</w:LatentStyles>
</xml><![endif]-->
<!--[if gte mso 10]>
<style>
/* Style Definitions */
table.MsoNormalTable
{mso-style-name:"Table Normal";
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-parent:"";
mso-padding-alt:0in 5.4pt 0in 5.4pt;
mso-para-margin:0in;
mso-para-margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:10.0pt;
font-family:"Times New Roman";}
</style>
<![endif]-->
<!--StartFragment-->
<br />
<address style="text-align: center;">
</address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">Who knew that healthcare reform was still
such a hot issue? <o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">Everybody's talking about the recent cover
article of Time magazine discussing the high costs of healthcare: <u><span style="color: grey;"><a href="http://healthland.time.com/2013/02/20/bitter-pill-inside-times-cover-story-on-medical-bills/">http://healthland.time.com/2013/02/20/bitter-pill-inside-times-cover-story-on-medical-bills/</a></span></u><o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> <div class="separator" style="clear: both; text-align: center;">
<a href="http://2.bp.blogspot.com/-bvIou0SL3tI/UYrapS6_gtI/AAAAAAAAB_w/rhyhhrTwg-c/s1600/tn.jpeg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="213" src="http://2.bp.blogspot.com/-bvIou0SL3tI/UYrapS6_gtI/AAAAAAAAB_w/rhyhhrTwg-c/s320/tn.jpeg" width="320" /></a></div>
</span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">Jon Stewart was so excited by the article
that he exclaimed, "I don't think I've ever said this before. Go out and
get Time magazine....It's unbelievable.": <u><span style="color: grey;"><a href="http://www.thedailyshow.com/watch/thu-february-21-2013/steven-brill">http://www.thedailyshow.com/watch/thu-february-21-2013/steven-brill</a></span></u><o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">In an impassioned interview, Steven Brill,
author of the Time article, explained to Stewart how it's like we live in an
"alternate universe" with 2 economies. There's the economy that all
of us live in where we've been losing money the last 5 or 6 years. Then there's
a little island – the healthcare economy – which just keeps making more and
more money by taking it from all of us. <o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">Many of us were disappointed with ObamaCare
because it barely scratches the surface. Yet we also seem to have a collective
sense of helplessness around the healthcare issue. <o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> <div class="separator" style="clear: both; text-align: center;">
<a href="http://2.bp.blogspot.com/-CkjOdAX2lPs/UYrbCfxMxcI/AAAAAAAAB_4/c11sKZI5PqQ/s1600/tn-1.jpeg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="273" src="http://2.bp.blogspot.com/-CkjOdAX2lPs/UYrbCfxMxcI/AAAAAAAAB_4/c11sKZI5PqQ/s320/tn-1.jpeg" width="320" /></a></div>
</span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">Lyme disease may come to be known as the
illness that exemplifies
the "all profit, no care" attitude of HMOs.<o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">Contrary to popular belief, Lyme disease is
not just on the East coast.<o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">It's a worldwide epidemic. According to
the CDC, rates of Lyme far surpass rates of AIDS in this country. <o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">We're all at risk for this deadly
disease. <o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">HMOs are fighting tooth and nail to prevent
this raging epidemic from becoming public due to fears about it becoming the
next costly AIDS epidemic.<o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">Countless people with Lyme are being
misdiagnosed with Parkinson's, Alzheimer's, ALS, MS, arthritis, depression,
bipolar disorder, etc.<o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">Even when patients do get properly
diagnosed, they can only receive 2 to 8 weeks of antibiotics.<o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">HMOs refuse to treat people with chronic
Lyme. <o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">As a result, patients are
suffering and dying from debilitating neurological problems and many other
physical symptoms.<o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">The Lyme community has decided to fight back.<o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">They are holding a worldwide protest
this May. <o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> <div class="separator" style="clear: both; text-align: center;">
<a href="http://2.bp.blogspot.com/-RDM8VI2kCvw/UYrbQV3zcoI/AAAAAAAACAA/EXPymY1uQHg/s1600/tn.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="240" src="http://2.bp.blogspot.com/-RDM8VI2kCvw/UYrbQV3zcoI/AAAAAAAACAA/EXPymY1uQHg/s320/tn.jpg" width="320" /></a></div>
</span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> <o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">If you've ever had a gripe with an HMO, join
them in the struggle. <o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">Lyme is not just an illness. It's a
movement. It's time to reform healthcare. Come stand with them on May 10 and
11th.<o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">To see how you're at
risk for Lyme watch: <u><span style="color: grey;"><a href="http://www.youtube.com/watch?v=sxWgS0XLVqw">http://www.youtube.com/watch?v=sxWgS0XLVqw</a></span></u><o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">For more information about the Lyme
epidemic: <u><span style="color: grey;"><a href="http://nationallymeheadquarters.com/">http://nationallymeheadquarters.com</a></span></u><o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">Find a Lyme protest near you:<a href="https://www.facebook.com/pages/Worldwide-Lyme-Protest-US/111527755675190?fref=ts"> <u><span style="color: grey;">https://www.facebook.com/pages/Worldwide-Lyme-Protest-US/111527755675190?fref=ts</span></u> <o:p></o:p></a></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"><a href="https://www.facebook.com/pages/Worldwide-Lyme-Protest-US/111527755675190?fref=ts"> </a></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">_______________________<o:p></o:p></span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;"> </span></address>
<address>
<span style="font-family: Helvetica; font-size: 14.0pt; mso-bidi-font-size: 10.0pt; mso-fareast-language: JA;">Jessica Bernstein, Psy.D. is a psychologist
with Lyme disease and Type 1 diabetes who has a private practice in Oakland, CA
specializing in chronic illness. She is producing a documentary film about
illness and suffering: <u><span style="color: grey;">www.bloodandhoney.or</span></u>g</span><span style="font-family: Helvetica; mso-fareast-language: JA;"><o:p></o:p></span></address>
<div class="MsoNormal">
<br /></div>
<!--EndFragment--></div>
Unknownnoreply@blogger.com1tag:blogger.com,1999:blog-5876257241074222326.post-69065859880762715912013-04-16T06:11:00.000-07:002013-04-16T06:15:12.734-07:00ESCAPE FIRE: The Fight To Rescue American Healthcare<div dir="ltr" style="text-align: left;" trbidi="on">
<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-cfxpp112I6E/UW02MKcALKI/AAAAAAAAB54/79VYH9ssQOo/s1600/escape+fire.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="358" src="http://3.bp.blogspot.com/-cfxpp112I6E/UW02MKcALKI/AAAAAAAAB54/79VYH9ssQOo/s640/escape+fire.jpg" width="640" /></a></div>
<br />
<br />
Last night on May 15, 2013, I was treated to a private screening of the important movie "Escape Fire". The screening was held by Maximized Living Chiropractors from around the country. This film focuses on our current unsustainable system of treating the sick. Some of the points focused on are....1. Why are so many of us sick? 2. Why do we treat only the symptoms instead of the underlying causes? 3. Where is there any true prevention? 4. How is money made in our current system? 5. How can we set up a preventative system where prevention is actually profitable?<br />
<br />
As the movie points out....despite the propaganda we hear that the U.S. is one of the best fed, healthiest nations in the world, this country is one of the lowest rated in health on the international scale. Our system in the U.S. is really one of disease care. Profits drive this system that doesn't want the people to get well...but it really doesn't want you to die either. The system wants to keep us alive and sick so we continue to be sources of profit. An example of this from personal experience...is the controversy surrounding the treatment of Lyme disease...both the acute and chronic forms. When Lyme disease goes under-treated or untreated and misdiagnosed as many different diseases, which supposedly have no known causes or cures...the disease festers and spreads under the surface while medical testing and drug companies make millions on the hundreds of symptoms caused by the untreated disease.<br />
<br />
The movie brought out the fact that insurance companies do not invest much in true prevention because people often stay with a specific insurance company sometimes only for a year or so. Medical training focuses on medication and expensive testing. Doctors in training receive very little education on the subject of nutrition...which is the main preventative factor of disease. Because what we eat and how well mineralized our food is.. determines our health...it would follow that a disease care system whose goal is profit...would minimize prevention and even intentionally advise us improperly. The movie stresses the idea that it is not the doctors who are to blame but the system that teaches them.<br />
<br />
Escape Fire shows us that the current system is completely irrational...as far as a system that is supposed to promote health. Our medical system rewards doctors for delivering MORE procedures, MORE drugs and for seeing MORE patients. This setup does not encourage or allow for adequate time spent with patients. Doctors are not taught to look for root causes of disease....or to look at the person as a whole. This results in root causes staying unidentified while only the symptoms are treated.<br />
<br />
Drug companies do not always warn the public of some of the serious side effects or outcomes of their drugs. One example given was the drug Avandia, a diabetes drug. <a href="http://www.pharmalive.com/avandia-scandal-leading-diabetes-doc-warned-fda-about-risks-2000">http://www.pharmalive.com/avandia-scandal-leading-diabetes-doc-warned-fda-about-risks-2000</a><br />
A study showed that the group taking Avandia in the study had a 30% increase of heart attacks. This fact was never mentioned to doctors or patients. A similar thing occurred with the Lyme disease vaccine Lymerix. A study showed that 30% of those in a vaccine study had a genetic tendency to acquire an arthritis from the vaccine itself that would be intractable to treatment. Nothing was said about this either. I did talk to numerous people who had gotten the vaccine and they were now diagnosed with fibromyalgia or Chronic Fatigue Syndrome.<br />
<br />
A large part of the problem lies with the lobbyists that the medical corporations hire. Many of our elected officials, including the President...are basically hired through campaign donations, by these corporations, to do their bidding.<br />
<br />
A large part of the movie discussed the problems of the system, which began to get a bit discouraging. However, the last part of the movie tried to focus more on the solutions. Some of these solutions were methods of natural pain relief, healthy diet, meditation and other lifestyle changes. When it comes down to the nitty gritty...we are the ones responsible for our own health and well being. When we give this responsibility totally away to commerce, it is never a good outcome.<br />
<br />
Is government funded healthcare the answer...as Michael Moore promotes? I don't think so. Government funded healthcare would just be more of the same and possibly even worse if it is based on the same premise of more and more testing and drugs. We may even be required to take toxic vaccines and other harmful treatments.<br />
<br />
I highly recommend that everyone see the movie "Escape Fire". Hopefully the healthcare industry won't have to crash before we can turn things around. But....something has to be done because it's almost to the point where the human race may not survive. The health of our soil (mineral density) is also another very crucial factor not mentioned in the movie. I will report on a couple of books on this subject in the future.<br />
<br />
The need is great to turn things around NOW! I have been very pleased with my Maximized Living Chiropractor and the comprehensive program they offer to patients. The more people who begin to turn to alternative and holistic healthcare...the more the medical industry will have to adapt in order to survive. Maybe we can all find some solutions together. Here is a link to something I posted about the Maximized Living Chiropractor who has helped me.<br />
<a href="http://www.lymesentinel.blogspot.com/search/label/MAXIMIZED%20LIVING%20CHIROPRACTIC%20CARE">http://www.lymesentinel.blogspot.com/search/label/MAXIMIZED%20LIVING%20CHIROPRACTIC%20CARE</a><br />
They offer many activities...exercise group, nutrition counseling, weight loss programs, recipe night and many other helpful lectures.....including viewing this movie. Yes...Maximized Living Practitioners are running a business also but the point is.....they are an example of how you can earn a living while at the same time actually be promoting health. It can be done. Check out my chiropractor's website <a href="http://www.drmirante.com/">www.drmirante.com</a> . You may call them to find Maximized Living Chiropractors around you. From the research I have done I feel that their nutritional advice and recipes are right on target and not based on the goals of the agricultural and medical industries.<br />
<br />
<iframe allowfullscreen="" frameborder="0" height="300" mozallowfullscreen="" src="http://player.vimeo.com/video/27450676?autoplay=1" webkitallowfullscreen="" width="400"></iframe></div>
</div>
Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-5876257241074222326.post-42052216253473004152013-03-06T05:08:00.002-08:002013-03-06T05:08:58.417-08:00Lyme Disease: A Biological Weapon?<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
<dt style="background-color: #e3d194; text-align: -webkit-auto;"><center>
<b>This article was originally posted on Rense.com </b></center>
<center>
<b style="text-align: -webkit-auto;"><span><br /></span></b></center>
<center>
<b style="text-align: -webkit-auto;"><span>Lyme Disease - </span></b></center>
<center>
<b><span>A Biological Weapon?</span></b></center>
</dt>
<dt style="background-color: #e3d194; text-align: -webkit-auto;"><center>
<span>By Marjorie Tietjen<br />daystar1952@yahoo.com<br />3-16-5</span></center>
</dt>
<dt style="background-color: #e3d194; text-align: -webkit-auto;"><center>
</center>
</dt>
<dt style="background-color: #e3d194; text-align: -webkit-auto;"><center>
<br /><table border="0" cellpadding="0" cellspacing="0" style="height: 85px; width: 553px;"><tbody>
<tr><td height="84" valign="TOP" width="601%">
<dl>
<dt><span>First let's begin with a discussion of what properties constitute an effective biological warfare agent. The Media, The Centers For Disease Control and The Department of Defense would have us believe that the most threatening biological agents are lethal microbes which cause acute disease and then death...such as anthrax and smallpox. It appears that we are being intentionally misled as to where the real danger lies.</span></dt>
<dt> </dt>
<dt><span>Government biological warfare documents speak of incapacitating agents as being the most effective at disabling a nation. When a population is infected with a lethal agent, it is very obvious that measures need to be taken such as quarantine, antibiotics, etc. This helps to curb and abort the epidemic.</span></dt>
<dt> </dt>
<dt><span>A much more discreet, diabolical and effective method of disabling a country would be to employ a moderately infectious organism or combination (Russian Doll Cocktails) which would pass slowly through the population unnoticed. Some of the criteria for effective disabling agents are:</span></dt>
<dt> </dt>
<dt><span>1. A biological agent which lacks objective signs that can be determined by medical testing. Many patients who are extremely ill with mycoplasma or lyme infections are told all their tests are normal therefore their problems must be all in their heads. Many people labeled with Chronic Fatigue Syndrome and Fibromyalgia are told the same thing....if they would only get a new job, hobby or begin to excercise...then they would be fine.</span></dt>
<dt> </dt>
<dt><span>2. An agent which would produce so many symptoms throughout the body that it would appear that the patient was malingering or faking. This criteria prevents the medical community from taking the disease seriously and in the meantime it passes quietly through the population being labeled as many separate diseases and conditions.</span></dt>
<dt> </dt>
<dt><span>3. If the disabling agent is a combination of several diseases, some of which could be genetically engineered, then it becomes very difficult if not impossible to diagnose and treat.</span></dt>
<dt> </dt>
<dt><span>4. Diseases which are spread by insect vectors are very much sought after. This makes an epidemic much easier to pass off as a natural event while concealing the identity of the perpetrators.</span></dt>
<dt> </dt>
<dt><span>Dr. Donald MacArthur who was in charge of the developement and testing of biological weapons for the Pentagon had this to say at a Hearing before a Subcommittee of the Committee on Appropriations in 1969.</span></dt>
<dt> </dt>
<dt><span>"Incapacitating agents are a more recent developement and are largely in the R&D phase (in 1969). In fact the prime emphasis in agent R&D is on developing better incapacitating agents. We are synthesizing new compounds and testing them in animals. I should mention that there is a rule of thumb we use before an agent can be classified as an incapacitant, we feel that the mortality should be very low. Therefore the ratio of the lethal dose to the incapacitating dose has to be very high. Now this is a technical job. We have some of the top scientists in the country working for years on how to get more effective incapacitating agents. It is not easy." He also tells us that an incapacitating agent "imposes a greater logistic burden on the enemy when he has to look after the disabled people."</span></dt>
<dt> </dt>
<dt><span>When a large portion of the population is sick and unable to work, this puts an enormous strain on the economy. I predict that if we do not make this issue an immediate priority, our country will indeed become quickly disabled.</span></dt>
<dt> </dt>
<dt><span>The next logical question would be...does Lyme Disease and it's coinfections fit into this scenerio? Certain doctors and researchers feel that lyme disease and it's coinfections....such as mycoplasma fermentens (patented by the U,S. Army) are actually microrganisms with excellent credentials for qualifying as disabling biowarfare agents..</span></dt>
<dt> </dt>
<dt><span>Much controversey surrounds the diagnosis and treatment of Lyme Disease and mycoplasma induced illnesses such as Gulf War Illness. Professor Garth Nicolson and Lieutenant Joyce Riley....among others...are seeing evidence everywhere that one cause of Gulf War Illness is microbial and that it is spreading to the families of the veterans and then on to the public in general. Many who become ill with this mycoplasma and or the lyme spirochete are being divided up into separate disease labels such as Multiple Sclerosis, Fibromyalgia, Chronic Fatigue Syndrome, Alzheimer's, Bi Polar Depression, Lupus,, ALS, etc. Most of these disease labels have no known definitive tests, causes or cures...only symptomatic treatments.</span></dt>
<dt> </dt>
<dt><span>The Lyme Spirochete (borrelia burgdorferi..Bb ) and mycoplasma fermentens are both extremely pathogenic and can cause problems in every body system. In fact they present with symptoms so similar to each other that one has to wonder what the connection is. Sufferers of Lyme Disease are very often coinfected with mycoplasmas, babesia, erlichiosis, Rocky Mountain Spotted Fever and certain viruses. We are told that Lyme Disease has been around for hundreds of years and that ticks are filthy organisms which can spread many diseases in one single bite. This apppears to be true but is this due to a natural evolutionary process or is this sudden proliferation of countless coinfections a process which has had some help from biowarfare researchers? Are all these ticks carrying multipathogens naturally this way or are they the result of The Russian Doll Cocktail concept? Have ticks themselves been modified to endure harsh weather extremes? The ticks that carry Lyme Disease appear to be surviving in climates previously inhospitable to this species. In fact this disease is becoming endemic in many parts of the world at once and seems to be just as controversial everywhere it spreads. Why is this? If Lyme Disease is an unaltered ancient organism then shouldn't the medical community be aware of it's very diverse symptom complex? Shouldn't they know that it is a Great Imitator such as it's close relative Syphilis? Global warming always seems to be one of the excuses used when insect vectors cross their climate boundaries...but maybe it's due to genetic engineering. For example...Ades Japonicus is a genetically altered strain of mosquito and is purported to be the most efficient vector for West Nile Virus. It just happened to appear over here....out of it's native habitat...just in time to be an efficient vector for the West Nile Virus outbreak.</span></dt>
<dt> </dt>
<dt><span>Borrelia burgdorferi...Bb...the causative agent of Lyme Disease presents with persistent infection and is many times incurable with the standard antibiotic regimes. While usually antibiotics are necessary in controlling and improving the lyme infection, it appears the organism may never be totally erradicated. It is known that there are techniques used to enhance bacterial resistance to antibiotics. So....while on the one hand the medical authorities are warning us of the dangers of the overuse of antibiotics and even limiting their valid applications...on the other hand they are creating and perhaps even letting loose antibiotic resistant germs.</span></dt>
<dt> </dt>
<dt><span>In 1984 Secretary of State Casper Weinberger reported "Normally harmless, non disease producing organisms could be modified to become highly toxic or produce disease which an opponent has no known treatment or cure." (Soviet Military Power, 1984, p. 73.</span></dt>
<dt> </dt>
<dt><span>Patients are being denied antibiotics for chronic persistent lyme. Doctors who are treating these chronic patients are being investigated and many have already had their licenses removed. Many are told they are malingering...that they either have antibiotic seeking behavior, depression or autoimmune disease.</span></dt>
<dt> </dt>
<dt><span>One could say that Bb is most definitely an excellent candidate as a biological warfare agent. Bb has been shown to pass from mother to fetus. Many feel that it can be sexually transmitted. Why are no studies being done in this area? It has been found in semen, tears, breast milk and other insects in addition to ticks. With lyme disease there is no immunity. One can be infected and reinfected. The disease is responsible for neuropsychiatric problems, marriages are often disrupted and patients are losing their jobs and their homes. Many of our nation's children are being labeled with learning disabilities when the cause is often lyme disease. I am also wondering if vaccines are contaminated with Bb and or mycoplasmas? Is there any way vaccine batches can be independantly studied? Well, there should be , don't you think?</span></dt>
<dt> </dt>
<dt><span>I recieved an abstract the other day put out by Brookhaven National Labs. I am including it below and will let readers come to their own conclusions. It sounds to me as if it is felt that Bb, erlichia and babesia are biological warfare candidates.</span></dt>
<dt> </dt>
<dt><span>Abstract</span></dt>
<dt> </dt>
<dt><span>Grant Number:</span></dt>
<dt><span>1U01AI056480-01</span></dt>
<dt> </dt>
<dt><span>PI Name:</span></dt>
<dt><span>DUNN, JOHN J.</span></dt>
<dt> </dt>
<dt><span>PI Email:</span></dt>
<dt><span><mailto:jdunn bnl.gov="">jdunn@bnl.gov</mailto:jdunn></span></dt>
<dt> </dt>
<dt><span>PI Title:</span></dt>
<dt><span>SENIOR SCIENTIST</span></dt>
<dt> </dt>
<dt><span>Project Title:</span></dt>
<dt><span>Rapid Detection and Identification of Zoonotic Pathogens</span></dt>
<dt> </dt>
<dt><span>Abstract: DESCRIPTION (provided by applicant): Zoonotic pathogens including those transmitted by insect vectors are some of the most deadly of all infectious diseases known to mankind. In the past, wars and natural disasters were the main catalysts that promoted epidemics of these ancient afflictions, which are normally transmitted by fleas, lice and ticks.</span></dt>
<dt> </dt>
<dt><span>Many of these diseases remain endemic in various regions of the world and therefore pose serious threats to U.S. armed forces troops and civilians who might enter endemic disease zones. A number of these agents have been further weaponized and are widely recognized as being the most significant biothreat agents.</span></dt>
<dt> </dt>
<dt><span>Study of disease agents and development of rapid means for their detection take on added importance in light of the use of anthrax for a bioterror attack on the U.S.A. The aim of this proposal is to modify a novel DNA-based methodology we have developed for profiling genomic DNAs to permit rapid, cultivation-free differential detection and identification of biothreat infectious agents in their natural environments, including intermediate infected hosts, and clinical specimens from humans or infected animals.</span></dt>
<dt> </dt>
<dt><span>We plan to use Borrelia burgdorferi, the arthropod-borne etiologic agent of Lyme disease and Yersinia pestis, the etiologic agent of plague, as our principle test agents to work through the systems. We will begin with B. burgdorferi since although it has a complicated life-cycle involving both arthropod and animal intermediates, it is easy to grow and we have extensive experience in working with it in different complex environments including ticks, rodents and human samples.</span></dt>
<dt> </dt>
<dt><span>Thus it gives us the opportunity of detecting this pathogen in a variety of complex environments. We also have significant experience with characterizing and identifying subtle changes in the genome of Y. pestis utilizing genomic signature tags. We will use these methods as the foundation of new, high-throughput sequence-based systems to detect zoonotic and/or vector-borne biothreat agents such as Yersinia pestis, Francisella tularensis, Rickettsia ricketsii and other human pathogens such as Ehrlichia and Babesia species.</span></dt>
<dt> </dt>
<dt><span>This technology can ultimately be adapted as a sensitive method to detect specific DNA signature sequences from both known and unknown pathogens in a wide variety of complex environments and since it is PCR-based it has the advantage that only minimal quantities of starting material are needed for analysis.</span></dt>
<dt> </dt>
<dt><span>Thesaurus Terms:</span></dt>
<dt><span>biohazard detection, communicable disease diagnosis, diagnosis design</span></dt>
<dt><span>/evaluation, genetic technique, high throughput technology, method</span></dt>
<dt><span>development</span></dt>
<dt><span>Borrelia, Yersinia pestis, cooperative study, informatics, molecular</span></dt>
<dt><span>biology information system, nucleic acid sequence</span></dt>
<dt><span>biotechnology, bioterrorism /chemical warfare, clinical research, human</span></dt>
<dt><span>tissue, laboratory mouse, microarray technology</span></dt>
<dt> </dt>
<dt><span>Institution:</span></dt>
<dt><span>BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB</span></dt>
<dt> </dt>
<dt><span>BROOKHAVEN NATIONAL LAB</span></dt>
<dt> </dt>
<dt><span>UPTON, NY 11973</span></dt>
<dt> </dt>
<dt><span>Fiscal Year:</span></dt>
<dt><span>2003</span></dt>
<dt> </dt>
<dt><span>Department:</span></dt>
<dt> </dt>
<dt><span>Project Start:</span></dt>
<dt><span>15-SEP-2003</span></dt>
<dt> </dt>
<dt><span>Project End:</span></dt>
<dt><span>29-FEB-2008</span></dt>
<dt> </dt>
<dt><span>ICD:</span></dt>
<dt><span>NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES</span></dt>
<dt> </dt>
<dt><span>IRG:</span></dt>
<dt><span>ZAI1</span></dt>
<dt> </dt>
<dt> </dt>
<dt> </dt>
<dt><span>It is interesting to note that many of the first outbreaks of these diseases occurred in areas adjacent to military or biological testing facilities such as Plum Island. In fact Erlichia Chaffiensis, one of the tickborne coinfections, is actually named after Fort Chaffi where it was first isolated. The United States has a long history of conducting field experiments on it's own citizens without their knowledge or consent. The U.S. Code, Sec. 50 states it is legal to do so.</span></dt>
<dt> </dt>
<dt><span>When I speak to others concerning the possibility that our country is already being intentionally decimated by several insiduous pathogens, they find it hard to believe that certain officials in our government may be allowing this to happen.</span></dt>
<dt> </dt>
<dt><span>In relation to this concern I would like to include part of an e-mail which was sent to me by one of those government officials. I had written an article concerning the fear mongering surrounding the flu vaccine issue being promoted by The Powers That Be. Someone from the government saw my article and posted it to one of their private lists. A congressman on this list then temporarily added me to this list because they were discussing my article. It was being sarcastically criticized and I responded back to them. The gentleman who had been the most negative with his comments was surprised to find out I had been able to read his comments. Part of his response to me, which follows, is an indication of the mindset of some of our leaders.</span></dt>
<dt> </dt>
<dt><span>He was asking me if I really thought that the article "Manipulation Through Fear...And It's Working" would really wake people up. While he agreed that the press was manipulating us....listen to his other thoughts. "If someone is stupid enough to wait in a 2 hour line for a flu shot or withdraw half of their child's college savings to buy 6 years worth of non perishable food and gas masks for their Y2K bunker, don't you think they deserve it? Perhaps the real question is, why are Americans so stupid and gullible to believe everything we read in the media, or to go further, every piece of forwarded chain e-mail we read spurting off the latest conspiracy theory? The way I see it, it's social Darwinism baby. And the more morons that leave this God forsaken earth, the happier I am. After all, I don't want to be sharing my rations with anyone in my WMD bunker. By the way, I am one of those "Powers that Be" :=) You must infiltrate before you can make the system capitulate."</span></dt>
<dt> </dt>
<dt><span>I wrote back to him briefly expressing my sadness that he must have had many difficulties in life to harden his heart so.</span></dt>
<dt> </dt>
<dt><span>I have spoken to a Red Cross pathologist who admitted that the Red Cross does not screen it's blood supply for Lyme Disease or Mycoplamsa Fermentens. Our Department of Defense knows that these pathogens are spreading through the population. Instead of taking preventative actions our government is actually blocking proper research, education, testing, diagnosis and treatment.</span></dt>
<dt> </dt>
<dt><span>We need to make these institutions accountable for their crimes against humanity.</span></dt>
<dt><span></span> </dt>
<dt><span></span> </dt>
<dt><b><span>COMMENT on Lyme DIsease article--Plum Island Connection</span></b><span></span></dt>
<dt><span>From Bob Anderson</span></dt>
<dt><span>3-20-5</span></dt>
<dt><span></span> </dt>
<dt><span>Hello, Jeff</span></dt>
<dt><span></span> </dt>
<dt><span>This IS interesting, and I have known for some years that "Lyme Disease" is a man-made illness.</span></dt>
<dt><span></span> </dt>
<dt><span>My ex-colleague John Quinn -- who as you may recall wrote a book on the so-called Montauk Project activities at Montauk Air Base on the east end of Long Island New York -- wrote that he was informed UNEQUIVOCALLY by project operative and subsequent whistleblower Preston Nichols that Lyme Disease was DEFINITELY developed by the US government at Plum Island Animal Disease research facility, directly offshore from Montauk in Long Island Sound. Nichols told Quinn that the disease was first engineered in the mid-1960s and was initially released at the Montauk base itself and the surrounding communities. Nichols averred that there was frequent collaboration between the two facilities.</span></dt>
<dt><span></span> </dt>
<dt><span>It is a FACT that the earliest victims of the disease were not in Old Lyme Connecticut but at Montauk. The disease rapidly became fairly widespread by the late 60s among the many farmers and fishermen in the area and was known at the time as "Montauk Knee" -- as it primarily affected major joints such as the knee.</span></dt>
<dt><span></span> </dt>
<dt><span>Even more disturbing: Nichols informed Quinn around 1999 that the Lyme Disease spirochete was a PRIME COMPONENT of the materials being spewed from the aircraft spraying CHEMTRAILS across the length and breadth of the PLANET EARTH!</span></dt>
<dt><span></span> </dt>
<dt><span>Comforting, No?</span></dt>
<dt><span></span> </dt>
<dt><span>Regards,</span></dt>
<dt><span>Bob Anderson<br /></span></dt>
</dl>
</td></tr>
</tbody></table>
</center>
</dt>
</div>
Unknownnoreply@blogger.com2